











This thesis has been submitted in fulfilment of the requirements for a postgraduate degree 
(e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following 
terms and conditions of use: 
• This work is protected by copyright and other intellectual property rights, which are 
retained by the thesis author, unless otherwise stated. 
• A copy can be downloaded for personal non-commercial research or study, without 
prior permission or charge. 
• This thesis cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author. 
• The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author. 
• When referring to this work, full bibliographic details including the author, title, 
awarding institution and date of the thesis must be given. 
 
EPIGENETIC AND CHROMATIN 
REPROGRAMMING IN MOUSE DEVELOPMENT 


















































Contents          a-j 
List of Tables          h-i 
List of Figures         j-l 
Declaration          i 
Abstract          ii 
Publications and communication arising from this thesis   iv 
Acknowledgements         vi 
Abbreviation          ix 
 
Chapter1 General Background 
1.1. Chromatin Structure        2 
1.1.1. Heterochromatin and Euchromatin     4 
1.2. Epigenetics – Definitions       9 
1.3 Histone Modifications and Epigenetics     10 
1.3.1 Histone Acetylation       10 
1.3.2 Histone Phosphorylation      11 
1.3.3 Histone Ubiquitination       11 
1.3.4 Histone Sumoylation       12 
1.3.5 Histone Methylation       13 
1.3.6 Histone Variants       14 
1.3.7 Reading the Histone code      19 
1.3.8 DNA Methylation        21 
1.3.9 Polycomb and Trithorax proteins     22 
1.3.10 Heterochromatin Protein 1 (HP1)     23 
1.4 Chromatin Modification in Mouse Development    24 
1.4.1 Chromatin Modification in Early Germ Cell Development  24 
1.4.2 Chromatin Modification in Oogenesis     25 
1.4.3 Chromatin Modification in Spermatogenesis    26 
1.4.4 Chromatin after Fertilization       31 
1.4.5 Chromatin at Peri-implantation      34 
Contents  Page 
 b
1.5 Genomic Imprinting Controlled by Epigenetics    36 
1.6 Epigenetic Alterations by Reproductive Biotechnology   39 
1.7 Epigenetic Control of Pluripotency and Differentiation   41 
1.8 Manipulation of Epigenetic Reprogramming     45 
1.9 Objectives of the Project       48 
 
Chapter 2 General Materials and Methods 
2.1 Animal and embryo manipulation      51 
2.1.1 Animals         51 
2.1.2 Immature oocyte recovery and in vitro maturation   51 
2.1.3 Zygote collection and culture      52 
2.1.4 Peri/Postimplantation embryo collection    52 
2.2 Cell culture         54 
2.2.1 Primary mouse adult fibroblast culture     54 
2.2.2 Primary mouse embryonic fibroblast (MEF) culture   54 
2.2.3 Embryonic stem cell culture      54 
2.2.4 Isolation of ES-like cell from blastocysts    55 
2.2.5 In vitro differentiation of ES cells     55 
2.2.6 In vitro implantation and blastocyst outgrowth    56 
2.2.7 Cell cryopreservation       56 
2.3 Detection of global epigenetic and chromatin modifications.   57 
2.3.1 Immunofluorescence       57 
2.3.1.1 Immunofluorescence for cell culture  
and whole mount embryo     57 
2.3.1.2 Immunohistofluorescence for postimplantation embryo 58 
2.3.1.3 Antigen retrieval       59 
2.3.1.4 Image Analysis and Software     59 
2.3.1.5 Flow cytometry analysis     60 
2.3.1.6 Positive and negative control for immunofluorescence 61 
2.3.2 Protein electrophoresis       61 
2.3.2.1 Histone extraction (Acid extraction)     61 
2.3.2.2 Whole cell extraction       62 
Contents  Page 
 c
2.3.2.3 Protein concentration measurement     62 
2.3.2.4 Western blot analysis       63 
2.4 Gene expression analysis       66 
2.4.1 Sample preparation for total RNA extraction    66 
2.4.2 Total RNA extraction by RNeasy kit (Qiagen)    66 
2.4.3 Precipitation of embryo mRNA using Pellet Paint® Co-Precipitant 67 
2.4.4 cDNA synthesis        67 
2.4.5 Polymerase Chain Reaction (PCR)      68 
2.4.6 Agarose Gels for DNA Electrophoresis    69 
2.4.7 Real time Quantitative Polymerase Chain Reaction (QPCR)  69 
2.4.8 Quantification strategy in QRT-PCR     70 
2.5 Gene knock-down by siRNA 
2.5.1 Transfection of siRNA into mouse embryonic fibroblast (MEF) cells 74 
2.5.2 Transfection siRNA into ES cells     74 
 
Chapter 3 Dynamic of histone lysine methylations, modifiers and 
satellite sequences in mouse preimplantation embryos  
3.1 Introduction 
3.1.1 Genetic reprogramming in preimplantation embryos   77 
3.1.2 Protein synthesis in preimplantation embryos    78 
3.1.3 Histone methylation in preimplantation embryos   78 
3.1.4 Non-coding RNA and transcript from repetitive element in  
preimplantation embryos.      79 
3.15 Objectives.        81 
3.2 Materials and methods        81 
3.2.1 Experimental design       81 
3.2.2 Comparative and Relative gene expression    81 
3.2.3 Statisrics        86 
3.3 Results          86 
3.3.1 Asymmetry of histone methylation at zygote    86 
3.3.2 Similarly dynamic pattern of H3K9me2 and H3K9me3 but not  
H3K9me1        87 
Contents  Page 
 d
3.3.3 Distinct pattern of H4K20me1, H4K20me2 and H4K20me3  87 
3.3.4 H3K4me3 and H3K27me3      88 
3.3.5 Most histone demethylases but not methyltransferases were detected 
through preimplantation development     89 
3.3.6 Histone demethylation of H3K9 at two-cell stage   89 
3.3.7 Suv4-20h was detected at late preimplantation embryos  90 
3.3.8 The differential expression of histone modifier blastocyst  
compare to ES cell       90 
3.3.9 The expression profile of major satellite and minor satellite    91 
3.4 Discussion         91 
3.4.1 Reprogramming of histone lysine methylation    92 
3.4.2 Repressive histone methylation peaked at the eight cell embryo stage 93 
3.4.3 Function of satellite transcripts in oocytes    93 
 
Chapter 4 Heterochromatin maturation in mouse development and ES 
cells  
4.1 Introduction         114 
4.1.1 Epigenetic regulate heterochromatin formation   114 
4.1.2 Function of heterochromatin markers H4K20me3 and HP1α   115 
4.1.3 Hypothesis        116 
4.2 Materials and Methods        117 
4.2.1 Samples         117 
4.2.2 Experimental design       117 
4.3 Results          118 
4.3.1 Epigenetic signature of mouse somatic heterochromatin  118 
4.3.2 Immature chromatin in preimplantation embryo   118 
4.3.3 Heterochromatin matures post implantation    119 
4.3.4 Dynamic of H4K20me3 and HP1α in ES cell    122 
4.3.5 H4K20me3 was higher associated with cell differentiation in vitro 
implantation than ES cell differentiation    123 
4.3.6 Global heterochromatin shows plasticity in early differentiation 124 
4.3.7 In vitro culture induce maturation of constitutive heterochromatin 124 
Contents  Page 
 e
4.4 Discussion         126 
4.4.1 The difference between ICM and ES cells    127 
4.4.2 Mechanism of heterochromatin maturation    127 
4.4.3 Chromatin and cell differentiation.     128 
4.4.4 Heterochromatin, tissue maturation and aging    129 
 
Chapter 5 Role of histone demethylases in mouse preimplantation 
development 
5.1 Introduction         155 
5.1.1 Histone demethylases       156 
5.1.2 Objectives of the study       156 
5.2 Materials and Methods        158 
5.2.1 Relative gene expression      158 
5.2.2 Isolation of inner cell mass (ICM) and trophectoderm (TE)  158 
5.3 Results          159 
5.3.1 Jmjd2c regulates cell fate during the morula to blastocyst transition 159 
5.3.2 Jmjd2a essential for very early development     160 
5.3.3 Jmjd1a is essential for early development and specific at TE  160 
5.3.4 Preliminary studies of histone methylation in jmjd1a and  
jmjd2a deficient embryos      161 
5.3.5 Zygotic gene expression in Jmjd1a and Jmjd2a deficient embryo 161 
5.4 Discussion         162 
5.4.1 Jmjd2 might control epigenetic asymmetry of parental genome 163 
5.4.2 Histone demethylases and zygotic gene activation   163 
5.4.3 Histone demethylases is important for blastocyst formation  164 
5.4.4 Redundancy or functional difference of Jmjd1 and Jmjd2 family 164 
 
Chapter 6 General Discussions 
6.1 Overview and discussions        178 
6.1.1 The dynamics of heterochromatin markers in preimplantation  
embryos         178 
Contents  Page 
 f
6.1.2 Heterochromatin maturation in postimplantation development  
and in ES cells        179 
6.1.3 The function of H4K20me3 in development    180 
6.1.4 Global epigenetic different between ES cell and inner cell mass 181 
6.1.5 The importance of demethylases in preimplantation development 182 
6.2 Conclusions         183 
6.3 Directions for future research       183 
6.3.1 Chromatin modifications in development embryos   183 
6.3.2 Heterochromatin and pluripotency     184 
6.3.3 Functions of Histone demethylases in developments   184 
6.3.4 Function of histone demethylases in cell reprogramming  185 
 
Bibliography         188 
 
Appendix 1 Detail of Chemicals and Reagents    216 
• Antibodies         216 
• Serum and BSA        216 
• DNA stain and mounting reagents      217 
• Western Blot         217 
• PCR          217 
• Hormones, growth factors and enzymes     217 
• Media          218 
• Chemicals         218 
• siRNA          218 
• Others          219 
• Software         219 
 
Appendix 2 Recipes of Buffer Media and Stock solutions  220 
• Mitomycin C Stock solution       220 
• 10x TBE stock        220 
• Gelatine for extracellular matrix      220 
Contents  Page 
 g
• Fibroblast cell medium       220 
• Mouse embryonic stem cell medium      221 
• Trypsin solution        221 
• Phosphate Buffered Saline (PBS)      221 
• Histone extraction Buffer       222 
• Paraformaldehyde (PFA) 20 % stock solution    222 
• Triton X-100 10 % stock solution      222 
• Tween 20 (5 % stock solution)      223 
• Blocking Solutions        223 
• Cryopreservation medium (2x) (10 ml)     223 
• RIPA buffer (Radioimmunoprecipitation assay)    223 
Contents  Page 
 h
List of Tables 
Table 1.1 Nomenclature of histone modifying enzymes    16 
Table 1.2 Histone methylation, methyltransferases, demethylases and their  
functions in mice        17 
Table 1.3 Differences between male and female gametogenesis   28 
Table1.4 Epigenetic modifiers that are critical for mouse development  
(knock-out mice model)       35 
Table 1.5 Imprinted gense that affect embryo and placental development  38 
Table 1.6 Pluripotency and differentiation defects are caused by epigenetic  
alteration         44 
Table 2.1 Primary antibodies used in the experiments    64 
Table 2.2 Secondary antibodies used in the experiments.    65 
Table 2.3 Primer sequences for PCR       72 
Table 2.4 Primer sequences for QPCR      73 
Table 2.5 siRNA sequences        75 
Table 3.1 Mouse strains that are commonly used to study epigenetics in  
development embryos       86 
Table 4.1 The presence and pattern of heterochromatin markers in development  
and ES cells.        130 
Table 5.1 Summary of histone lysine (K) demethylase (KDM) nomenclature and 
substrate specificity for mice and human     157 
Table 5.2 Effect of siRNA knock down at specific genes on preimplantation 
development.        165 
Table 5.3 Relative gene expression of ICM compare to TE.    166 
Table 5.4 Non-relative gene expression (no normalisation with reference genes)  
of ICM compare to TE        166 
Table 5.5 Relative gene expression of Jmjd2c depletion embryos compare to  
normal embryos.        167 
Table 5.6 Non-relative gene expression (no normalisation with reference genes)  
of Jmjd2c depletion embryos compare to normal embryos.  167 
Table 5.7 Relative gene expression in Jmjd1a deficient two-cell embryos  
compare with control       168 
Contents  Page 
 i
Table 5.8 Non-relative gene expression in Jmjd1a deficient two-cell embryos  
compare with control       168 
Table 5.9 Relative gene expression in Jmjd2a deficient two-cell embryos  
compare with control       169 
Table 5.10 Non-relative gene expression in Jmjd2a deficient two-cell embryos  
compare with control       169 
Table 5.11 Estimated gene expression profile in early implantation embryo  
from published microarray data and qPCR of the present study.  170 
Contents  Page 
 j
List of Figures 
Figure 1.1 Model of nucleosome at 2.8 Å      4 
Figure 1.2 The major structures of chromatin compaction    5 
Figure 1.3 A map of chromosome territory in a human cell.   6 
Figure 1.4 Heterochromatin in mouse fibroblast.     8 
Figure 1.5 Summary of histone modifying enzymes     18 
Figure 1.6 Summary of histone modification binding domains/proteins   20 
Figure 1.7 Diagram of mouse development      29 
Figure 1.8 Epigenetic changes in germ cell development    30 
Figure 1.9 Dynamics of histone methylation in preimplantation development 33 
Figure 2.1 Diagram of embryonic stages collected in this experiment  53 
Figure 3.1 Expression of reference gene Gapdh       83 
Figure 3.2 Model for calculation of Ct value     84 
Figure 3.3 H3K9me1 in preimplantation embryos.     94 
Figure 3.4 H3K9me2 in preimplantation embryos     95 
Figure 3.5 H3K9me3 in preimplantation embryos     96 
Figure 3.6 H4K20me1 in preimplantation embryos     97 
Figure 3.7 H4K20me2 in preimplantation embryos     98 
Figure 3.8 H4K20me3 in preimplantation embryos     99 
Figure 3.9 H3K4me3 in preimplantation embryos.     100 
Figure 3.10 H3K27me3 in preimplantation embryos    101 
Figure 3.11 Semi-quantification of total nuclear fluorescent intensity of  
H3K9me1, H3K9me2 and H3K9me3 in preimplantation embryos 102 
Figure 3.12 Semi-quantification of total nuclear fluorescent intensity of  
H4K20me1 and H4K20me2 in preimplantation embryos  103 
Figure 3.13 Semi-quantification of total nuclear fluorescent intensity of  
H3K4me3 and H3K27me3 in preimplantation embryos   104 
Figure 3.14 Comparative and relative gene expression of Eset, Suv39h1 and  
Suv39h2 in preimplantation embryo     105 
Figure 3.15 Comparative and relative gene expression of Eset, Ehmt2, Suv39h1  
and Suv39h2 in preimplantation embryo     106 
Contents  Page 
 k
Figure 3.16  Comparative and relative gene expression of Jmjd2a and Jmjd2c in 
preimplantation embryo       107 
Figure 3.17 Comparative and relative gene expression of Jmjd1a in  
preimplantation embryo       108 
Figure 3.18 Comparative and relative gene expression of minor and major  
satellite in preimplantation embryo     109 
Figure 3.19 Comparative and relative gene expression of minor and major  
satellite in preimplantation embry     110 
Figure 3.20 Relative gene expressions of Eset, Suv39h1 and Suv39h2  
compared between blastocyst and ES cell.    111 
Figure 3.21 Relative gene expressions of Jmjd1a, Jmjd2a and Jmjd2c  
compared between blastocyst and ES cell.    112 
Figure 4.1 Model for heterochromatin spreading and gene relocation affecting  
gene expression during development and differentiation   131 
Figure 4.2 Experimental designs of the study      132 
Figure 4.3 Heterochromatin markers in somatic cells     133 
Figure 4.4 Immunofluorescence microscopy images of heterochromatin markers  
in pre-implantation embryo nuclei      134 
Figure 4.5 The mRNA level of suv4-20h1 and suv4-20h     135 
Figure 4.6 Immunofluorescence confocal microscopy images of in vitro  
implantation embryos        136 
Figure 4.7 Effect of culturing In vitro implantation embryos cultured for 4 days 137 
Figure 4.8 Immunofluorescence confocal microscopy images of in vivo pre-
implantation and post-implantation embryos     138 
Figure 4.9 H3K9me3, not H4K20me3 and HP1α, was found in early  
postimplantation embryos       139 
Figure 4.10 Immunofluorescence images of post-implantation embryo (E8.5)  
from paraffin section        140 
Figure 4.11 Heterochromatin marker H4K20me3 and HP1α was not detected in  
E8.5 embryos         141 
Figure 4.12 Immunofluorescence microscopy images (H4K20me3) of post-
implantation embryos         142 
Contents  Page 
 l
Figure 4.13 Immunofluorescence microscopy images (HP1α) of post-implantation 
embryos          143 
Figure 4.14 Western blots of post-implantation embryos extract SDS-PAGE 144 
Figure 4.15 Dynamic of H4K20me3 and HP1α in ES cells    145 
Figure 4.16 Correlation between H4K20me3 and Oct4 of in vitro postimplantation 
embryo         146 
Figure 4.17 Correlation between H4K20me3 and Oct4of in vitro ES cell  
differentiation        147 
Figure 4.18 Proteomic profile of epigenetic marker during ES cell differentiation 148 
Figure 4.19 Heterogeneous populations of ES cells     149 
Figure 4.20 ES-like cells (noo01)       150 
Figure 4.21 Immunofluorescence microscopy images of ES cells   151 
Figure 4.22 Western blot of ES cell cultured in medium contained serum  
compare with serum free medium     152 
Figure 4.23 Model for immature heterochromatin in early development   153 
Figure 5.1 Validation siRNA by transfection into ES cells    171 
Figure 5.2 In vitro development of siRNA-injected embryos    172 
Figure 5.3 Loss of H3K9me2 asymmetry in Jmjd1a deficient zygotes   173 
Figure 5.4 Loss of H3K9me3 asymmetry in jmj2a deficient zygotes   174 
Figure 5.5 Loss of H3K9me2 asymmetry in jmjd1a deficient two-cell embryos  175 
Figure 5.6 Loss of H3K9me3 asymmetry in jmjd2a deficient two-cell embryos  176 
Figure 6.1 Model for removal of heterochromatin markers     186 
Figure 6.2 Summary of the differences between inner cell mass (ICM)  






I declare that this thesis has been composed by myself and has not been submitted for 
any previous degree. The work described herein is my own and all work of other 
authors is duly acknowledged. I also acknowledge all assistance given to me during the 
course of these studies 
 
 
        Tuempong Wongtawan 
 ii
ABSTRACT 
It is well established that epigenetics and chromatin modifications are important factors 
that can govern gene activity and nuclear architecture. They are also proven to be 
essential for normal embryonic development and cell differentiation. One important 
event during mouse development is the establishment of epigenetic reprogramming 
which is believed to be essential for normal growth and development, however; the 
mechanism is still poorly understood. The general objective of this PhD study was to 
investigate the profiles and mechanisms of epigenetic and chromatin modifications 
during normal mouse development and in embryonic stem cells. Mouse pre- and post-
implantation embryos and ES cells were used in experiments employing a range of 
different methodologies. The dynamics of epigenetic DNA and histone methylation 
were captured using laser confocal immunofluorescent microscopy and western 
blotting. The activity of epigenetic modifiers was monitored by real-time PCR and 
candidate genes were validated using siRNA technology. The present studies 
demonstrate that heterochromatin markers H3K9me3, H3K9me2, H4K20me2, 
H4K20me3, HP1α and HP1β are reprogrammed during early development. 
Demethylation of H3K9me2, H3K9me3 and H4K20me3 took place at two-cell stage 
and remethylation occurred at four-cell stage except for H4K20me3. The 
reestablishment of H4K20me3 was initially observed in early postimplantation embryos 
in extraembryonic tissue, specifically in the mural trophectoderm. In embryonic tissue, 
H4K20me3 was not clearly detected until in mid to late postimplantation development. 
The mechanism of H3K9me2 and H3K9me3 demethylation might be due to either an 
imbalance of epigenetic modifiers or the presence of Jmjd2a and Jmjd1a histone 
demethylase postfertilisation. We have also report evidence that HP1α and Suv4-20h 
are required in heterochromatin before the recruitment of H4K20me3 during mouse 
development and in ES cells. Therefore H4K20me3 removal was believed to involve 
the lack of prerequisite heterochromatin complexes such as HP1α and Suv4-20h 
enzymes. Furthermore, the presence and levels of H4K20me3 and HP1α might be 
strongly associated with cell differentiation and tissue maturation in mouse in vivo 
development but not in vitro early differentiated ES cells. Surprisingly, the results 
showed that chromatin modifications and their modifiers in ES cells are different from 
 iii
ICM and epiblast. Chromatin modifications H4K20me3 and HP1α were absent from 
ICM and epiblast, but were detected in ES cells. Notably, H4K20me3 and HP1α were 
established after early incubation of ICM into ES cell medium, but this change was not 
dependent on the presence of serum and leukaemia inhibiting factor. Epigenetic 
modifier Jmjd2a but not Jmjd1a was found in ICM. Conversely, Jmjd1a is highly 
expressed in ES cells while Jmjd2a was inactivated. In addition, the present studies 
revealed the substantial role of histone demethylases in development, as it may be 
important for epigenetic reprogramming. The results demonstrated that inhibition of 
demethylase Jmjd2a and Jmjd1a caused preimplantation embryos to arrest at the two-
cell stage while Jmjd2c deficient embryos failed to reach blastocyst. Thus it is possible 
that Jmjd2a and Jmjd1a were essential for epigenetic reprogramming while Jmjd2c is 
critical for cell fate establishment during blastocyst formation. In conclusion, the global 
chromatin signature in ES cells differs from ICM and epiblast; heterochromatin 
reprogramming occurs at two-cell stage; maturation of heterochromatin occurs at 
postimplantation; and histone demethylases Jmjd1a, Jmjd2a and Jmjd2c are important 
in preimplantation development. Results from the present studies could provide crucial 
information for developmental biology and stem cell research, and provide as a model 
for improvement of reproductive biotechnologies such as somatic cell reprogramming, 
and diagnosis of epigenetic abnormalities in early development.  
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Nanog    Nanog homeobox 
NTFI    Nuclear total fluorescent intensity 
Oct4    Octamer-4 
PBS    Phosphate Buffer Saline 
PFA    Paraformaldehide 
PMSG    Pregant Mare Serum Gonadotrophin 
PCR    Polymerase chain reaction 
Pol    Polymerase 
PcG    Polycomb group protiens 
QPCR    Quantitative polymerase chain reaction 
REF    Reference gene 
RT    Reverse transcriptase 
RNA    Ribonucleic acid 
RNAi    RNA interference  
siRNA    Small interference RNA 
Sox2    SRY (sex determining region Y)-box 2 
Suv    Suppressor of variegation 
SINE    Short interspersed repetitive 
SUMO    Small ubiquitin-related modifier 
TE    Trophectoderm 
TRG    Targeted gene 
 xi
TrxG    Trithorax group proteins 
TRITC    Tetramethyl Rhodamine Iso-Thiocyanate 
TDMs    Tissue-specific differentially methylated regions 
Xi    Inactive X-chromosome 
XIST    X-inactive specific transcript 
ZGA    Zygotic gene activation 
 












1.1 Chromatin Structure  
DNA and histones are the major components of chromatin in the eukaryotic nucleus. 
The DNA helix is wrapped around core histones to form a “beads-on-a-string” structure 
of around 11 nm thickness, of which the basic subunit is called the nucleosome (Figure 
1.1) (Felsenfeld and Groudine, 2003, Lewin, 2004). The histone core contains two types 
of complexes, a tetramer formed by two pairs of histone 3 and histone 4 (H32-H42) and 
two dimers of histone 2A and 2B (Figure1.1). Chromatin also contains various non-
histone proteins that are required for its assembly and packaging, DNA replication, 
chromatin modification, gene transcription, and DNA repair and recombination 
(Felsenfeld and Groudine, 2003, Lewin, 2004, Tremethick, 2007). The secondary 
structure of chromatin organisation involves a coiling of the array of nucleosomes into a 
superhelical type of fibre of 30 nm thickness (Figure 1.2). Each nucleosome is 
connected to its neighbours by a short segment of linker DNA (approximately 10–80 bp 
in length) associated with linker histone H1 (Figure 1.2). Finally, the 30 nm chromatin 
fibre undergoes further levels of packing to form an entire chromosome (Figure 1.2) 
(Felsenfeld and Groudine, 2003, Lewin, 2004, Tremethick, 2007). 
The largest unit of organisation of eukaryotic chromatin is the chromosome. Each 
chromosome maintains itself individually during the cell cycle and occupies a spatially 
limited volume, known as a chromosome territory (Bolzer et al., 2005). Each 
chromosome has a preferred position relative to the centre or periphery of the nucleus, 
(Figure 1.3) (Fraser and Bickmore, 2007, Bolzer et al., 2005). Chromosome territories 
are not random, they vary between cell types, and this has an effect on chromosome 
interactions in trans with other parts of the genome (Meaburn and Misteli, 2007, Bolzer 
et al., 2005). The positional organisation of chromosomes within the nucleus could 
influence other aspects of genome function, in particular the regulation of gene 
expression (Fraser and Bickmore, 2007, Meaburn and Misteli, 2007). Concurrently with 
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transcriptional activation, some genes can relocate a substantial distance outside of their 
chromosome territory, for example the Hox gene cluster (Mahy et al., 2002, 
Chambeyron and Bickmore, 2004). Conversely, gene repression in the inactivated X-
chromosome happens within a chromosome territory; this phenomenon is associated 
with Xist RNA that coats the chromosome which will be inactive excluding Pol II from 
the compartment that comprises the X-chromosome territory (Chaumeil et al., 2006). 
The nucleosome exhibits at least three dynamic properties in vivo: composition 
alteration, covalent modification and translational repositioning. First, the composition 
alteration is achieved by the exchange between histone variants and canonical histones. 
For example, remodelling complexes of the SWR1 family can remove the canonical 
H2A-H2B dimers and replace them with histone variant H2A.Z-H2B dimers, forming a 
nucleosome with unique tails that might bind particular regulatory proteins to promote 
gene activation (Saha et al., 2006, Henikoff and Ahmad, 2005). Secondly, nucleosomes 
can be covalently modified, for example by acetylation on lysine residues in their N-
amino-terminal tails that extend from the octamer core (Saha et al., 2006, Cheung et al., 
2000). The acetylation of histones removes the positive charge that resides on the NH+ 
group; this neutralisation of the overall positive charge of protein reduces interactions 
with DNA phosphates. This may alter chromatin structure and contribute to the DNA 
becoming more accessible to the transcription machinery (Henikoff, 2005, Wade et al., 
1997). Thirdly, nucleosomes can be repositioned or evicted by chromatin remodelers to 
provide regulated access to DNA sequences (Saha et al., 2006, Li et al., 2007). The 
repositioning and eviction are important for many chromatin functions: to properly 
space chromatin during chromatin assembly, to enable the ordered access of 
transcription factors to specific genes during transcription, and to regulate the access of 
DNA-repair factors to chromatin lesions (Saha et al., 2006, Li et al., 2007).  












Figure 1.1 Model of nucleosome at 2.8 Å, (Left) the crystal structure and (Right) a 
schematic image of nucleosome core particle. The nucleosome contains the DNA helix 
(black line) wrapped around a tetramer of Histone H3 (dark blue) and H4 (light blue) 
followed by a dimer of Histone H2A (yellow) and a dimer of Histone H2B (gold). 
(Images are modified from Allis et al., 2006).  





Figure 1.2 The major structures of chromatin compaction. DNA, the nucleosome, 
the 10nm "beads-on-a-string" fibre, the 30nm fibre and the metaphase chromosome 
(Images are modified from Felsenfeld and Groudine, 2003) 






Figure 1.3 A map of chromosome territories in a human cell nucleus. Human cells 
have 24 chromosome pairs and each chromosome has its own nuclear location 
represented by a different colour. Numbers 1-22, X and Y are chromosome names.(1-
21, X and Y) (Images are modified from Bolzer et al., 2005) 
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1.1.1 Heterochromatin and Euchromatin 
Generally, chromatin is not uniform with regards to gene distribution, architecture, 
replication timing and transcriptional activity; instead it is divided into two distinct 
domains, heterochromatin and euchromatin (Figure 1.4) (Grewal and Jia, 2007, Dillon, 
2004). Euchromatin describes regions within the weakly stained nuclear area in which 
chromatin is decondensed during interphase and contains actively transcribed genes 
(Grewal and Jia, 2007, Dillon, 2004). Heterochromatin is defined as regions that remain 
densely stained nuclear area and highly condensed throughout the cell cycle and largely 
consists of trancriptionally silenced elements. Heterochromatin can be specifically 
subdivided into constitutive and facultative heterochromatin (Grewal and Jia, 2007, 
Dillon, 2004). 
Constitutive heterochromatin describes the highly condensed regions of the genome that 
are visible as bright nuclear speckles after staining with DNA dyes such as 4',6-
diamidino-2-phenylindole (DAPI) or Hoechst (Figure 1.4A) (Kobayakawa et al., 2007, 
Martin et al., 2006). These regions often comprise repetitive DNA (such as satellite 
sequences surrounding centromeres) and non-coding regions. Such areas can exert a 
strong repressive effect on gene transcription, particularly when a gene is inserted 
within or close to heterochromatin (Lewin, 2004, Grewal and Jia, 2007). 
Facultative heterochromatin describes a previously permissive chromatin that is 
transformed to transcriptional silent chromatin (Lewin, 2004). However, the precise 
property of facultative heterochromatin has not been fully defined, and different genes 
might employ a variety of silencing mechanisms. Unlike constitutive heterochromatin, 
facultative heterochromatin often can not be visualised. One notable exception is the 
formation of the Barr body on the inactivated X-chromosome in female mammalian 
cells, which is visible as a distinct DNA-dense structure often located close to the 
nuclear periphery (Lucchesi et al., 2005). 





Figure 1.4 Heterochromatin in a mouse fibroblast cell. (A) The nucleus of a mouse 
fibroblast is stained with DAPI (blue), bright blue dense speckles represent constitutive 
heterochromatin (Original image by Tuempong Wongtawan). (B) Model of a 
chromosome showing the separation into heterochromatin (orange) and euchromatin 
(blue) (Image is modified from original image on David Ussery’s website 
http://www.cbs.dtu.dk/dtucourse/cookbooks/dave/Chromosome-anat.html).  
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1.2 Epigenetics - Definitions 
Historically, the word “epigenetics” was coined by C. H. Waddington in 1942 as a 
portmanteau of the words “genetics” and “epigenesis”. Originally the term epigenetics 
was defined as “the interactions of genes with their environment that bring the 
phenotype into being” (Waddington, 1942). Epigenetics could be regarded as 
Waddington's model of how genes within a multicellular organism interact with their 
environment to produce a phenotype, because all cells within an organism inherit the 
same DNA sequences. However at the time when Waddington first used the term 
“epigenetics”, the physical nature of genes and their role in heredity was unknown 
(Waddington, 1942, Goldberg et al., 2007).  
Presently, epigenetics generally means “the study of heritable changes in genome 
function that occur without an alteration in DNA sequence” (Goldberg et al., 2007, 
Bird, 2007). This may include the study of inherited gene expression from one cell to its 
descendants, alteration of gene expression during cell differentiation, and how 
environmental factors can induce the change of gene activities (The-Epigenome-
Network-of-Excellence, 2009). There are many implications of epigenetic research for 
agriculture and for human biology and disease, which bear on our understanding of 
stem cells, cancer, development and ageing (Laird, 2005, Roloff and Nuber, 2005, 
Srebro, 1993). 
Epigenetic modifications can be subdivided into four major categories, most of which 
are interdependent. First is the modification of DNA called DNA methylation which 
occurs at cytosine residues in CpG dinucleotides. It is usually associated with gene 
regulation by transcriptional silencing (Bird, 2002). Second are the modifications of 
core histones, in particular methylation of specific residues in the histone tails. This 
modification can have either an active or repressive effect on transcription (Kimura et 
al., 2005, Shilatifard, 2006). Third, variant histones such as protamines or macro-H2A 
have been shown to correlate with epigenetic states in the mouse. The dynamic 
exchange of histones and histone variants in chromatin may correlate with the 
transcriptional status of a given locus (Henikoff and Ahmad, 2005). Finally, the 
Polycomb (PcG)and Trithorax (TrxG) group of proteins is considered to be one of the 
General Background  Chapter 1 
 10
classical epigenetic systems (Bird, 2007), as they work by maintaining the repression or 
activation of developmentally important genes (Ringrose and Paro, 2004).  
 
1.3 Histone Modifications and Epigenetics 
Histone N-terminal tails and to lesser extent C-terminal tails and globular domains can 
be modified at many sites; there are more than 60 different residues on histone tails 
where modifications have been detected (Kouzarides, 2007). Histones are diversely 
modified by acetylation, methylation, phosphorylation, sumoylation and ubiquitination 
(Kouzarides, 2007). Histone modifications are summarised in Figure 1.5. The new and 
former nomenclature of histone modifying enzymes is shown in Table 1.5. 
1.3.1 Histone Acetylation 
Acetylation occurs at lysine residues in the amino-terminal tails of the histones, which 
results in  neutralisation of the positive charge of the histones decreasing their affinity 
for DNA (Bhaumik et al., 2007). The acetylation may alter the nucleosomal 
conformation and lead to a chromatin architectural change renders chromosomal 
domains more accessible. In addition, histone acetylation acts to recruit regulatory 
proteins that carry bromodomains, which bind histone acetyl groups. Consequently, the 
transcription machinery including RNA polymerase II, SRC1, GCn5/PCAF and 
CBP/p300 may be attracted and be able to access promoters and hence initiate gene 
transcription (Bhaumik et al., 2007).  
Histone acetylation is very dynamic, and is regulated by histone acetyltransferases 
(HATs) and histone deacetylases (HDACs). Acetylation of histones induces 
transcriptional activation whereas deacetylation leads to transcriptional repression. 
HATs may work as co-activators of transcription while HDACs work as repressors and 
can be associated with DNA methylation and repressive histone methylation (Kimura et 
al., 2005). Moreover, histone acetylation is not only at the core of transcriptional 
regulation but also seems to influence other processes such as chromatin replication, 
site-specific recombination and DNA repair (Wolffe and Hayes, 1999, Roth et al., 2001) 
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Histone acetylation may also act as a biological switch allowing inter-conversion 
between permissive and repressive chromatin structures and domains. Although both 
global and local histone acetylations are necessary for transcription, they are insufficient 
to establish fully accessible chromatin (Eberharter and Becker, 2002). The switch to a 
permissive chromatin structure requires the recruitment of nucleosome remodelling 
complexes of the SWI2/SNF2 family that contain ATPase, which can weaken histone–
DNA interactions resulting in histone relocation (Fry and Peterson, 2001). On the 
contrary, the switchback to repressive chromatin involves histone deacetylation, which 
promotes the condensation of the nucleosomal fibre and invites repressive factors such 
as histone methylation, DNA methylation and heterochromatin associated proteins 
(Eberharter and Becker, 2002). 
1.3.2 Histone Phosphorylation 
Phosphorylation of histones often occurs at specific sites during cell division and 
follows spatial and temporal patterns. For example, histone H3 phosphorylation in 
different organisms is commonly found in metaphase chromosomes, but after exit of 
mitosis/meiosis a global dephosphorylation of H3 is observed  (Barber et al., 2004, 
Hans and Dimitrov, 2001). Moreover phosphorylation of serine 10 in histone H3 has 
been shown to correlate with gene activation in mammalian cells of for example c-fos 
and c-jun (Nowak and Corces, 2004), but the mechanism by which phosphorylation 
contributes to transcriptional activation remains uncertain. One simple explanation 
might be that addition of negatively charged phosphate groups to histone tails probably 
neutralises their basic charge and reduces their affinity for DNA (Grant, 2001). 
Furthermore, phosphorylation of histone H2A is also known to occur after activation of 
DNA-damage signalling pathways; this suggests that phosphorylation may mediate an 
alteration of chromatin structure, which in turn facilitates DNA repair (Foster and 
Downs, 2005). 
1.3.3 Histone Ubiquitination  
Ubiquitin (Ub) is a 76-amino acid protein that is ubiquitously distributed and highly 
conserved amongst eukaryotic organisms. Ubiquitination can be mono or poly-Ub on 
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lysine residues (Bhaumik et al., 2007, Weake and Workman, 2008). It has been found to 
be associated with numerous processes including protein degradation, DNA repair, cell-
cycle control, stress response, cell differentiation, ribosome biogenesis, peroxisome 
biogenesis, viral infection, neural/muscular degeneration and transcription (Jason et al., 
2002, Finley and Chau, 1991, Jennissen, 1995) 
Histone ubiquitination is reversible; the levels are determined by the availability of free 
ubiquitin and enzymatic activities involved in adding or removing the ubiquitin moiety 
from histones. Addition of a ubiquitin moiety to a protein involves the sequential action 
of E1, E2, and E3 enzymes whereas deubiquintination is performed by a class of thiol 
proteases known as ubiquitin-specific proteases (USPs in mammals) (Weake and 
Workman, 2008, Nijman et al., 2005). Ubiquitinated H2A and H2B (ubH2A and 
ubH2B) are the most abundant ubiquitin conjugates in higher eukaryotes (Jason et al., 
2002). In mammals, the H2A is conjugated to only a single ubiquitin (rather than being 
polyubiquitinated) at lysine 119 and H2B at lysine 120 in mammals (Osley, 2006). H2B 
ubiquitination is involved in the DNA repair and protein degradation pathways, and 
gene regulation; the mechanisms for these may be induced by the cross-talk with other 
histone modifications  (Weake and Workman, 2008, Bhaumik et al., 2007, Jason et al., 
2002). In humans, H2A ubiquitination is mediated by at least two different E3 ubiquitin 
ligases, Ring1B and 2A-HUB, both of which are associated with transcriptional 
silencing (Wang et al., 2004, Zhou et al., 2008b, Cao et al., 2005) and DNA damage 
(Zhou et al., 2008a). Recent work in mammalian cells indicates that H2A.Z is mono-
ubiquitinated (ubH2A.Z) at lysine 120 or lysine 121, and enriched on the inactive X 
chromosome (Xi) in female cells, but unmodified H2A.Z is excluded from this 
chromosome (Sarcinella et al., 2007)  
1.3.4 Histone Sumoylation 
Small ubiquitin-related modifier (SUMO) is a member of the ubiquitin-like protein 
family involved in post-translational modifications. In mammals, there are three 
members of the SUMO protein family: SUMO-1, SUMO-2 (SMT3a), and SUMO-3 
(SMT3b) (Melchior, 2000). SUMO is covalently attached to other proteins through the 
activities of an enzyme cascade (E1–E2–E3) similar to ubiquitination (Nathan et al., 
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2003) and involves protein-protein interactions, inhibition of ubiquitin-mediated 
degradation and transcriptional repression (Park-Sarge and Sarge, 2009, Shiio and 
Eisenman, 2003). Moreover, protein sumoylation has also been particularly well 
characterised as a regulator of many nuclear processes and nuclear structure (Park-Sarge 
and Sarge, 2009).  
Amongst the four major core histones, only histone H4 is currently found to be 
efficiently modified by both SUMO-1 or SUMO-3, and the N-terminal tail is a target for 
SUMO moieties (Shiio and Eisenman, 2003). This modified region is the same as that 
targeted by other histone modifications, suggesting that cross-talk between sumoylation 
and other histone modifications may occur. The mediation of transcriptional repression 
by sumoylation of H4 has been found to occur through recruitment of histone 
deacetylases and heterochromatin protein 1 (HP1) (Shiio and Eisenman, 2003).  
1.3.5 Histone Methylation 
Unlike other histone modifications that are dynamic, histone methylations appear to be 
more stable modifications. They are maintained through cell division and only some 
demethylases have been discovered, which qualifies histone methylation as a true 
epigenetic mark. Methylation of histones can occur on lysine (K) or arginine (R) 
residues by histone methyltransferases (HMTs). Conversely, demethylases work in the 
opposite way, as they remove methyl groups from these residues. A summary of histone 
methylation and the enzymes involved is shown in Table 1.1. 
Histone lysine residues can be mono-(me), di-(me2), or tri-methylated (me3), and this 
has a decisive influence on gene and chromatin functions (Li et al., 2007). For instance, 
H3K9me3 represses gene transcription and can form constitutive heterochromatin while 
H3K9me2 represses genes in euchromatin and forms facultative heterochromatin 
(Lachner and Jenuwein, 2002). Modifications of histone lysine can act as either 
repressive or active marks. For example, methylations of H3K4, H3K36 and H3K79 
have been highly correlated with transcriptional activation, whereas methylations of 
H3K9, H3K27 and H4K20 are associated with repressive chromatin states (Vakoc et al., 
2006, Sims et al., 2006, Kourmouli et al., 2005, Schotta et al., 2004, Peters et al., 2003, 
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Brinkman et al., 2006). A combination of histone lysine modifications can occur; this 
system can separate chromatin or the chromosome into different areas. For instance, 
H3K27me3 combines with H3K9me2 and H4K20me1 to organise chromatin into 
facultative heterochromatin, such as the imprinted regions of the inactive X 
chromosome, whereas H3K9me3, H4K20me3 and H3K27me1 together lead chromatin 
to form constitutive heterochromatin (Vakoc et al., 2006, Sims et al., 2006, Kourmouli 
et al., 2005, Schotta et al., 2004, Peters et al., 2003, Brinkman et al., 2006).  
Recently, the methylation of lysine 20 on histone H4 (H4K20) has received more 
attention. Although H4K20me was discovered more than four decades ago, the 
biological role of this modification has remained a mystery (Murray, 1964). The HMTs 
responsible for H4K20 have been recently discovered (SetD8 and Suv4-20h), but the 
demethylase has not been identified (Schotta et al., 2004, Yin et al., 2005). This 
possibly makes the H4K20 mark more stable than other histone modifications. Previous 
studies strongly suggest that H4K20 methylation and their HMTs are involved in many 
important DNA-associated processes such as transcriptional silencing, higher order 
chromatin structure, cell differentiation, genomic stability, cell division, cancer and 
imprinted genes (Martens et al., 2005, Schotta et al., 2004, Brinkman et al., 2006, 
Pogribny et al., 2006, Sanders et al., 2004).  
Methylation of histone arginine residues by arginine methyltransferases (PRMTs) has 
been found to play a significant role in gene regulation. Histone arginine methylation 
can be transcriptionally activating (Chen et al., 1999) or repressive (Pal et al., 2004) 
depending on the target residue, and on whether the methylation is symmetric or 
asymmetric. In mammals, PRMT1- and CARM1-catalysed histone asymmetric histone 
dimethylation at arginine is involved in gene activation (Chen et al., 1999) while 
PRMT5-catalyzed symmetric histone dimethylated arginine is associated with gene 
repression (Pal et al., 2004).  
1.3.6 Histone Variants 
In the past few years, histone variants and their special associated mechanisms have 
been shown to play important roles in chromatin organisation and epigenetic 
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maintenance. Many variant histones can be seen as polymorphisms of the major 
canonical form and just assembled into chromatin (Henikoff and Ahmad, 2005). 
However, other variants are distinct from the canonical form, either in mechanism or 
function (Henikoff and Ahmad, 2005). The centromeric chromatin protein named 
CENP-A has been found to be an H3 variant, and it is vital for chromosome segregation 
and centromeric heterochromatin formation (Palmer et al., 1991). Histone H3.3 is 
similar to canonical H3 and is enriched in active chromatin: it can also be methylated 
and is correlated with active transcription (McKittrick et al., 2004, Hendzel and Davie, 
1990). One study of H2AZ genetically altered mice showed that embryos die during 
implantation, suggesting that it has a critical role in early development (Faast et al., 
2001). Moreover, H2AZ has been found in heterochromatin and it can interact with 
HP1α (Fan et al., 2004). H2AX phosphorylation has been demonstrated to have a role in 
DNA repair, cell cycle checkpoints, regulated gene recombination events, and tumour 
suppression (Fernandez-Capetillo et al., 2004). Furthermore, MacroH2A is enriched in 
regions of the mammalian inactive X chromosome that is associated with facultative 
heterochromatin, Xist RNA and H3K27me3 (Chadwick and Willard, 2004, Chadwick 
and Willard, 2001). 
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Table 1.1 Nomenclature of histone modifying enzymes (Allis et al., 2007) 
New Name Old Name  New Name Old Name  New Name Old Name 
KDM1 LSD1/BHC110  KMT1    KAT1 HAT1 
KDM2    KMT1A SUV39H1  KAT2   
KDM2A JHDM1a/FBXL11  KMT1B SUV39H2  KAT2A hGCN5 
KDM2B JHDM1b/FBXL10  KMT1C G9a  KAT2B PCAF 
KDM3A JHDM2a  KMT1D EuHMTase/GLP  KAT3   
KDM3B JHDM2b  KMT1E ESET/SETDB1  KAT3A CBP 
KDM4    KMT1F CLL8  KAT3B P300 












KDM5    KMT2D MLL4  KAT6B MORF/MYST4 
KDM5A JARID1A/RBP2  KMT2E MLL5  KAT7 HBO1/MYST2 
KDM5B JARID1B/PLU-1  KMT2F hSET1A  KAT8 HMOF/MYST1
KDM5C JARID1C/SMCX  KMT2G hSET1B  KAT9 ELP3 
KDM5D JARID1D/SMCY  KMT2H ASH1  KAT10   
KDM6A UTX  KMT3    KAT11   
KDM6B JMJD3  KMT3A SET2  KAT12 TFIIIC90 
   KMT3B NSD1  KAT13A SRC1 
   KMT3C SYMD2  KAT13B ACTR 
   KMT4 DOT1L  KAT13C P160 
   KMT5    KAT13D CLOCK 
   KMT5A Pr-SET7/8    
   KMT5B SUV4-20H1    
   KMT5C SUV4-20H2    
   KMT6 EZH2    
   KMT7 SET7/9    
   KMT8 RIZ1    
KDM: Lysine (K) demethylase,; KMT: lysine (K) methyltransferase; KAT: lysine (K) acetyltransferase
General Background  Chapter 1 
 17
Table 1.2 Histone methylation, methyltransferases, demethylases and their functions in 
mice (Allis et al., 2007, Lall, 2007, Li et al., 2007, Bhaumik et al., 2007, The-UniProt-
Consortium, 2008, Kouzarides, 2007, Hemberger, 2007, Vakoc et al., 2006, Wagschal 
et al., 2008, Schotta et al., 2008)  
Modification HMTase Demethylase Functions 














Heterochromatin formation  
Imprinted gene 
H3K4me1 MLL3, MLL2, MLL4, 
MLL5, Set1A, Set1B, 
ASH1 
LSD1, JARID1B Transcriptional activation 
H3K4me2 MLL3, MLL2, MLL4, 





H3K4me3 MLL3, MLL2, MLL4, 





H3K27me1 Ezh2  Heterochromatin formation 
H3K27me2 Ezh2 UTX Transcriptional repression 
H3K27me3 Ezh2 UTX, JMJD3 Transcriptional repression 
X-inactivation 
Imprinted gene 
H4K20me1 SetD8  Transcriptional repression, 
elongation 
H4K20me2 Suv420h1, Suv420h2  Transcriptional repression 
H4K20me3 Suv420h1, Suv420h2  Heterochromatin formation 
Imprinted gene 
H3K36me1  Smyd2 JHDM1a, JHDM1b Transcriptional elongation 
H3K36me2 Smyd2, NSD1 JHDM1a, JHDM1b, 
JMJD2a, JMJD2c 
Transcriptional elongation 
H3K36me3 Setd2, NSD1 JMJD2a, JMJD2c Transcriptional activation 
H3K79me1 Dot1L  Transcriptional activation 
H3K79me2 Dot1L  Transcriptional activation 
H3K79me3 Dot1L  Transcriptional repression, 
heterochromatin 
 




Figure 1.5 Summary of histone modifying enzymes. KAT, KMT and KDM are new 
nomenclature (see former name in Table 1.5). “h” represents human, “sc” represents S. 
cerevisiae (Image is modified from www.abcam.com ). 
General Background  Chapter 1 
 19
1.3.7 Reading the Histone Code 
It has been proven that the post-translational modified histones serve as selective 
binding platforms for specific regulatory proteins that drive distinct nuclear processes. It 
is interesting that a simple and very small chemical modification on a comparatively 
huge histone can make such a dramatic difference in specific nuclear functions (Turner, 
2000, Jenuwein and Allis, 2001). Recent findings indicate that certain evolutionarily 
conserved domains found within specific regulatory proteins possess the ability to 
selectively bind a certain histone modification with very high affinity, meaning that 
specific regulatory proteins can read the histone code to initiate DNA-template 
programs (Turner, 2000, Jenuwein and Allis, 2001). Many domains and proteins have 
been found to specifically recognise histone modifications (Lall, 2007) (summarised in 
Figure 1.6), for example, the bromodomain, a conserved motif found within many 
transcription factors, binds to acetylated lysine residues on histone H3 and/or H4 
(Loyola and Almouzni, 2004). This specific binding may result in the initiation, 
stabilisation and enhancing of the transcriptional machinery at the target regions 
(Loyola and Almouzni, 2004). By contrast, regions containing hypoacethylated histones 
are unable to effectively bind these transcription factors resulting in transcriptional 
inactivation of the target region (Loyola and Almouzni, 2004, Grewal and Jia, 2007). 
Notably, inactive regions also contain modified histones which are likely serve to 
maintain this inactivated state. For instance, the methylation of histone H3 on lysine 
residue 9 (H3K9) and H4 on lysine 20 (H4K20) are shown to occur specifically in 
inactivated chromatin (also known as heterochromatin) (Grewal and Jia, 2007). It was 
shown that methylated H3 K9 can recruit and bind a transcriptionally repressor protein, 
heterochromatin protein 1 (HP1), via its evolutionarily conserved chromodomain 
(LeRoy et al., 2009, Grewal and Jia, 2007). This interaction could lead to the structural 
formation of compacted chromatin that physically inhibits the access of the 
transcriptional machinery to the underlying DNA (Grewal and Jia, 2007). 
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Domain Binding protien Histone modification 
 
 
Figure 1.6 Summary of histone modification binding domains/proteins (modified from 
www.abcam.com). 
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1.3.8 DNA Methylation  
DNA methylation is associated with chromatin structure and transcriptional repression 
and occurs mainly at the fifth position of cytosine (5mC) in the dinucleotide CpG. In 
humans CpGs occupy about 1% of the genome and more than 70% of CpGs are 
methylated (Ehrlich et al., 1982). Some localised areas of the genome contain a high 
frequency of CG dinucleotides called CpG islands which are typically 300-3000 base 
pairs in length (Fatemi et al., 2005). They correspond to approximately 40% of 
promoters in mammals (Fatemi et al., 2005) and about 70% in humans (Saxonov et al., 
2006). CpG islands are usually non-methylated in genes except imprinted genes, the 
female X chromosome, germ line specific genes and tissue specific genes (Bird, 1986). 
In mouse, approximately 5% of CpG islands are tissue-specific differentially methylated 
regions (TDMs). The expression of genes associated with these regions is correlated 
with methylation status (Song et al., 2005). The majority of the TDMs appear to be 
associated with 5′ promoter CpG islands and may have important roles in establishing 
or maintaining gene silencing during or after tissue differentiation (Song et al., 2005). 
Notably, the majority of DNA methylation occurs in repetitive sequences which make 
up approximately 40% of the mammalian genome (Goodier and Kazazian, 2008, Yoder 
et al., 1997). The role of DNA methylation may be to inactivate repetitive sequences 
such as transposable element to maintain genomic stability (Goodier and Kazazian, 
2008). 
Several hypotheses have been proposed to explain the mechanism of gene regulation by 
DNA methylation. The first possibility is that DNA methylation prohibits the binding of 
CpG specific transcription factors to promoters (Tate and Bird, 1993). Second, the DNA 
methylation may alter nucleosome structure so that gene silencers may bind more 
effectively to the promoter than the transcription machinery (Kass et al., 1997). The 
third possibility is that DNA methylation may recruit specific factors that prevent the 
binding of transcription factors (Lewis et al., 1992). In mammalian cells, DNA 
methylation is maintained and established by three DNA methyltransferases (Dnmt). 
Dnmt1 has a high affinity for hemi-methylated DNA rather than unmethylated DNA; 
this enzyme is critical for the maintenance of DNA methylation after DNA replication 
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(Bird, 2002). Dnmt1 is expressed in ES cells and all somatic cells, except in oocyte 
where Dnmt1o, oocyte specific form is active and essential for maintenance imprints 
during early development (Latham et al., 2008). Dnmt2 is not essential for DNA 
methylation and mice development; however, it has been reported that Dnmt2 is an 
RNA methyltransferase with specificity for aspartic acid tRNA (Goll et al., 2006).  
Dnmt3 has several splice variants, Dnmt3a and Dnmt3b, which are particularly 
important for de novo methylation, are highly expressed in ES cells and are down 
regulated upon differentiation (Okano et al., 1999). Dntmt3L shares homology with 
Dnmt3a and 3b but it lacks the catalytic domain activity necessary for DNA 
methyltransferase (Latham et al., 2008). Dnmt3L can interact with Dnmt3a and 3b to 
enhance the efficiency of methylation activity. Dnmt3L is not necessary for zygotic 
development but is important for establishment of paternal and maternal imprints 
through mouse development (Latham et al., 2008, Arnaud et al., 2006, Bourc'his et al., 
2001, Hata et al., 2006) and Dnmt3L-deficient males have impaired spermatogenesis 
(Webster et al., 2005, Hata et al., 2006). It is believed that Dnmt3L together with 
Dnmt3a2 isoform is responsible for the establishment of imprints in the germ line 
(Sakai et al., 2004). 
1.3.9 Polycomb and Trithorax proteins 
Polycomb proteins (PcG) are usually associated with gene silencing and they are 
essential to epigenetic maintenance and normal development in multicellular organisms 
(Ringrose and Paro, 2004, Schwartz and Pirrotta, 2007). PcG can be biochemically and 
functionally separated into two major multiprotein complexes, polycomb repressive 
complex 1 (PRC1) and PRC2 which is also known as initiation complex (Lund and van 
Lohuizen, 2004). The well known complex of PRC2 comprises Eed, Ezh1, Ezh2 and 
Suz12 while PRC1 complexes contain Cbx2, Cbx4, Edr1, Edr2, Ring1, Rnf2, Rnf110, 
Bmi-1 and Znf134 (Lund and van Lohuizen, 2004). Bmi-1 and Ring1B of the PRC1 are 
associated with histone ubiquitination, Ring1B is an E3 ligase that participates in the 
ubiquitination of lysine 119 of histone H2A, and the binding of Bmi-1 stimulates the E3 
ligase activity (Li et al., 2006).  
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Unlike PcG, thrithorax proteins (TrxG) are commonly linked to the general 
transcription process and gene activation, and they work as antagonists to PcG 
(Ringrose and Paro, 2004, Schwartz and Pirrotta, 2007).  PcG and TrxG regulate many 
developmentally important genes (Hanson et al., 1999, Boyer et al., 2006) and also 
associate with X chromosome inactivation (Schwartz and Pirrotta, 2007). Moreover, 
most of the PcG-occupied genes contain nucleosomes modified for H3K27methylation, 
suggesting that the role of PcG and TrxG might be related to H3K27 methylation both 
in methyltransferase function and histone-protein complexes (Boyer et al., 2006). 
1.3.10 Heterochromatin Protein 1 (HP1) 
In mammals, three isoforms of HP1 have been identified, HP1α, HP1β and HP1γ. These 
are associated with constitutive heterochromatin as well as some forms of facultative 
heterochromatin (Jones et al., 2000, Li et al., 2002). In somatic mammalian cells, HP1α 
and HP1β are predominantly localised at the pericentric heterochromatin, whereas HP1γ 
uniformly distributes at both heterochromatin and euchromatin (Schmiedeberg et al., 
2004, Dialynas et al., 2007, Vakoc et al., 2005, Fischle et al., 2005). Notably, HP1α, but 
not HP1β and HP1γ, remain associated with heterochromatin during cell division 
(Fischle et al., 2005, Schmiedeberg et al., 2004). Studies of their chromatin binding 
proteins showed that HP1α has a higher affinity for either chromatin or DNA than HP1β 
and HP1γ (Gilbert et al., 2003, Remboutsika et al., 1999, Meehan et al., 2003). 
Although all HP1 isoforms may be associated with gene silencing (Smallwood et al., 
2007), HP1γ seems to be connected to transcription activation (Vakoc et al., 2005).  
Collectively this makes HP1α a more specific marker for constitutive heterochromatin 
and a true epigenetic mark. 
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1.4 Chromatin Modification in Mouse Development 
In the mammalian reproductive system, the male and female gametes have very 
different chromatin organisations. This chapter summarises the chromatin modifications 
during gamete development and post-fertilisation to post-implantation development. 
The diagram of mouse development is shown in Figure 1.7 and 1.8. 
1.4.1 Chromatin Modification in Early Germ Cell Development 
Germ cells are the progenitors of gametes. Mouse primordial germ cells (PGC) begin to 
form at embryo day 7.5 (E7.5) in the posterior primitive streak and then migrate to 
genital ridge by day E11.5 (McLaren, 2003). There they undergo global epigenetic and 
chromatin reprogramming. Most of the DNA methylation at imprinted genes and repeat 
sequences is removed in this process (Hajkova et al., 2002, Hajkova et al., 2008, 
Morgan et al., 2005). Some DNA demethylation occurs specifically at paternally 
inherited imprinted genes (Hajkova et al., 2002). Although the DNA methylation at 
repeat sequences is mostly removed, some retrotransposons such as LINE 1 and IAPs 
are resistant (Lane et al., 2003, Hajkova et al., 2002). The differential erasure of DNA 
methylation persists until new imprints are established (Hajkova et al., 2002, Lee et al., 
2002). 
Recently Hajkova and colleagues (2008) reported dynamic changes in chromatin 
modifications during mouse early germ line development. Initially at E8.5 loss of 
heterochromatin marker H3K9me3 is observed despite the presence of histone 
methyltransferase G9a. Conversely, repressive histone mark H3K27me3, histone 
methyltransferase Ezh2 and active histone modifications such as H3K4me2, H3K4me3 
and H3K9ac seem to increase as well as the symmetrical methylation of arginine 3 on 
H4 (H4R3me2s) and H2A (H2AR3me2s) (Hajkova et al., 2008). A massive 
remodelling of heterochromatin and chromatin modifications is found at E11.5, when 
linker histone H1 and heterochromatin markers such as H3K9me3, H3K27me3, HP1α, 
HP1β, HP1γ, ATRX and M33 become undetectable or redistribute simultaneously with 
the loss of chromocentres (stained with DAPI) as well as nuclear enlargement (Hajkova 
et al., 2008). In addition, the active mark H3K9ac is also removed (Hajkova et al., 2008) 
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and new arrangements or reappearance of chromatin modifications as well as 
heterochromatin are observed around E12.5 (Hajkova et al., 2008). The loss of many 
repressive marks and heterochromatin markers may suggest that the chromatin of germ 
cells may be in the loose and open state to allow resetting of the epigenetic and 
chromatin profile.  
Although male germ cells enter a mitotic arrest at E13.5 that lasts until after birth, 
epigenetic and chromatin remodelling does not stop and seems to be dynamic 
(Yoshioka et al., 2009). A temporal and spatial reorganisation of chromocentres and 
heterochromatin markers H3K9me3 and HP1α has been found (Yoshioka et al., 2009). 
A diagram of epigenetic change in germ cell development is shown in Figure 1.8. 
1.4.2 Chromatin Modification in Oogenesis 
The main function of the female gamete formed by oogenesis is to produce and store 
cytoplasmic enzymes, mRNA, organelles and metabolic substrates needed to initiate 
and maintain metabolism and development (Gilbert, 2000). After arriving at urogenital 
ridge PGCs differentiate to self-renewing stem cells called oogonia, they undergo 
mitotic proliferation but most of oogonia die during this period, then at E12.5 the 
remaining oogonia enter meiosis these cells are named primary oocytes (Edson et al., 
2009, Gilbert, 2000). Thereafter primary oocytes progress through the first meiotic 
prophase, at this stage genetic reassortment occurs by homologous chromosome 
exchange, a phenomenon called chromosome crossing over (Alberts et al., 2002, 
Gilbert, 2000). The oocyte arrest at diplotene stage of meiosis I and do not resume 
meiosis until sexual maturity progressing to metaphase of meiosis II (usually called 
metaphase II). Only after fertilisation is meiosis completed (Edson et al., 2009) (see 
Figure 1.7 and 1.8).  
Oogenic meiosis conserves the volume of oocyte cytoplasm in a single cell rather than 
splitting it equally among four progeny. When the primary oocyte divides, its nucleus, 
called the germinal vesicle, breaks down, and then metaphase spindle migrates to the 
periphery of the cell (Gilbert, 2000). At telophase, the oocyte divides to produce a two 
daughter cells, one cell contains very little cytoplasm (known as the first polar body), 
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whereas the other cell has nearly the entire volume of cellular constituents referred to as 
the secondary oocyte (Gilbert, 2000). During the second division of meiosis (meiosis 
II), sister chromatids are separated and the genome becomes haploid (Cooper, 2000). 
An unequal cytokinesis also takes place, most of the cytoplasm is retained by the mature 
oocyte (metaphase II oocyte) (Gilbert, 2000).  
During oocyte development, chromatin structure is globally altered, and most genes are 
transcriptionally silenced (Kageyama et al., 2007, Kim et al., 2003). Many marks for 
histone methylation, acetylation and DNA methylation significantly increase from 
primary oocytes to germinal vesicle stage (GV) (Kageyama et al., 2007). This global 
change in chromatin modification coincides with increased gene expression of both 
methyltransferases and acetyltransferases (Kageyama et al., 2007). Gene repressive as 
well as active histone marks seem to co-localise with heterochromatin regions 
(Kageyama et al., 2007). Moreover, somatic linker histone H1 is replaced by an oocyte 
specific H1 variant named H1Foo, which is abundant in lysines and has many potential 
sites for methylation and acetylation (Kimmins and Sassone-Corsi, 2005). Taken 
together, it seems likely that epigenetic and chromatin modifications take place during 
oogenesis in association with chromatin architecture but this does not seem to be related 
to global gene expression. 
After meiosis, acetylation of all histones is reduced to an undetectable level by HDAC 
(Kim et al., 2003). A study of deacetylation in meiotic oocytes showed that p34cdc2 
kinase activity and/or ATRX (A member of SWI/SNF family, a chromatin remodelling 
protein) are responsible for the activation of HDACs (Akiyama et al., 2004, De La 
Fuente et al., 2004).  
1.4.3 Chromatin Modification in Spermatogenesis 
The development of male germ cells (spermatogenesis) differs from female (oogenesis) 
in many ways (see Table 1.6 for comparison). The main function of sperm is to transfer 
paternal genomic information to the oocyte during fertilisation, to form the zygote. 
During spermatogenesis, sperm chromatin undergoes dramatic changes, during which 
the histones are replaced by special proteins named protamines. This results in an 
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extremely compact chromatin compared to somatic cell nuclei (Ward and Coffey, 
1991). However the histone replacement by protamines is incomplete; it has been 
shown that the proteins associated with DNA are approximately 85% protamine and 
15% histone and other proteins (van der Heijden et al., 2006, Oliva, 2006, Gatewood et 
al., 1990). Most histone modifications are significantly decreased or absent after 
spermatogenesis while the remaining modifications such as acetylation of H4K8 and 
K12 are transmitted to the zygote after fertilisation (van der Heijden et al., 2006). The 
DNA methylation status at specific sites in three spermatogenesis-specific genes, Pgk-2, 
ApoA1 and Oct-3/4 is unmethylated in adult spermatogenic cells in the testis, but 
remethylated in mature spermatozoa in the vas deferens (Ariel et al., 1994). A sperm 
chromatin architecture study showed that the centromere are organised in a 
chromocentre, well positioned inside the nucleus while the telomeres forming dimers 
are positioned at the nuclear periphery (Oliva, 2006). Additionally, several epigenetic 
modifiers are important for spermatogenesis, for example, disruption of Suv39h2 or 
G9a or Jmjd1a (H3K9-HMT) which are preferentially expressed in the testis, results in 
infertility due to spermatogenetic failure (Tachibana et al., 2007, Peters et al., 2001, 
Okada et al., 2007) 
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Table 1.3 Differences  between  male and female gametogenesis (Handel and Eppig, 
1998). 
 
Female oogenesis Male spermatogenesis 
Meiosis initiated once in a finite 
population of cells 
Meiosis initiated continuously in a 
mitotically dividing stem cell population 
One gamete produced per meiosis Four gametes produced per meiosis 
Completion of meiosis delayed for 
months or years 
Meiosis completed in days or weeks 
Meiosis arrested at first meiotic prophase 
and reinitiated in a smaller population of 
cells 
Meiosis and differentiation proceed 
continuously without cell cycle arrest 
Differentiation of gamete occurs while 
diploid, in first meiotic prophase 
Differentiation of gamete occurs while 
haploid, after meiosis ends 
All chromosomes exhibit equivalent 
transcription and recombination during 
meiotic prophase 
Sex chromosomes excluded from 
recombination and transcription during first 
meiotic prophase 
 







Figure 1.7 Diagram of mouse development. (Image from NIH stem cell information 
website http://stemcells.nih.gov/) 







Figure 1.8 Epigenetic changes in germ cell development. Dashed lines indicate that 
the level of epigenetic modification is lower during these periods than that shown by the 
solid lines. FG, fully grown; MSCI, meiotic sex-chromosome inactivation; MI, 
metaphase I; MII, metaphase II; NG, non-growing; PGC, primordial germ cell (Image 
from Sasaki and Matsui, 2008). 
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1.4.4 Chromatin after Fertilisation 
At fertilisation, the parental genomes are in different stages of the cell cycle and have 
different chromatin organisations. The paternal chromatin has been delivered by sperm, 
and is mostly densely packaged with protamines rather than histones (Oliva, 2006). By 
contrast, the maternal chromatin is arrested at metaphase II and is packaged with 
histones (van der Heijden et al., 2005). Upon fertilization, sperm nucleoprotamine is 
decondensed and rapidly replaced with new histones, after which modification may 
occur (van der Heijden et al., 2005). Maternal chromatin, however; already contains 
histones and has abundant DNA methylation and chromatin modifications at fertilisation 
(van der Heijden et al., 2006, Santos et al., 2002). Previous studies under fluorescence 
microscopy reveal that most types of histone methylation such as H3K4, H3K9, H3K27, 
H4K20 are already present in female chromatin whereas only H3K9me1, H3K4me1, 
H4K20me1 are found in male chromatin (Erhardt et al., 2003, Torres-Padilla et al., 
2006, van der Heijden et al., 2005). After chromatin decondensation, active DNA 
demethylation occurs in male chromatin by an unknown mechanism (Santos et al., 
2002, Mayer et al., 2000, Yamazaki et al., 2007); at the same time new histones are 
modified (van der Heijden et al., 2005, Santos et al., 2005) including H3K4me1, 
H4K20me1, and acetylation of H3 and H4 (van der Heijden et al., 2005, Santos et al., 
2005, Adenot et al., 1997, Kim et al., 2003). Both the mechanism and the function of 
paternal genome demethylation are still unclear. It is hypothesised that the oocyte 
cytoplasm contains demethylation factors that are specifically targeted to sperm 
chromatin (Beaujean et al., 2004b, Yoshida et al., 2006). Histone variant H3.3 is already 
present in the oocyte as a maternal factor, and then incorporates preferentially into the 
male pronucleus before gamete activation (Torres-Padilla et al., 2006).  That paternal 
chromatin has DNA demethylation and fewer histone modifications may associated 
with the fact that zygotic gene transcription of paternal chromatin is higher and occurs 
earlier than in maternal chromatin (Aoki et al., 1997, Schultz, 2002). Furthermore, both 
H3K79me2 and H3K79me3 are decreased soon after fertilisation. The level of 
H3K79me2 is maintained until morula stage, whereas H3K79me3 is not detected 
throughout preimplantation (Ooga et al., 2008). However recent studies using chromatin 
immunoprecipitation and western blot from sperm extract found that most histone 
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modifications are found in spermatozoa (Dindot et al., 2009, Hammoud et al., 2009, 
Brykczynska et al., 2010). This may explain that the amounts of many histone 
modifications in sperm are very low and could not be detected by fluorescence 
microscope in single sperm sample. 
Zygotic gene activation (ZGA), the critical event that direct the transition from maternal 
to embryonic control of development, occurs during the 2-cell stage in mice (Schultz, 
2002). The demethylation of H3K9 methylation (Liu et al., 2004) and significant 
chromatin reorganisation also happens simultaneously at the 2-cell embryo stage 
(Martin et al., 2006, Probst et al., 2007, Schultz, 2002). For these reasons, it may be 
suggested that a highly permissive chromatin in 2-cell embryo allows access of the 
transcriptional machinery so as to activate zygotic gene expression. The dynamic 
changes of histone methylation are shown in Figure 1.9. 




Figure 1.9 Dynamics of histone methylation in preimplantation development. 
M=male pronuclei, F=Female pronuclei, ICM=Inner cell mass and TE=trophectoderm. 
Most of data come from the present studies except data mark with* is mean data from 
previously published report and so the quantification of histone methylation cannot be 
performed.  H3K27me1 (Erhardt et al., 2003, van der Heijden et al., 2005);  H3K27me2 
(Erhardt et al., 2003, van der Heijden et al., 2005); H3K79me2 (Ooga et al., 2008); 
H3K79me3 (Ooga et al., 2008), and H3K64me3 (Daujat et al., 2009). H3K9me1, 
H3K9me2, H3K9me3, H4K20me1, H4K20me2, H4K20me3, H3K4me3, H3K27me3 
was from the present study (Tuempong result in Chapter 3). The gradient of each colour 
represents the level of histone methylation. 
High                                        Low
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1.4.5 Chromatin at Periimplantation 
Blastocyst is the stage during which the embryo prepares to implant in the uterine 
epithelium. There are two populations of cells at this stage; inner cell mass (ICM) which 
develops into the future postimplantation embryo, and trophectoderm (TE) which forms 
the placenta. It has been shown that DNA methylation and H3K27me3 are significantly 
higher in ICM than in TE, suggesting that they are essential to establish and maintain 
pluripotency and separate cell population (Erhardt et al., 2003, Santos et al., 2002). 
Histone arginine methylation can also regulate pluripotency in the early mouse embryo. 
One study showed that higher levels of H3 arginine methylation predisposes 
blastomeres to contribute to the pluripotent cells of the ICM (Torres-Padilla et al., 
2007). Increase of H3K9me3 and H4K20me3 was found in the neural tube of 
postimplantation embryos (E12.5) indicating that they may be associated with neural 
differentiation (Biron et al., 2004).  
Many studies using gene knock-out mice models have demonstrated that epigenetic 
mechanisms are essential for development. A summary of the phenotypes of gene 
knock-out mice is shown in Table 1.2. 
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Table1.4 Epigenetic modifiers that are critical for mouse development (knock-out mice 
model). 
Name Function Embryonic 
lethality 
Extraembryonic tissue References 
Ehmt1 H3K9me E9.5 Chrioallantoic fusion defect (Tachibana et al., 
2005) 
Ehmt2/G9a H3K9me E8.5 Chorioallantoic fusion defect, 
small placenta, reduction of 
giant cell 
(Tachibana et al., 
2002, Wagschal et 
al., 2008) 
ESET H3K9me E3.5-E5.5 Abnormal blastocyst (Dodge et al., 2004) 
Suv3-9h H3K9me E14.5 No data (Peters et al., 2001) 




E6.5 Lack of amnion and 
ectoplacental cavity 
(Pawlak et al., 2000) 
Dnmt1 DNAme E9.5 Chorioallantoic fusion defect (Li et al., 1992) 
Suv4-20h H4K20me E17-E19 Labyrinth trophoblast defect, 
small size of placenta 
(Schotta et al., 2008) 
and (Schotta personal 
communication) 
Dicer RNAi E9.5 No data (Bernstein et al., 
2003) 
Dnmt3L DNAme E9.5 No labyrinth formation, less 
spongiotrophoblast, more 
trophoblast giant cell 
(Arima et al., 2006) 
Dnmt3b DNAme E15.5 No data (Okano et al., 1999) 
Eed H3K27me E9.5 Secondary giant trophoblast 
defect 
(Wang et al., 2002, 
Faust et al., 1995) 
Nsd1 H3K36me E10.5 Lack of allantoids (Rayasam et al., 
2003) 
HDAC1 deacetylase E9.5 Lack of allantois formation (Lagger et al., 2002) 
Suz12 H3K27me E10 Lack of chorion, amnion and 
ectoplacental cavity 
(Pasini et al., 2004) 
Dot1L H3K79 E9.5-10.5 
 
abnormal vascular 
morphology in yolk sac,  
severe cardiac dilation 
(Jones et al., 2008) 
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1.5 Genomic Imprinting Controlled by Epigenetics 
Genomic imprinting is a genetic phenomenon in which certain genes called imprinted 
genes are expressed in a parent-of-origin-specific manner. It is an inheritance process 
independent of classical Mendelian genetics, which describes the inheritance of traits as 
due to either dominant or recessive gene. Unlike Mendelian laws, in which both 
parental copies are equally likely to contribute to the phenotype or gene expression, 
imprinted gene expression depends only on which parent it was inherited from (Swales 
and Spears, 2005, Ideraabdullah et al., 2008). For example, gene H19 is expressed only 
from the allele inherited from the mother whereas IGF-II is expressed from the allele 
inherited from the father (Ideraabdullah et al., 2008). Studies in many species indicate 
that imprinting is broadly conserved among placental mammals, including primates, 
rodents, ruminants and marsupials (Monk et al., 2006, Lucifero et al., 2006, Umlauf et 
al., 2004, Vu et al., 2006). 
Many imprinted genes are found in clusters throughout the genome. Their gene 
expression is regulated by imprinting control regions (ICRs), which are marked by 
DNA methylation, histone modification, polycomb protein and non-coding RNA on one 
of two parental alleles (Delaval and Feil, 2004, Ideraabdullah et al., 2008). These allelic 
epigenetic marks are established in either the female or male germ line, following the 
epigenetic reprogramming in the primordial germ cells. The parental imprinted genes 
escape from the global epigenetic reprogramming after fertilisation, so that their 
epigenetic marks are maintained during preimplantation development (Ideraabdullah et 
al., 2008). 
DNA methylation is arguably the most studied mechanism in epigenetically controlled 
imprinted genes. The expressed imprinted genes are not marked with DNA methylation, 
while repressed imprinted genes are enriched for DNA methylation (Fowden et al., 
2006). Histone modifications also play a vital role in the regulation of imprinted genes. 
DNA methylated ICRs are associated with H4K20me3 and H3K9me3, whereas the 
unmethylated allele has H3K4me2 and H3ac (Delaval et al., 2007).  
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Another type of genomic imprinting is the imprinted X chromosome inactivation (XCI) 
which is found in female cells that have two X chromosomes (XX). XCI is a 
developmentally regulated process that causes one of the two X chromosomes to 
become transcriptionally silenced, thus equalising the expression of X-linked genes 
between male and female (Sado and Ferguson-Smith, 2005, Thorvaldsen et al., 2006). 
In postimplantation embryos, either the parental or maternal X-chromosome has to be 
inactivated, which is referred to as random XCI, whereas in the preimplantation embryo 
and extra-embryonic lineages, XCI is paternally imprinted (Thorvaldsen et al., 2006). 
The imprinted XCI is marked by repressive epigenetic markers such as H3K27me3 
(Erhardt et al., 2003), H4K20me1, H3K9me2 (Erhardt et al., 2003) and DNA 
methylation (Sado and Ferguson-Smith, 2005) whereas the active X chromosome is 
marked by active markers such as histone acetylation and H3K4me3 (Ideraabdullah et 
al., 2008).  
It has been demonstrated that imprinted genes play vital roles in fetal and placental 
growth and development (Arnaud and Feil, 2005, Fowden et al., 2006, Nafee et al., 
2008). They affect the growth, morphology and nutrition by controlling nutrient demand 
and supply between fetus and placenta (Fowden et al., 2006). Abnormal development in 
fetus and placenta has been found in mice in which imprinted genes were genetically 
deleted or altered (see table 1.3). Epigenetic dysregulation could also affect the fetal and 
placenta growth through malfunction of imprinted genes (see Table 1.2).  
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Table 1.5 Imprinted gense that affect embryo and placental development (Modified 
from Fowden et al., 2006)  
Allele Gene Gene product Knockout proportion 
of normal weight, % 
Placenta 
localisation 
   Fetus Placenta  
Paternally 
expressed 
Igf2 IGF II growth factor 50 60 All 
 Igf2P0 IGF II growth factor 75 70 Labyrinth 
trophoblast 
 Peg1 α/β hydrolase 87 86 Labyrinth 
blood vessel 
 Peg3 Zinc finger transcription 80 72 Labyrinth and 
spongiotropho
blast 
 Ins ½ Insulin 80 No result Yolk sac 
 Slc 
38a4 
System A amino acid 
transporter 




H19 Non-coding RNA 130 140 All 
 Igf2r IGF II receptor 140 140 All 
 Ip1 Cytoplasmic protein   100 140 Labyrinth 
trophoblast 
 Grb10 Adaptor protein 146 130 Labyrinth 
trophoblast 
 p57kip2 Cyclin-dependent kinase 
inhibitor 
100 140 All 
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1.6 Epigenetic Alterations by Reproductive 
Biotechnology 
In the last decade, the use of reproductive biotechnologies such as hormonally induced 
ovulation, artificial insemination (AI), in vitro maturation of oocyte (IVM), in vitro 
fertilisation (IVF) and intracytoplasmic sperm injection (ICSI) have been proven to 
resolve some infertility problems in humans (Horsthemke and Ludwig, 2005, De Rycke 
et al., 2002), to increase production of farm animals and to save endangered species 
(Andrabi and Maxwell, 2007, Paterson et al., 2003). However, the recent realisation of 
the critical importance of epigenetic information and its impact on health has focused 
attention on assisted reproductive technique (ART) births (Horsthemke and Ludwig, 
2005, De Rycke et al., 2002).  
There is increasing evidence that in vitro culture of preimplantation embryos may be 
associated with epigenetic alterations resulting in abnormal growth, phenotypic 
abnormalities, and developmental failure. One possible cause is an inappropriate use of 
culture medium. Khosla et. al. (2001) showed that the culture mouse embryos in M16 
containing fetal calf serum (FCS) induces aberrant DNA methylation of imprinted genes 
causing repression of the H19 gene. Furthermore, the culture of preimplantation ovine 
and bovine embryos in medium containing serum  frequently causes overgrowth and 
diverse developmental abnormalities during fetal and postnatal development and is 
related to abnormal pattern of DNA methylation at ICR controlling the imprinted 
IGF2R gene (Young et al., 1998). These aberrant phenotypes are named ‘large offspring 
syndrome’ (Young et al., 1998, Young et al., 2001), which is the model for Beckwith-
Wiedemann syndrome (BWS) in human. Recent studies in mouse also showed that in 
vitro mouse embryo culture can affect global DNA methylation patterns (Zaitseva et al., 
2007) but not histone modifications such as acetylation of H4, methylation of H3K9, 
and phosphorylation of H3 serine 10 (Huang et al., 2007). 
Moreover, aberrations of DNA methylation by unknown mechanisms during ART may 
cause abnormalities at imprinted genes. There are few clinical investigations of 
epigenetic errors that may arise during early development caused by ART (De Rycke et 
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al., 2002, Kelly and Trasler, 2004, Dean et al., 2005), but they are though to mimic 
certain genetic disorders. Firstly, the Beckwith-Wiedemann syndrome (BWS) is a 
pre/postnatal overgrowth syndrome associated with errors at the imprinting cluster. 
BWS is thought to be a result of the inappropriate epigenetic imprinting at specific loci 
on the maternal allele, such as inactivation of the cyclin-dependent kinase CDKN1C or 
defects of the H19 DMR. Secondly, Angelman Syndrome (AS) is caused by epigenetic 
alteration resulting in loss of function in the brain of the maternal copy of Ube3a.e. 
Thirdly, retinoblastoma sometime is caused by hypermethylation of the promoter region 
of RB gene (tumour suppressor gene) through interactions with DNMT1. Finally, ATR-
X syndrome is an X-linked syndrome characterized by severe mental retardation, 
reduced or absent speech, delayed developmental milestones, and also facial 
dysmorphism, -thalassemia, and sexual dysgenesis, and is associated with DNA 
methylation defects in specific regions of the genome. 
Advances in biotechnology such as nuclear transfer (NT) techniques have allowed the 
propagation of multiple genomic copies of an animal utilizing both embryonic and 
somatic cells as donors of genetic materials (Wilmut et al., 1997, Wilmut et al., 2002). 
The employment of NT has also provided a way to control the genetic content and 
accurate genetic modification of animal species, thus providing a route for the study of 
gene function, production of biopharmaceutical proteins (Schnieke et al., 1997), 
modification of production traits or disease susceptibility (Wilmut et al., 2000), 
preservation of endangered species (Gomez et al., 2004) and creation of pluripotent 
stem cells to serve in patient-specific cell transplantation for treatment of degenerative 
disease (Yang et al., 2007b). Notwithstanding, there are many advantages of NT, the 
success rate of reconstructive embryo to ES cell and full term offspring is extremely 
low (Wilmut et al., 2002). The majority of cloned animals die during pre-implantation 
and gestation due to developmental abnormalities (Wilmut et al., 2002). Epigenetic 
malfunction has been observed in several species of cloned embryos (Santos et al., 
2003, Yang et al., 2007a, Beaujean et al., 2004a); this may produce inaccurate gene 
expression and lead to developmental failure (Eilertsen et al., 2007, Vignon et al., 2002, 
Blelloch et al., 2006, Inoue et al., 2006). For these reasons, successful cloning is likely 
to require the reorganisation of donor chromatin to a state compatible with embryonic 
development. The transferred genome must properly activate genes important for early 
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embryonic development and also adequately suppress differentiation-associated genes 
that are transcribed in the original donor cell (Suzuki et al., 2006).  
In order to these resolve epigenetic abnormalities, several studies have attempted to use 
epigenetic reagents to improve the developmental success rate of NT and round 
spermatid injection (ROSI). For example, Trichostatin A (TSA), a deacetylase inhibitor, 
can induce global histone acetylation in many cells. Treating mouse cloned embryos 
with TSA after nuclear implantation of specific cell types can significantly improve the 
development to blastocyst (Rybouchkin et al., 2006) and full term development 
(Kishigami et al., 2006a). Another study in ROSI shows that unusual remethylation of 
the paternal genome occurs after normal active demethylation, but using TSA can 
reduce the DNA remethylation of paternal chromatin (Kishigami et al., 2006b). 
Furthermore, studies in bovine nuclear transfer show that partial removal of DNA 
methylation by using either TSA or 5-aza-2’deoxycytidine (a DNA methyltransferase 
inhibitor) can increase blastocyst development of bovine cloned embryos (Enright et al., 
2003). 
 
1.7 Epigenetic Control of Pluripotency and 
Differentiation 
The definition of pluripotency refers to cells such as embryonic stem (ES) cells that 
have the capacity to differentiate into three germ layers: endoderm, mesoderm, or 
ectoderm, and have an ability for infinite propagation (Smith, 2001). There are many 
applications for ES cells: first, the unique property of ES cells is that they can be easily 
subjected to gene introduction, after which genetically modified ES cells can be injected 
into blastocysts to produce transgenic animals (Wobus and Boheler, 2005). Second, the 
ability to differentiate into germ layers is comparable to postimplantation development; 
so this characteristic can be used as a model for developmental biology and pathology 
(Wobus and Boheler, 2005, Keller, 2005). Furthermore, in vitro differentiated ES-
derived progenitor cells might be of use as a source for cell transplantation for 
intractable diseases such as cardiovascular diseases, neurodegenerative diseases, 
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diabetes, and reproductive disease (Nagano, 2007, Laflamme and Murry, 2005, 
Schroeder et al., 2006). 
There is recent evidence that DNA and histone modifications might play an important 
role in the regulation of gene expression patterns in ES cells. It has been shown that the 
promoter region of active genes in ES cells, such as Oct4 and Nanog, are marked by 
acetylation of H3 and H4, and H3K4me3 which is an important mark for active gene 
transcription; then after differentiation these modifications are replaced with repressive 
markers such as DNA methylation, H3K9me3, H3K27me3 (Hattori et al., 2004, Kimura 
et al., 2004, Feldman et al., 2006, Hattori et al., 2007). Also remarkable and important is 
the finding of bivalent chromatin structures in ES cells. This unusual chromatin 
modification profile is highly specific to ES cells (Azuara et al., 2006, Bernstein et al., 
2006) and has been demonstrated for histone modification patterns at multiple lineage-
control gene loci in mouse ES cells. The critical transcription factor genes for cell 
lineage determination such as Sox1, Nkx2-2, Msx1, Irx3, and Pax3, that are not 
expressed in ES cells, are associated with both active (H3K4me3) and repressive 
(H3K9me3 and H3K27me3) histone modifications within their promoter loci. The 
bivalent histone modification patterns disappear after the differentiation of ES cells into 
the neuronal lineage. Only H3K4me3 remains at the promoters of neural genes whereas 
H3K27me3 is removed; conversely, the promoters of other genes that were silent in 
neurons lose H3K4me3, and are enriched for H3K27me3. This is consistent with other 
studies showing the important role of polycomb proteins associated with H3K27me3 in 
maintaining ES cell pluripotency and plasticity (Boyer et al., 2006). This evidence 
suggests that H3K27me3 might be functionally important for preventing expression of 
lineage-control genes in ES cells 
Furthermore, evidence from various sources indicates that chromatin might generally be 
less compact and more transcriptionally permissive in undifferentiated ES cells 
compared to differentiated cells. For example, differentiation of mouse ES cells results 
in the progressive increase in the cluster number of pericentric heterochromatin 
(Kobayakawa et al., 2007). Moreover, from a different perspective, the global 
chromatin status of ES cells can be assessed by measuring the exchange rate of 
chromatin-associated proteins using fluorescent recovery after photobleaching (FRAP) 
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(Meshorer et al., 2006). Histones H2B and H3 and the heterochromatin-associated 
protein HP1, which bind H3K9me2 and H3K9me3, were found to have a markedly 
increased exchange rate in ES cells compared with differentiated cells. The higher 
recovery rate presumably reflects a loose binding of these proteins to the chromatin, so 
that chromatin is more accessible to transcription factors and chromatin modifiers. At 
the same time, the exchange rates of the histone variant H3.3, which marks actively 
transcribed regions, was generally unaltered upon differentiation (Meshorer et al., 
2006). 
There are many publications that report that ES cells can survive without certain 
heterochromatin associated proteins but subsequently fail to undergo proper 
differentiation. These results suggest that these proteins are not necessary for ES cells 
and that chromatin in ES cells is flexible and/or does not form mature or real 
heterochromatin (see table 1.4).  
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Table 1.6 Pluripotency and differentiation defects are caused by epigenetic alteration 
Name ES cell 
viability  
  Differentiation 
abnormality 
References 
Dicer No Yes (mesoderm) (Bernstein et al., 
2003) 
Dicer Yes Yes  
(mesoderm, endoderm ) 
(Kanellopoulou et 
al., 2005) 
Suv39h Yes No data (Peters et al., 2001) 
Ehmt2 Yes No data (Tachibana et al., 
2002) 
Suv420h Yes No data (Benetti et al., 2007) 
Ezh2 No No data (O'Carroll et al., 
2001) 





 (cardiocyte, erythoid, 
myeloid) 
(Jackson et al., 
2004) 
Dot1L Yes No data (Jones et al., 2008) 
ESET No No data (Dodge et al., 2004) 
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1.8 Manipulation of Epigenetic Reprogramming 
By nature, cells and organisms possess mechanisms that can epigenetically reprogram 
gene expression. One notable example is the epigenetic reprogramming that occurs 
during development; a phenomenon which is critical for normal development and relies 
on a variety of endogenous chemical and enzymatic mechanisms (Reik, 2007, Morgan 
et al., 2005). Not only mechanisms of endogenous origin, but also exogenous factors 
can be used to manipulate epigenetic profiles and in this way can alter cell fate. There 
are currently several techniques used to manipulate epigenetic profiles such as nuclear 
transfer, cell fusion, treating cell with ES cell extraction or small molecule, and over 
expression of defined transcription factors (Jaenisch et al., 2005, Collas and 
Gammelsaeter, 2007, Takahashi et al., 2007). Cell reprogramming strategies may be 
useful for future therapies for example: the treatment of cancers which have epigenetic 
abnormalities, or cell replacement therapies for degenerative tissue, and also as a model 
for regenerative and developmental biology. 
Studies from different species using the nuclear transfer technique have shown that eggs 
or oocytes have the ability to erase old epigenetic pattern (“epigenetic memory”) of the 
donor nucleus and replace these with new marks (Ng and Gurdon, 2005, Martin et al., 
2006, Lee et al., 2002, Shi et al., 2003, Yang et al., 2007a). After a somatic cell is 
transferred into an oocyte, its nuclear epigenetic marks are removed and replaced with 
the embryonic epigenetic pattern (Eggan and Jaenisch, 2003, Rideout et al., 2001). 
However reprogramming by nuclear transfer is incomplete as most nuclear transfer 
embryos fail to achieve full term development (Mann et al., 2003, Kang et al., 2001, 
Young et al., 2001).  
The idea that pluripotent cells such as embryonic germ  (EG) cells, ES cells and 
embryonal carcinoma (EC) cells have an ability to reprogram a differentiated cell to a 
pluripotent or multipotent cell was exhibited by cell fusion experiments (Tada et al., 
1997, Ambrosi and Rasmussen, 2005). After the ES cell is fused with a somatic cell, 
epigenetic reprogramming is promoted by the pluripotent cell’s proteins, which in turn 
switches on pluripotent gene expression (Oct4, Nanog, Sox2) in somatic cells (Tada et 
al., 1997, Pells et al., 2002). However the use of such hybrid cells is considered to be 
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impractical due to the presence of double set of chromosomes and the method cannot 
produce vast cell numbers. An alternative technique involves the use of nuclear extracts 
from pluripotent cells. This may be more appropriate, as the previous studies have 
shown that pluripotent cell extracts can retain the factors capable of epigenetic 
reprogram Oct4 promoter by removing DNA methylation (Taranger et al., 2005) and 
repressive histone methylation (Collas and Taranger, 2006). 
Recently, it has been demonstrated that a cocktail of ectopic expression or recombinant 
proteins of the pluripotency transcription factors (Oct4, Sox2, Klf4,Myc, Nanog, Lin28) 
is sufficient to reprogram somatic cell into ES-like cell in mouse (Takahashi and 
Yamanaka, 2006, Zhou et al., 2009) and human cells (Park et al., 2008b, Takahashi et 
al., 2007, Kim et al., 2009, Yu et al., 2009), these cells have been named as induced 
pluripotent stem cells (iPS cells) (Takahashi and Yamanaka, 2006). The study of their 
global epigenome shows that these techniques can induce global epigenetic 
reprogramming from fibroblast to ES-like cell epigenome (Maherali et al., 2007, 
Takahashi et al., 2007). iPS cells are a promising tool for deriving either patient-specific 
or disease-specific pluripotent cells. These cells might be used for cell therapy, drug 
screening, and as a model for the pathogenesis of degenerative diseases such as 
Alzheimer’s, Parkinson’s or multiple sclerosis (Park et al., 2008a). The study of iPS 
cells that are corrected for a gene mutation to rescue sickle cell anaemia in mouse model 
has been a ‘proof of principle’ for the use of iPS cells combined with gene therapy for 
disease treatment (Hanna et al., 2007). Although the mechanisms of epigenetic 
reprogramming by transcription factors are still poorly understood, the general 
hypothesis is that epigenetic reprogramming in iPS cells may be the result of two steps: 
firstly, exogenous chromatin remodelers, Klf4 and Myc (Jiang et al., 2008, Knoepfler et 
al., 2006) might govern global chromatin to be more permissive to allow the 
transcription machinery access to the chromatin domain. Secondly, the exogenous 
pluripotent transcriptional factors, Oct4 and Sox2 access the open chromatin and initiate 
global gene expression, and subsequently expression of endogenous pluripotent genes 
such as Oct4, Nanog, Sox2. This is consistent with recent evidence showing that Oct4 
protein is at the heart of epigenetic reprogramming in ES cells through histone 
demethylases Jmjd1a and Jmjd2c to help maintain pluripotency (Loh et al., 2007).  
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In the last decade, a variety of small molecules have been created and discovered. Some 
small molecules have the potential to alter epigenetic marks whilst others can reprogram 
terminally differentiated cells to progenitor cells. One example includes demethylating 
agents such as 5-azacytidine.  5-azacytidine (5-AzaC) is a cytosine analogue that can 
cause extensive global DNA demethylation and reduce DNA methyltransferase activity 
in the cells (Taylor, 1993). It was originally developed as an antitumor agents, and has 
been useful in the treatment of both childhood and adult leukaemia (Taylor, 1993). 5-
AzaC can reverse the differentiation state of ES cells through its DNA demethylating 
activity at differentiation-related genes (Tsuji-Takayama et al., 2004). However the 
effect of 5-azacytidine is unpredictable it can cause either reverse differentiation or 
induce differentiation (Taylor, 1993). Another type of modifiers includes histone 
deacetylase (HDAC) inhibitors such as valproic acid (VPA) and trichostatin (TSA). 
VPA has been utilised for decades as a treatment for epilepsy, as a mood stabiliser and 
in migraine therapy, while TSA is currently applied as an anticancer medicine (Butler 
and Bates, 2006, Marks and Jiang, 2005). It has been shown that both VPA and TSA 
can inhibit HDACs and then trigger active global demethylation of the mammalian 
epigenome, causing reprogramming of gene expression (Milutinovic et al., 2006). VPA 
combined with two factors, Oct4 and Sox2 enables reprogramming of primary human 
fibroblasts, without the need for the oncogenes c-Myc or Klf4 to become iPS cells that 
resemble human ES cells in pluripotency, global gene expression profiles and 
epigenetic states (Huangfu et al., 2008). In addition, histone methylation inhibitors such 
as BIX-01294. (a diazepin-quinazolin-amine derivative) have been demonstrated to 
selectively impair G9a (Ehmt2) HMTs and H3K9me2 (Kubicek et al., 2007). A 
combination of BIX-01294 with defined factors with or without c-Myc (a chromatin 
remodeller) could increase the cellular and epigenetic reprogramming rate of iPS 
methodology (Shi et al., 2008). 
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1.9 Objectives of the Project 
Cell reprogramming post-fertilisation is fundamental and has major implications for the 
application of modern technologies such as nuclear transfer, and iPS cell generation. 
However the success rate of reprogramming for both technologies is extremely low and 
the mechanisms involved are not well understood. One aspect believed to be very 
important for reprogramming is the resetting of chromatin and epigenetic signature. To 
improve the technology we need to understand the principle of natural reprogramming 
using mouse preimplantation mouse development as a model. In the present study, 
chromatin and epigenetic signatures and the mechanisms involved were explored during 
normal mouse development.  
The overall objective of the PhD project was to study chromatin organisation in normal 
mouse development. These studies will provide crucial information on the 
developmental transitions in nuclear chromatin organisation, and increase our 
understanding of how heterochromatin is established after fertilisation. In addition, they 
could serve as a model for improvement of reproductive biotechnologies such as 
somatic cell reprogramming, diagnosis of genetic abnormalities and medical 
applications of stem cell technology for other species such as human and livestock. 
More specifically, the aims of the research project were: 
1. To investigate epigenetic heterochromatin formation in developing mouse 
embryos derived from natural fertilisation. 
2. To investigate the epigenetic heterochromatin transition from the in vivo 
inner cell mass of blastocysts to in vitro embryonic stem cells. 
3. To investigate global changes of epigenetic heterochromatin markers during 
in vitro early differentiation of ES cells as a model for early differentiation in 
mouse development. 
4. To investigate heterochromatin maturation in mouse development from 
preimplantation to postimplantation. 
5. To investigate the mechanism of epigenetic and chromatin reprogramming in 
the preimplantation embryo. 
6. To investigate the function of epigenetic modifiers such as histone 
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methyltransferases and demethyltransferase in mouse preimplantation 
embryos. 
The critical hypothesis tested in these studies was whether heterochromatin in 
preimplantation embryos is more immature than that of postimplantation embryos and 
pluripotent embryonic stem cells. 
Finally, the results from this project are expected to provide benefits by assisting in the 
creation of novel techniques for epigenetic manipulation. It may improve epigenetic 
reprogramming protocols for either nuclear transfer or transcription factor 
reprogramming, and for directing ES cell differentiation into specific lineages. 
Moreover, further understanding of epigenetic and chromatin modification in mouse 
development will provide useful models for human and other species to study the 
mechanisms at the basis of developmentally epigenetic abnormalities and cancer 
development from progenitor or stem cells. 
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Chapter 2 
Materials and Methods  
In this Chapter the manipulations of animals and embryos, cell culture techniques, 
methods to detect epigenetic and chromatin modifications, gene expression assays, and 
gene knock-down technology are described. The full details of reagents and chemicals 
are shown in Appendix 1. Media preparation is described in Appendix 2. 
 
2.1 Animal and embryo manipulation 
2.1.1 Animals 
The mouse colony (B6CBAF1) was maintained in phase I of the animal unit at the 
Chancellor’s Building of the University of Edinburgh, under 12 hour dark/light cycle.  
Six to eight week old B6CBAF1 (C57BL/6 x CBA) female mice were used to collect 
oocytes and embryos. Eight to ten week old male mice were used for natural mating. 
The experiments and scientific procedures on living animals were performed under 
project licences and personal licences that were approved by the Home Office. 
2.1.2 Immature oocyte recovery and in vitro maturation 
Follicle development was induced by intraperitoneal injections (i.p.) of 5 IU pregnant 
mare serum gonadotrophin (PMSG) (Intervet) into female mice. After 47 hours, mice 
were euthanised by cervical dislocation and ovaries were transfer to M2 medium 
(Sigma).  Immature oocytes were collected using small needle (26 Gauge) to puncture 
follicles. Cumulus oocyte complexes (COCs) were washed three times in M2 medium 
before transferring to a drop of 40 µl of αMEM (Invitrogen) supplemented with 0.5 
IU/ml sheep FSH (Sigma), 1 mg/ml Fetuin (Sigma) and 1ng/ml EGF (Sigma) in 60 mm 
cell culture dishes (Falcon) Ten to fifteen COCs were cultured in the same drop of 
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culture medium and were incubated at 37°C in 5% CO2 95% air atmosphere in a 
humidified incubator for 17 hours to mature.  
The maturation rate was approximately 90%, observed by the presence of the first polar 
body and metaphase plate using Hoechst staining (Sigma). Oocytes were incubated in 
Hoechst 33342 (5 µg/ml) diluted in M2 medium for 5 minutes in a 37°C warm box, then 
washed in M2 three times before being transferred into PBS for observation of the 
metaphase plate using a fluorescence microscope. 
2.1.3 Zygote collection and culture 
Female mice were superovulated by intraperitonial injections of 5 IU pregnant mare 
serum gonadotrophin (PMSG) (Intervet) and 5 IU of human chorionic gonadotrophin 
(hCG) (Intervet) given 47 hours apart. After hCG injection, mice were allowed to mate 
with 8 to 10 week-old male mice. Female mice were euthanised by cervical dislocation 
21 hours post hCG. Ovaries and oviducts were removed, and zygotes were recovered 
from the ampulla of the oviducts using tweezers to puncture the oviduct membrane.  
Thereafter, cumulus cells were removed from zygotes by short incubation (30 seconds) 
in 1% hyaluronidase (Sigma) in M2 medium at 37 ºC. Denuded zygotes were then 
cultured in 40 µl drops of Potassium Simplex Optimised Medium (KSOM) (Millipore) 
under mineral oil (Fluka) at 37°C in 5% CO2 95% air atmosphere humidified incubator. 
Each drop contained 10-15 zygotes. Embryos were cultured in 60 mm cell culture 
dishes (Falcon) for 4-5 days to the blastocyst stage. A diagram of embryonic 
development is shown in Figure 2.1. 
2.1.4 Peri/Postimplantation embryo collection 
To understand epigenetic changes that take place during implantation, different 
postimplantation stages of embryos were collected. Mice were naturally mated at night 
and the presence of vaginal plugs the next day was considered day 0.5 post-mating 
(E0.5). Preimplantation embryos (E3.5) and periimplantation embryos (E4.5) were 
collected by flushing the uterus with 1 ml of M2 medium with blunt needle (26 Gauge). 
Postimplantation embryos (E5.5, E6.5, E7.5, E8.5, E14.5 and E17.5) were dissected 
using a needle and forceps, the embryo was released by making a small puncture at the 
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implantation side then using forceps to press around puncture site to release embryo. 
The stages of post-implantation development are shown in Figure 2.1. 
Zygote                    2-cel                     4-cell                  8-cell                     Morula                        Blastocystl




Figure 2.1 Diagram of embryonic stages collected in this experiment. The scale bar 
represents 50 µm for preimplantation embryos, 100 µm for E4.5 and E6.5 embryos,  200 
µm for E7.5 and E8.5 embryos,, 2,000 µm for E14.5 embryos and 3,000 µm for E17.5 
embryos. (Images were modified from Edinburgh mouse atlas project; 
http://genex.hgu.mrc.ac.uk/).  
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2.2 Cell culture 
In the present studies, fibroblast cells from adult or foetal mice were compared to ES 
cells and embryos. Fibroblast cells represent finally differentiated cells whereas ES cells 
served as an in vitro model for embryo development. 
2.2.1 Primary mouse adult fibroblast culture 
Primary adult fibroblast cells were obtained from skin of B6CBAF mice and cultured in 
fibroblast medium containing DMEM (Invitrogen) supplemented with 10% Foetal 
bovine serum (FBS) (Invitrogen) and  and 100 IU/ml penicillin/100 ug/ml streptomycin 
(Sigma). Pieces of mouse ear skin were cut and sliced using a surgical blade, and left in 
a small volume of culture medium allowing the skin tissue to attach to the culture dish 
(10cm dish). Skin tissue was incubated at 37°C in 5% CO2 95% air atmosphere 
humidified incubator for 1-2 days. After fibroblast-like cells were visible, medium was 
added to cover the tissues and incubated until the cells were 80-90% confluent. 
Thereafter cells were passaged (1:3) using 0.25% trypsin (see Appendix 2) and moved 
into new culture dishes. After 3-4 passages, only adult fibroblast cell remained.  
2.2.2 Primary mouse embryonic fibroblast (MEF) culture 
Primary foetal fibroblast cells were obtained from 14.5 days foetuses (E14.5, see Figure 
2.1). Foetuses were collected from the uterus and then left in 37 ºC in PBS (Lonza). 
Head and visceral organs were removed and the body skin was cut into small pieces and 
incubated in 0.25% trypsin for 10-30 minutes. Foetal cells were centrifuged 700 xg for 
2.5 minutes, and then PBS was removed. The wash and centrifuge steps were repeated 
three times. The supernatants were removed and pellets were resuspended in fibroblast 
medium (see 2.2.1), before culture at 5% CO2 and 95% air atmosphere humidified in a 
37°C incubator. After 3 to 4 passages (Split 1:3), only fibroblast cells remained, and the 
MEF passage number was considered to be passage one.  
2.2.3 Embryonic stem cell culture 
Established ES cells and new ES-like cells were used. ES cells (E14tg2a) were 
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originated from 129/J mice (Hooper et al., 1987) and these cells were provided by 
Institute of Stem cell Research, the University of Edinburgh. ES-like cells (noo01) were 
derived during this project and early passages of these cells were used. ES cells were 
cultured on gelatinised culture plate (0.1% gelatine) (Sigma) using ES cell medium. ES 
cell medium contained knockout-DMEM (Invitrogen), 15% FBS (Invitrogen), 100 
IU/ml leukaemia inhibition factor (LIF) (Chemicon), 100 µM 2-mercaptoethanol 
(Invitrogen), 100 µM non-essential amino acids (Invitrogen), 2 mM L-glutamine 
(Invitrogen) and 100 IU/ml penicillin/100 ug/ml streptomycin (Sigma). ES cells were 
cultured at 37°C in 5% CO2 95% air atmosphere humidified incubator. Ratio for ES cell 
splitting is 1:3. 
2.2.4 Isolation of ES-like cell from blastocysts 
ES cells were isolated from late blastocysts. MEF cells were used as a feeder layer and 
they were prepared one day before ES cell isolation. MEF cells were inactivated by 10 
µg/ml mitomycin C in fibroblast medium and incubated at 37°C in 5% CO2 95% air 
atmosphere humidified incubator for 3 to 4 hours. Thereafter feeder cells were washed 
with PBS and cultured with ES cell medium at 37°C in 5% CO2 incubator for 24 hours. 
Expanded blastocysts were used for isolation of ES cells. The zona pellucida was 
removed using acid Tyrode’s solution (Sigma). Zona free blastocysts were then placed 
in a 4-well culture plate containing feeder layer and ES cell medium at 37°C in 5% CO2 
incubator. After 4-6 days, inner cell mass (ICM) outgrowths were disaggregated by 
placing into 0.025% trypsin (see Appendix 2) drop for 2-3 minutes. Mechanical 
aspiration was done using a pipette until the ICM broke into small clumps. These cells 
were transferred to new feeders and ES medium (see 2.2.3). After 1-3 days ES-like 
colonies were visible, cells were disaggregated and placed into 30 cm culture dishes; 
this step was considered first passage. 
2.2.5 In vitro differentiation of ES cells 
ES cell differentiation into embryoid body (EB) is commonly used as a model for early 
differentiation of mouse development (Wobus and Boheler, 2005). ES cells (4x106 cell) 
were induced to form EB by placing ES cell into 10 cm Petri dish (Sterilin) and cultured 
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with differentiation medium (similar to ES cell medium but without LIF) at 37°C in 5% 
CO2 95% air atmosphere humidified incubator. EBs were cultured for 4 days with a 
daily change of medium. Thereafter they were collected for protein or RNA extraction. 
For immunofluorescence EBs were transferred to a chamber slide to allow to 
attachment to the slide for 24 to 48 hours at 37°C in 5% CO2 incubator before staining. 
For cardiomyocyte spontaneous differentiation, EBs were cultured for 2-4 weeks in cell 
culture dish (10 cm) to allow EBs to attach to the dish surface. Differentiation medium 
was changed daily. Beating cardiomyocytes appeared approximately 2 weeks after 
differentiation was initated. 
2.2.6 In vitro implantation and blastocyst outgrowth 
In order to observe very early implantation embryos, an in vitro implantation technique 
was used. Expanded blastocysts were incubated in ES cell medium on gelatinised 
chamber slides. After 24 hours, trophectoderm (TE) attached the plate and differentiated 
to trophoblast while ICM would grow and form colony-like epiblast cells. Embryos 
were collected approximately 24 hours post-culture were described as in vitro 
periimplantation embryos while embryos collected later than 24 hours were categorised 
as postimplantation embryos. 
2.2.7 Cell cryopreservation  
Confluent cells from 10cm culture dish were trypsinised and centrifuged 700 xg for 5 
minutes. Supernatants were removed and cells were resuspended with culture medium. 
Cells were counted and diluted to 2x106.cell/ml and 2x-freezing medium (see Appendix 
2) with equal volume of culture medium (500 µl) was slowly added into cell suspension. 
One ml of cell suspension (1x106 cells) was pipetted into 1.8 ml cryopreservation tube. 
Tubes were placed into a slow freezing foam box and then a box was placed into -80 ºC 
freezer for overnight. The next day, the tubes were transferred into liquid nitrogen for 
long term storage. For thawing, frozen cells in the cryotube were thawed in 37 ºC water 
bath for 1-2 minutes. Cell suspensions were transfer to a 15 ml centrifuge tube 
(Corning) and diluted with 5 ml culture medium. Cell suspensions were centrifuged 700 
xg for 5 minutes, and then supernatants were discarded. Cell pellets were resuspended 
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with culture medium and transfer to appropriate culture dish (a 10cm dish is suitable for 
1x106 cells). 
 
2.3 Detection of global epigenetic and chromatin 
modifications. 
Several techniques were used to detect epigenetic and chromatin modifications. DNA 
methylation, histone modification, transcription factor and related proteins were 
detected by using highly specific antibodies. Western blot and indirect 
immunofluorescence, with and without flow cytometry, were used to observe epigenetic 
changes in cultured cells. Whole-mount immunofluorescence was used for 
preimplantation embryos and early postimplantation embryos. Western blot and 
immuno/histofluorescence were used for postimplantation embryos (E8.5-E17.5). 
Dilution of antibodies and their source is shown in Table 2.1, and details of the 
antibodies used are shown in Appendix 1. 
2.3.1 Immunofluorescence 
2.3.1.1 Immunofluorescence for cell culture and whole mount embryo. 
Specimens were fixed in 4% paraformaldehyde (PFA, Sigma) in PBS (Invitrogen) (see 
Appendix 2) for 15 minutes at room temperature. For the detection of DNA 
methylation, specimens were treated with 4M Hydrochloric Acid (HCl) at room 
temperature (10 minutes for embryos, 5 minutes for cells) before permeabilisation to 
denature the DNA to allow antibody binding to methyl-C groups. After washing twice 
with PBS, specimens were permeabilised in 0.2% Triton X-100 (Sigma) for 15 minutes. 
After that, specimens were washed twice with 0.01% Tween (Sigma) in PBS and 
incubated in blocking solution 2% bovine serum albumin (BSA) (Sigma) or 5% donkey 
serum (DS) (Sigma) for either 2 hours or overnight. Specimens were then incubated 
with primary antibodies either at room temperature for an hour or at 4 ºC for overnight. 
After washing three times, specimens were incubated with secondary antibodies for an 
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hour. Then specimens were washed three times and mounted with 1.5 µg/ml DAPI 
diluted in glycerol (Vectashield) 
2.3.1.2 Immunohistofluorescence for postimplantation embryo 
Postimplantation embryos (E8.5 to E17.5, see Figure 2.1) were prepared in paraffin 
section or cryosection. For paraffin section, samples were fixed in 4% PFA for an hour, 
and then held in 70% ethanol overnight at room temperature. Embryos were embedded 
in paraffin by Centre for Reproductive Biology (CRB) histology service (University of 
Edinburgh). Sections were cut by microtome (Leica) with a thickness of 3 to 5 µm. 
After section, slides were dried in 60 ºC incubator for overnight and then the antigen 
retrievals were performed (see 2.3.1.3). Thereafter, sections were deparaffinised and 
rehydrated in sequence: xylene two changes for 5 minutes, 100%, 95%, 80%, 50% 
ethanol for 20 seconds each. Slides were rinsed in PBS and they were ready for 
immunofluorescence. 
For cryosection, samples were placed in OTC Embedding Medium (Raymond A Lamb) 
and immediately frozen on dry ice for 30 minutes. Samples were stored in -80 ºC until 
ready for cryosection. The cryosection was performed using cryostat machine (Leica) in 
CRB histology unit. After cryosection, slides were dried 5 minutes, and then fixed in 
4% PFA 5 minutes before immunofluorescence.  
For immunoflurescence, samples from paraffin section or cryosection were 
permeablised with 0.1% Triton X100 in PBS, washed in PBS for 5 minutes and blocked 
with 2% BSA+5% donkey serum for an hour. Samples were washed in PBS for 5 
minutes and then incubated with primary antibodies either at 4ºC overnight or at room 
temperature for 2 hours. Thereafter, samples were washed in 0.05% Tween in PBS three 
times for 15 minutes each and one time in PBS for 5 minutes. Samples were incubated 
with secondary antibodies at room temperature for 2 hours. Next, the samples were 
washed in 0.05% Tween in PBS three times for 15 minutes each, and one time in PBS 
for 5 minutes. Excess liquid was absorbed by using paper and then mounted with 1-2 
drop of Prolong Gold antifade reagent with DAPI (Invitrogen). Mounting reagent was 
left for curing overnight at room temperature in the dark. Finally slides were sealed with 
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nail varnish and stored at 4 ºC until observation with a fluorescence microscope (see 
section 2.3.1.4). 
2.3.1.3 Antigen retrieval  
After the paraffin embedding, some antigens may lose sensitivity and it may be 
necessary to ‘unmask’ or retrieve the antigen through pre-treatment of the specimens 
before staining. This step is known as antigen retrieval or recovery. Two methods, 
either pressure cooker (heating method) or trypsin digestion (enzymatic method) were 
used in these experiments. 
For the heating method, two litres of antigen retrieval buffer (see Appendix 1 and 2) 
were added into Tefal Clypso pressure cooker and then boiled. Dewaxed and rehydrated 
slides were placed on cooker and boiled for 5 minutes. The slides were removed and 
washed in cold water. 
For the enzymatic method, trypsin (Sigma) was used. The trypsin tablet was dissolved 
in deionized water (1mg/ml) and then dropped on specimen slides. Slides were 
incubated at room temperature for 10 minutes. Afterwards each slide was washed with 
PBS (Invitrogen) for 5 minutes. 
2.3.1.4 Image Analysis and Software 
Images were captured by both fluorescence microscopy and laser confocal microscopy. 
The microscopes and software used in these studies were Zeiss fluorescence microscope 
(Zeiss Axioscope 2) with OpenLab Software (Improvision), Nikon fluoresecence 
microscope (Nikon) with Velocity (Improvision), Zeiss laser confocal microscope 
(Zeiss LSM) with LSM Meta software and Leica laser confocal microscope (Leica SP5) 
with Leica image software. The details of software, manuals and relevant websites are 
shown in Appendix 1. 
Z stack series were mainly obtained on the Zeiss LSM using LSM-meta software. 3D, 
2D and merged images were created by LSM-image browser. Image adjustment and 
measurements of fluorescence intensity were performed using the programme ImageJ 
(Rasband, 1997-2004).  
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The volume of each stage of embryo is varies considerably with development, so when 
the embryo decreases in nuclear volume (through division), the chromatin density 
increases (Sawicki et al., 1974). Thus, the nuclear volume has an effect on nuclear 
intensity and also fluorescence intensity (Beaujean et al., 2004). To resolve the effect of 
nuclear volume on chromatin intensity, the nuclear total fluorescence intensity (NTFI) 
method was used for semi-quantitative analysis of fluorescence intensity. The NTFI was 
calculated using an average of 2D nuclear intensities multiplied by nuclear volume. This 
method was modified from Fuoka Aoki’s Lab, University of Tokyo (Akiyama et al., 
2006, Kageyama et al., 2007, Liu et al., 2004). The nuclear volume was calculated using 
ellipsoid volume equation   (abc = radii). Radii were measure by LSM-image 
browser. The intensity was measured over all nuclei of each embryo, except in morula 
where at least eight nuclei were randomly measured, and in blastocysts where at least 
eight nuclei from inner cell mass and eight nuclei from trophoectoderm were measured. 
2.3.1.5 Flow cytometry analysis 
Flow cytometry was used to analyse the relationship of histone modification and early 
differentiation in ES cells, and also applied to analyse transfection efficiency and 
apoptosis rate after siRNA transfection. Flow cytometry allows simultaneous multi-
parameter analysis of single cells, it can analyse more than ten thousand cells in less 
than 5 minutes, and it is more efficient and accurate than manual visual cell counting.  
Not only can it detect fluorescence signal, it also can detect cell size and complexity 
(sometimes called granularity). The signals of fluorescence intensity, cell size and 
complexity together can be used to distinguish cell populations. 
Cultured cells were trypsinised and then centrifuged at 700 xg for 5 minutes. 
Suspension was removed and washed with PBS-azide (Sigma), and centrifuged three 
times. Then cells were fixed in 0.4% PFA in 1.5 ml centrifuge tubes at room 
temperature for 15 minutes. After centrifugation, the fixative was removed and washed 
with PBS. Cells were permeabilised with 0.2% TritonX-100 for 15 minutes. Thereafter, 
cells were blocked with 2%BSA+5%Donkey serum for 30 minutes, and primary 
antibodies were added later (see Table 2.1). Cells were washed in PBS and rotated for 5 
minutes and then centrifuged at 700 xg for 5 minutes. This washing step was repeated 
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three times. After that the cells were incubated with secondary antibodies in light 
protected tubes. Cells were washed in PBS and rotated for 5 minutes and centrifuged at 
700 xg for 5 minutes. This wash step was repeated three times. Flow cytometry analysis 
was performed using FACSCalibur® flow cytometer (BD Bioscience). Data were 
analysed using the programme Cell Quest (BD Bioscience). Samples incubated with 
blocking solution alone or secondary antibodies alone were used as negative controls 
for autoflorescence and non-specific fluorescence. 
2.3.1.6 Positive and Negative control for immunofluorescence 
Mouse embryonic fibroblasts were used as positive control for histone antibodies and 
ES cells for pluripotentcy marker as it show in many publications. Samples were treated 
with either no antibody or only secondary antibodies and then observed under 
fluorescence microscopy and flow cytometry to evaluate autofluorecence and non-
specific binding of secondary antibodies. 
 
2.3.2 Protein electrophoresis 
Western blot analysis was used to detect global histone modification and 
heterochromatin proteins in fibroblast and ES cells in order to find the association 
between chromatin modification and cell differentiation.   
2.3.2.1 Histone extraction (Acid extraction) 
Histone extracts were prepared from either cultured cells or embryos. Cultured cells 
were trypsinised and centrifuged 700 xg for 5 minutes. Supernatants were removed and 
lysis buffer was added to the pellets and mixed using a pipette. For embryos, lysis 
buffer was added to a metal bead then homogenised for 1 minute by homogeniser (Ball 
Mill Model MM301, Retsch). The lysis buffer contained 10 mM HEPES pH 7.8 
(Sigma), 1.5 mM MgCl2 (Sigma), 10 mM KCL (Sigma), 0.5 mM DTT (Sigma), 1.5 mM 
PMSF (Sigma). Hydrochloric acid (HCl) was added into a final concentration of 200 
mM. The samples were incubated at 4°C for 30 minutes then taken through a brief 
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sonication (1 Watt for 2 seconds) (XL2000, Microson). Samples were centrifuged at 
13,000 xg, 4 °C for 10 minutes. Supernatants containing the acid-soluble proteins were 
collected and stored at -20 ºC before western blot analysis. In order to concentrate the 
histone protein, eight volumes of acetone were added to the samples which were then 
incubated at -20ºC overnight. Thereafter, samples were centrifuged 2,000 xg at 4 ºC for 
10 minutes and supernatants were removed. Samples were washed with acetone/HCL 
(100 mM stock) (10:1), and centrifuged 2,000 xg at 25 ºC for 10 minutes. This was was 
repeated twice. Supernatants were removed and pellets were washed with acetone (10 
volumes), then centrifuged 2,000 xg at 25 ºC for 10 minutes. This was was repeated 
three times. Supernatants were removed and then pellets were dried at room 
temperature. The pellets were either stored at -80 ºC until or dissolved in 0.2 M 
hydrochloric acid before being stored. The full details regarding preparation of cell 
extraction buffer is in Appendix 2. 
2.3.2.2 Whole cell extraction 
In order to analyse a house keeping protein (Beta-actin) and pluripotency marker (Oct4 
and Nanog), whole cell extract solution (RIPA buffer) was used to extract whole cell 
protein. RIPA buffer contained 50 mM Tris HCl pH 8 (Sigma), 150 mM NaCl (Sigma), 
1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 2 mM EDTA pH 7.4, 1.5 mM 
PMSF. Samples were incubated in lysis buffer at 4 °C for 30 minutes, and then briefly 
sonicated. Samples were centrifuged at 13,000 xg 4 °C for 10 minutes, and supernatants 
were stored at -20 °C. The full details regarding preparation of cell extraction buffer is 
in Appendix 2. 
2.3.2.3 Protein concentration measurement 
Protein concentration was measured using the DC protein assay (Bio-Rad) which is a 
colorimetric assay developed from the well-documented the Lowry assay (Lowry et al., 
1951). Firstly, working reagent A’ was prepared by adding 5 µl of reagent S into 250 µl 
of reagent A’ (working reagent A was stable for 1 week). BSA solution 0.2 to 1.5 mg 
was used to prepare a standard curve. One µl of standards and samples were added into 
the cuvette. Thereafter, 5 µl of working reagent A’ was added into each cuvette.  Finally 
200 µl of reagent B was added, and then vortexed to mix. Samples were incubated at 
Chapter 2  Materials and Methods 
 63
room temperature for 15 minutes before measuring absorbance at 750 nm using 
spectrophotometer (Thermo).  
2.3.2.4 Western blot analysis 
The western blot is a method of detecting specific proteins in a sample from tissue 
homogenate or extract. It uses gel electrophoresis to separate native or denatured 
proteins by the length of the polypeptide. 
Western blot was performed using the NuPAGE® system (Invitrogen) which is a pH 
discontinuous SDS-PAGE, precast polyacrylamide mini-gel system. Samples (10 to 
20µg protein) were mixed with NuPAGE® LDS sample buffer and NuPAGE® Reducing 
agent (500mM dithiothreitol), then heated to denature proteins at 70°C for 10 minutes. 
Protein electrophoresis was performed using precast 4-12% gradient Bis-Tris-Gels 
(Invitrogen), Xcell Surelock™ Mini-Cell and NuPAGE® MES SDS running buffer plus 
NuPAGE® antioxidant. The running conditions were 200 V constant voltages, starting 
at 110-125 mA/gel, ending with 70-80 mA/gel for 35 minutes. Thereafter, proteins were 
transferred onto a PVDF membrane (Amersham) with a XCell II™ Blot module using 
NuPAGE® transfer buffer plus NuPAGE® antioxidant. Conditions were 30 V constant 
voltage, starting at 170 mA, ending with 100 mA, for 1 hour.  
After the protein transfer step, membranes were removed from the block.  They were 
blocked with 5% skim milk, and then incubated with primary antibodies for either 1-3 h 
at room temperature or at 4°C for overnight (see Table 2.1). Membranes were washed 
five times with 0.1 % Tween 20 in PBS for 10 minutes. Thereafter membranes were 
incubated with secondary antibodies conjugated with HRP (see Table 2.2). 
Chemofluorescence was produced by reaction with ECL solution (Amersham) and was 
detected with X-ray film (Fujifilm) and Kodak imaging system (Kodak). All 
membranes were stained with anti-histone H3 or anti-histone H4 or β-actin primary 
antibodies to confirm equal protein loading. 
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Table 2.1 Primary antibodies used in the experiments 
Antibodies  
 
Dilution     Temp 
(ºC) 
Block Supplier 
 WE-F EF-IF EC-IF C-IF FC WB    
H3k9me1  1:200 1:100 1:200 1:500 1:500 1:1000 4  BSA Upstate 
H3K9me2 1:200 1:100 1:200 1:500 1:500 1:1000 4  BSA Upstate 
H3k9me3 1:200 1:100 1:200 1:500 1:500 1:1000 4  BSA Upstate 
H4K20me1 1:200 1:100 1:200 1:500 1:500 1:1000 4  BSA Upstate 
H4K20me2 1:200 1:100 1:200 1:500 1:500 1:1000 4  BSA Upstate 
H4k20me3 1:200 1:100 1:200 1:500 1:500 1:1000 4  BSA Upstate 
H3K27me3 1:200 Not used Not used 1:500 1:500 1:1000 4  BSA Upstate 
H3K4me3 1:200 Not used Not used 1:500 1:500 1:1000 4  BSA Upstate 
HP1β 1:300 Not used Not used 1:600 1:600 1:5000 4  DS Euromedex 
HP1α  1:100 1:50 1:100 1:300 1:300 1:5,000 RT DS Chemicon 
Oct4  1:100 Not used Not used 1:300 1:300 1:3000 4  DS Santa Cruz 
Nanog 1:500 Not used Not used 1:1000 1:1000 1:5000 RT DS Chemicon 
β-actin Not used Not used Not used Not used Not used 1:20000 4  Milk Abcam 
H3 Not used Not used Not used Not used Not used 1:20000 4  Milk Upstate 
H4 Not used Not used Not used Not used Not used 1:1000 4  Milk Upstate 
5MeC 1:200 Not used Not used 1:500 Not used Not used RT BSA Eurogentec 
WE-IF = Whole embryo immunofluorescence. EF-IF = Embryo paraffin section immunofluorescence 
C-IF = Cell immunofluorescence. FC = Flow cytometry. WB = Western blotting.  DS=Donkey serum. 
BSA= Bovine serum albumin. RT = Room temperature. Temp = Incubation temperature 
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Table 2.2 Secondary antibodies used in the experiments. 
Dilution Supplier Ab/companies 
WE-IF histo FC C-IF WB  
Anti-mouse FITC 1:200 1:200 1:200 1:200 Not used Jackson 
Anti-rabbit FITC 1:200 1:200 1:200 1:200 Not used Jackson 
Anti-rabbit TRITC 1:200 1:200 1:200 1:200 Not used Jackson 
Anti-mouse Alexa  488  1:500 1:200 Not used Not used Not used Molecular probe 
Anti-rabbit Alexa  488 1:500 1:200 Not used Not used Not used Molecular probe 
Anti-rabbit Alexa  543 1:500 1:200 Not used Not used Not used Molecular probe 
Anti-mouse HRP Not used Not used Not used Not used 1:5000 Santa Cruz 
Anti-rabbit HRP Not used Not used Not used Not used 1:5000 Amersham 
Anti-rabbit PE Not used Not used Not used 1:200 Not used Santa cruz 
Histo = histofluorescence. WE-IF = Whole embryo immunofluorescence.  
C-IF = Cell immunofluorescence. FC = Flow cytometry. WB = Western blotting. 
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2.4 Gene expression analysis 
The Reverse Transcription Polymerase Chain Reaction (RT-PCR) technique was used 
to qualify and quantify the mRNA expression level in cells and embryos. These steps 
involved total RNA extraction, RNA concentration measurement, cDNA synthesis, 
semi-quantitative PCR and Quantitative real-time PCR. 
2.4.1 Sample preparation for total RNA extraction 
Cells were trypsinised into a 1.5 ml tube, and cell number was counted. RNA was 
extracted from up to 1x107 cells using the RNeasy kit (Qiagen). Cells were centrifuged 
at 700 xg for 4 minutes and supernatants were discarded. The pellets were stored at -80 
°C.  
Embryos were washed in M2 medium and then placed into 200 µl PCR tubes (ABgene) 
containing 10 µl of RNALater buffer (Ambion). Samples were incubated at 4ºC 
overnight and then transferred to -80 ºC for long term storage.  
2.4.2 Total RNA extraction by RNeasy kit (Qiagen) 
Lysis buffer was freshly prepared by mixing 990 µl of RLT with 10 µl of 
betamercaptoethanol. 350 µl of lysis buffer were used for less than 5 x106 cells, if more 
than that 600 µl was used. Lysis buffer was added into the cell extract (this step was 
performed on ice) and then mixed. Thereafter the samples were homogenised by pipette 
the lysate onto QIAshredder spin columns (Qiagen), centrifuged at 9,000 x g for 2 
minutes. One volume of 70% ethanol was added to the lysate and mixed using a pipette. 
Samples were applied to RNeasy minicolumns in 2-ml collection tubes and centrifuged 
at 8,000 xg for 15 seconds, and the flow-through was discarded. Before the next step 
DNase I was prepared by gently mixing 70 µl RDD buffer with 10 µl DNase I. Then 80 
µl of DNase I was gently pipetted into sample columns, and incubated at room 
temperature for 15 minutes to remove DNA.  350 µl of buffer RW1 was added into 
columns and then centrifuged at 8,000 xg for 15 seconds. Flow-through and used 
collection tubes were discarded. Columns were transferred to new 2-ml collection tubes 
and 500 µl of buffer RPE was added to columns then centrifuged at 8,000 xg for 15 
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seconds. Flow-through and collection tubes were discarded before 500 µl of buffer RPE 
was added to columns, centrifuged at 8,000xg for 2 minutes. Next, columns were 
transferred to 1.5 ml collection tubes for elution step. RNase-free water was added to 
columns (30 µl for cells, 50 µl for embryos) and centrifuge at 8,000 xg for a minute. 
The RNA was stored at -80 °C. 
2.4.3 Precipitation of embryo RNA using Pellet Paint® Co-Precipitant 
As the quantity of RNA yield from embryo was small. Pellet Paint® Co-Precipitant 
(Novagen) was used to concentrate embryonic RNA. Pellet Paint is a visible dye-
labelled carrier formulated specifically for use in alcohol precipitation of nucleic acids. 
To each tube of embryo RNA 2 µl of Pellet Paint was added with 0.1 volumes (i.e. 5 µl) 
of 3M sodium acetate and mixed briefly. Thereafter, two volumes (i.e. 100 µl) of 100% 
ice-cold ethanol was added and then mixed briefly. Samples were incubated at room 
temperature for 2 minutes. Afterward samples were centrifuged at 15,000 xg for 30min 
at 4°C, and supernatants were carefully removed.  Pellets were washed with 500 µl of 
ice-cold 70% ethanol in DEPC-treated water, mixed briefly and centrifuged at 15,000 
xg 4 °C for 25 min. The supernatants were removed, centrifuged again briefly and as 
much ethanol as possible was removed.  Pellets were dried on ice with tubes lids opened 
for approximately 10-15 minutes. Pellets were resuspended in 9 µl RNase-free water 
and transferred RNA to pre-labelled 0.5 ml PCR tubes. Tubes were stored on ice, before 
proceeding to cDNA synthesis, or stored in -80 ºC for storage. 
2.4.4 cDNA synthesis 
cDNA synthesis was performed by using either Cloned AMV first strand synthesis kit 
(Invitrogen) or Verso™ cDNA Kit (ABgene).  
For Cloned AMV first strand synthesis kit (Invitrogen), all steps were performed in 0.5 
ml PCR tubes (ABgene), on ice. The RNA in 9 µl RNase-free water (for cells we used 1 
µg), 1 µl of random hexamer and 2 µl of 10mM dNTP were mixed, then heated at 65 ºC 
for 5 minutes. The master mix was prepared on ice as follows: 4 µl of 5x cDNA 
synthesis buffer (vortex prior to use), 1 µl of  0.1M DDT, 1 µl of RNaseOUT, 1 µl of 
DEPC treated water, 1 µl of cloned AMV RT. Control (RT-ve) sample consisted of 
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RNA without reverse transcriptase. Eight µl of mastermix reaction was added to each 
tube of denatured RNA on ice. RNA was transferred to Hybaid PCR machine (Hybaid) 
to perform cDNA synthesis. The reverse transcription cycling program was as follows: 
(1) 25°C 10 minutes, (2) cDNA synthesis 50ºC for 50 minutes, (3) inactivation 85ºC for 
5 minutes. The product can be stored at -20 ºC before performing PCR.  
For Verso™ cDNA synthesis, VersoTM reverse transcriptase was used as RNA 
dependent DNA polymerase with a significant attenuate RNAse H activity can 
synthesise long cDNA up to 11 kb between the temperatures 42 and 57ºC. The 
recommended amount of starting RNA is between 1 рg to 1 µg. RT enhancer was used 
to eliminate contaminating DNA during RT step.  RNA was heated at 70 ºC for 5 
minutes to reduce secondary structure, and then immediately placed on ice. 11 µl 
diluted RNA was mixed with 4 µl of 5XcDNA synthesis buffer, 2 µl dNTP mix, 1 µl of 
random hexamer andc zx 1 µl of Verso enzyme mix.  Thereafter, tubes were transferred 
to Hybaid PCR machine (Hybaid) to perform cDNA synthesis. The reverse transcription 
cycling program was as follows: (1) cDNA synthesis 50ºC for 30 minutes, (2) 
inactivation 95ºC for 2 minutes. 
RT-negative samples were prepared similar to normal sample except adding reverse 
transcriptase enzymes. RT-negative samples were used to ensure the RNA used was 
free of DNA contaminants. 
2.4.5 Polymerase Chain Reaction (PCR)  
The Thermostart PCR mix (2x) (ABgene) containing dNTP’s 1.5mM MgCl2 and hot-
start taq polymerase was used for PCR. PCR mastermix was prepared containing: 12.5 
µl PCR buffer, 1.25 µl forward primers, 1.25 µl reverse primer and 8 µl distilled water. 
The 23 µl of mix were added to each tube in PCR hood. On lab bench 2 µl of cDNA 
was added, mixed well, centrifuged tubes briefly, kept tubes on ice. Tubes were 
transferred to PCR machine (Hybaid).  PCR programme was, 1 cycle of 95 °C  for 15 
min, 35 to 40 cycles of 95°C for 30 sec, 55 to 65°C for 30 sec, followed by 72°C for 45 
sec, 1 cycle of 72°C for 5 to 7 min, cool to 4°C and hold at 4°C. A list of the primers 
and relevant references is shown in Table 2.3. 
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2.4.6 Agarose Gels for DNA Electrophoresis 
The PCR products were run on an agarose gel. Agarose (Fisher Scientific) was added 
into 1X Tris Borate EDTA (TBE) buffer (see Appendix 2) to make 1.5% agarose gel. 
SYBR gold (Molecular probes, Invitrogen) (1 µl in 100 ml of TBE) was added into 
mixture. The mixture was heated using a microwave until the agarose had dissolved. . 
The gel was cooled before pouring into the gel cassette and allowed to polymerise. 15 µl 
of PCR product were loaded into each lane on 1.5% agarose gel. Electrophoresis was 
run in TBE buffer with 90 Volts for 30 to 60 minutes. PCR products were observed by 
UV light and images were captured using Gel-DOC programme (Bio-Rad). The 10 µl of 
100 bp DNA ladder (New England Biolab) was used to determine size of PCR products. 
2.4.7 Real time Quantitative Polymerase Chain Reaction (QPCR) 
QPCR is becoming important for gene expression analysis. One method for real-time 
quantification uses SYBR Green I, a dye that fluoresces when bound non-specifically to 
double stranded DNA. SYBR Green I is more economical and sensitive than using 
probes; however, it is less specific.  The QPCR using SYBR Green requires 
optimisation of the primer concentration and PCR conditions before doing the 
experiment. Basically, the fluorescent dye SYBR Green I binds to the minor groove of 
the DNA double helix. The unbound dye molecule weakly fluoresces, producing a 
minimal background fluorescence signal which is subtracted during computer analysis. 
After the annealing step, a few dye molecules can bind to the double strand and then 
more dye molecules bind to the newly synthesised DNA during the elongation step, 
resulting in a dramatic increase of the SYBR Green I molecules emitting light on 
excitation. Upon denaturation of the DNA before the next heating cycle, the dye 
molecules are released and the fluorescence signal significantly decreases. Fluorescence 
measurement was performed at the end of the elongation step of every PCR cycle to 
monitor the real-time continuously increasing amount of amplified DNA. A melt curve 
analysis was usually performed subsequently to the PCR to identified primer dimer, and 
DNA contamination. So using PCR with the SYBR Green I together with melt curve 
analysis provides an excellent tool for specific product identification and quantification. 
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A 2-Step QPCR technique was used in the present studies. cDNA synthesis was 
performed by using VersoTM cDNA synthesis kit. For PCR step, we use ABsolute™ 
Blue QPCR SYBR green with low ROX Mix (ABgene) contained Therm-StartTM DNA 
polymerase for doing PCR and ROX dye which  is an internal passive reference used to 
normalise the fluorescent reporter signal generated in qPCR. The final concentration of 
ROX dye was 25 nM in 1x reaction. The concentration of MgCl2 was 3mM in the final 
1x reaction. The DNA polymerase was activated at 95ºC for 15 minute before PCR. 3 
step QPCR program was used as follow: (1) denature 95ºC for 15 sec, (2) annealing 
temperature 15 seconds, (3) Extension 15 seconds for product size less than 200 kb, 30 
seconds for product size between 200 to 500 kb, 60 seconds for product size more than 
500 bp. The PCR was repeated for 40 cycles and then melt curve analysis was 
performed. In this study we used a PCR platform called the Rotor-GeneTM 6000 
(Corbett life science).  The total reaction volume was 25 µl in 200 µl PCR tubes 
(Corbett Life Science). QPCR primer sequences were obtained from publications (see 
Table 2.4) and primer bank (Wang and Seed, 2003). The names of genes, primers 
sequence and reference are shown in Table 2.4.  
2.4.8 Quantification strategy in QRT-PCR  
Generally, three major strategies are performed in real-time RT-PCR to measure the 
levels of expressed genes: (1) absolute quantification, (2) relative quantification and (3) 
comparative quantification. 
Absolute quantification is used to determine the amount of sample mRNA (copy 
number or ng, etc). Basically, it translates the PCR signal to a defined unit of interest by 
calculation with a calibration curve using known DNA standard molecules. The 
reliability of an absolute real-time RT-PCR assay depends on the condition of 
‘identical’ amplification efficiencies for both the native target and the calibration curve 
in RT reaction and in the following kinetic PCR. Absolute quantification is commonly 
used for diagnosis purposes such as viral or bacterial load determination, amount of 
microorganism in food and the percentage of genetic modified organisms in food 
(Pfaffl, 2004). 
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Relative quantification measures the relative change in mRNA expression levels 
between multiple samples and is represented as a ratio or fold change. Unlike absolute 
quantification, a calibration curve is not necessary for relative quantification. However 
it may require a serial dilution of calibrator to give a standard curve which can be used 
to calculate reaction efficiency. The reaction efficiency should represent the 
repeatability and reliability of the experiments and is also inserted into the mathematical 
model for calculating relative gene expression. Genes of interest have to be normalised 
with reference genes which are stable expression genes, for example, house keeping 
genes Gapdh and beta-actin. The reliability of the result is dependant on the stability of 
the gene used for normalisation, so it makes the selection of reference genes critical for 
valid results. The relative quantification method is widely used to study the pattern of 
gene expression in many experiments such as a comparison between control and 
treatment or between different tissues. 
Comparative quantification is quite similar to relative method, but reference genes are 
not required and sometimes reaction efficiency may be unnecessary.  It can be used to 
study a high throughput of different gene expression in various samples.  
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Table 2.3 Primer sequences for conventional RT-PCR (The concentration for all 
primers is 10 µM) 





Suv3-9h1 F  CGCATCGCATTCTTTGCC 184 60 
 R AAGCCGTTGTCCCACATTTG   
(Lehnertz et al., 2003) 
Suv3-9h2 F  AAATCCAACCAGGCACTCCC 278 60 
 R CTCGTAGTCCAGGTCAAAGAGGTA   
(Lehnertz et al., 2003) 
Suv4-20h1 F  CACGACAGTGACAGCAACCT 655 58 Wongtawan, T 
 R GTCTGAAGGCCCTATGTGGA    
Suv4-20h2 F  TGCGTGAAGAGGATGAAGAC 800 58 Wongtawan, T 
 R TAGGCGGGTAAGTTCCACAC    
Oct4 F  GGCGTTCTCTTTGGAAAGGTGTTC 312 55 
 R CTCGAACCACATCCTTCTCT   
(Chambeyron and 
Bickmore, 2004) 
Gapdh F  AACAACCCCTTCATTGACCTC 458 60 
 R TTCTGAGTGGCAGTGATGGC   
(Lehnertz et al., 2003) 
Ehmt1 F  CCTGGAGGAGCCAGTAAATG 350 55 Wongtawan, T 
 R GCTGTCTGGGACTTTGTGGT    
Ehmt2 F ATCCTTAAGCGGGAGACCAT 221 58 Wongtawan, T 
 R CAGTGGGGACAGAAGACCAT    
HP1a F  AGGGCAACCTACCTGTTGTG 547 55 Wongtawan, T 
 R GGCTCCTCTCCAAAAATTCC    
Jmjd1A F  GCCTAGCATTCTTGGCTTTG 597 58 Wongtawan, T 
 R ATGACATTGGCTGCATCAGA    
Jmjd2a F  GCTGCAGCACAGACATCAAT 504 58 Wongtawan, T 
 R GGAAGCACGTGATGAAGACA    
Jmjd2c F  GATGACTGGCCTTACGTGGT 702 58 Wongtawan, T 
 R GTCCCAATGTGTACCCCAAG    
Ezh2 F  AAGCACAATGCAACACCAAA 170 58 Taylor, J 
 R AGACGGTGCCAGCAGTAAGT    
*Annealing temperature. F=Forward primer. R=Reverse primer 
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Table 2.4 Primer sequences for QPCR 








Oct4 F ACATCGCCAATCAGCTTGG 50 60 900 
 R AGAACCATACTCGAACCACATCC   900 
(Brambrink et al., 2008) 
Sox2 F ACAGATGCAACCGATGCACC 52 60 50 
 R TGGAGTTGTACTGCAGGGCG   300 
(Brambrink et al., 2008) 
Gapdh F TTCACCACCATGGAGAAGGC 51 60 300 
 R CCCTTTTGGCTCCACCCT   300 
(Brambrink et al., 2008) 
Ehmt2 F ATCCTTAAGCGGGAGACCAT 221 60 900 Wongtawan, T 
 R CAGTGGGGACAGAAGACCAT   50  
Suv3-9h1 F CGCATCGCATTCTTTGCC 184 60 900 
 R AAGCCGTTGTCCCACATTTG   900 
(Lehnertz et al., 2003) 
Suv3-9h2 F AAATCCAACCAGGCACTCCC 278 60 300 
 R CTCGTAGTCCAGGTCAAAGAGGTA   900 
(Lehnertz et al., 2003) 
Jmjd2a F TAATGTCTGAAAGCGGCTTCTG 112 60 900 
 R TTCTGTTTGGAAACTGACCAGG   900 
(Wang and Seed, 2003) 
Jmjd1a F CAGCAACTCCATCTAGCAAGG 161 60 900 
 R TGTTCTCGGTACTTCAGGTTTTG   300 
(Wang and Seed, 2003) 
Jmjd2c F TGGAGAGTCCCCTAAATCCCA 129 60 300 
 R CCTTGGCAAGACCTGCTCG   900 
(Wang and Seed, 2003) 
Nanog F CACCCACCCATGCTAGTCTT 130 60 900 
 R ACCCTCAAACTCCTGGTCCT   900 
(Masui et al., 2007) 
Eset F CCTGGGTGCATGAGTTTGG 118 60 300 
 R TGTACTGACGAAGTTCCTCCATA   300 
(Wang and Seed, 2003) 
MuERV F TTCTCAAGGCCCACCAATAGT 301 58 300 
 R GACACCTTTTTTAACTATGCGAGCT   900 
(Sonehara et al., 2008) 
Elf1a F AAAAACAGGCGCAGAGGTAAA 142 58 300 
 R TCCTCACACCGTCAAAGCAC   900 
(Wang and Seed, 2003) 
Zcan4D F TGTAGCCGTCGCTTTCGCCA 196 58 900 Wongtawan, T 
 R GTGGCAATCCACAAGCATGTTA   900  
Rpl13a F CCTGCTGCTCTCAAGGTTGTT 146 60 300 
 R CGATAGTGCATCTTGGCCTTT   900 
(Wang and Seed, 2003) 
β-actin F CAACGAGCGGTTCCGATG 67 60 300 
 R GCCACAGGATTCCATACCCA   300 
(Lefever et al., 2009) 
Cdx2 F AGGCTGAGCCATGAGGAGTA 124 60 300 (Masui et al., 2007) 
 R CGAGGTCCATAATTCCACTCA   300  
*Annealing temperature. F=Forward primer. R=Reverse primer 
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2.5 Gene knock-down by siRNA 
The short interfering RNA (siRNA) or silencing RNA, is a class of 20-25 nucleotide-
long double-stranded RNA molecules that play a variety of roles in biology. Most 
notably, siRNA is involved in the RNA interference (RNAi) pathway, where it 
interferes with the expression of a specific gene. The use of siRNA for gene silencing is 
a rapidly evolving tool in molecular biology to study gene expression and function. In 
these experiments, siRNA was used to study the function of HMTase and DHTMase. 
2.5.1 Transfection siRNA into ES cells 
ES cells (2x105 cells) were plated into each well of 6-well plate, and cultured with 2 ml 
of ES cell medium (without antibiotics) for 1 hour, at 37°C in 5% CO2 incubator. After 
45 minutes, siRNA solution was prepared as follows: 125 pmole siRNA (6.25 µl) was 
added to 250 µl Opti-MEM, mixed gently.  Diluted transfection reagent was prepared 
by adding 5 µl Lipofectamine™ 2000into Opti-MEM®, gently mixed and incubated at 
room temperature for 15 minutes. The 250 µl of siRNA was gently mixed with 250 µl 
Lipofectamine™ 2000, and incubated at room temperature for 15 minutes to form a 
complex. After that, 500 µl of complexes were added to each well containing cells and 
medium, gently mixed by rocking the plate back and forth. Finally cells were incubated 
at 37°C in 5% CO2 incubator for 16-24 h. 
2.5.2 siRNA injection into zygote 
For embryo knock-down experiments, intracytoplasmic injection technique was used to 
deliver siRNA into embryonic cytoplasm. Pipettes were purchased from Biomedical 
Instruments Ltd (Germany, cat no.PI1.2). The diameter of the injection needle was 
approximately 1.2 µm. Injection was performed using Narishige micromanipulation 
system connected to a Nikon Microscope by Dr. Jane Taylor (University of Edinburgh). 
The volume of liquid injection was controlled using a PV820 PicoPump (World 
Precision Instruments Ltd.). One to two microlitres of siRNA (50 to 100 µM) was 
loaded into injection pipette and approximately 1 pl of liquid was injected into zygote 
cytoplasm. Injection of either RNAi-negative control (Negative Control #1 siRNA, 
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Ambion) or buffer was used as negative controls while Oct4 siRNA was used as a 
positive control. The siRNA sequences and suppliers are shown in Table 2.5. 
 
Table 2.5 siRNA sequences  
 
Gene Sequence OligoID Suppliers 
Jmjd2c sense UGAACAGGAGUACAAUGCAACUGUU MSS233760 Invitrogen
Jmjd2c antisense AACAGUUGCAUUGUACUCCUGUUCA MSS233760 Invitrogen
Oct4 sense GGAUGUGGUUCGAGUAUGGtt 151960 Ambion 
Oct4 antisense CCAUACUCGAACCACAUCCtt 151960 Ambion 
Jmjd2a sense GCCACACAGACAGGUUGCUUGGAAA MSS200432 Invitrogen
Jmjd2a antisense UUUCCAAGCAACCUGUCUGUGUGGC MSS200432 Invitrogen
Jmjd1a sense CAGGAGAGCCGAGUGUGAAGAAGAA MSS214043 Invitrogen
Jmjd1a antisense UUCUUCUUCACACUCGGCUCUCCUG MSS214043 Invitrogen
Negative control* StealthTM RNAi negative control duplex  12935-300 Invitrogen
Transfection 
control* 
Block-itTM alexa Fluor® Red Fluorescent 
Oligo 
14750-100 Invitrogen
* No sequence information provide from companies. 
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Chapter 3 
Dynamics of histone lysine methylations, modifiers and 
satellite sequences in mouse preimplantation embryos. 
3.1 Introduction 
3.1.1 Genetic reprogramming in the preimplantation embryo 
One of the most critical events for the beginning of new life is the transition of maternal 
oocyte to embryonic zygote upon fertilisation. Oocytes synthesise and store transcripts 
and proteins that are important for genetic and epigenetic reprogramming 
postfertilisation (Ma et al., 2008, Bachvarova, 1985, Zeng et al., 2004, Vitale et al., 
2007). The transition of the maternal oocyte to embryonic zygote is comprised of three 
steps: first, degradation of maternally inherited transcripts and proteins occurs 
immediately after fertilisation (Bachvarova, 1985, Piko and Clegg, 1982, Clegg and 
Piko, 1982, Flach et al., 1982). This degradation is specific for mRNA used during 
oogenesis, but not mRNA required for embryo development (Alizadeh et al., 2005). 
Second, stored maternal transcripts and proteins are replaced with new zygotic 
transcripts and proteins such as housekeeping genes at the one to two-cell stage 
(Schultz, 2002, Minami et al., 2007, Flach et al., 1982). Third, expression of new 
embryonic-specific transcripts starts at the time point which is called zygotic gene 
activation (ZGA) or embryonic gene activation (EGA) (Schultz, 2002, Minami et al., 
2007). 
ZGA in mice mainly occurs at the 2-cell stage, and requires changes in gene regulation 
and chromatin organisation (Bell et al., 2008, Schultz, 2002). Gene enhancers become 
more active after the ZGA event in order to relieve the transcriptional repressive state 
(Henery et al., 1995, Wiekowski et al., 1993). Approximately 70 % of transcripts in the 
oocytes are derived from TATA-containing promoters; this fundamentally changes after 
fertilisation to utilise TATA-less promoters in preimplantation embryos. It is likely that 
TATA-less promoters are more efficient and can accelerate the expression of vital 
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totipotent genes (Davis and Schultz, 2000, Schultz, 2002). Two-cell embryos contain 
both maternal mRNA and new transcripts of which approximately 50 % are found in 
oocytes (Evsikov et al., 2004, Evsikov et al., 2006) and 15 % of transcripts correspond 
to repetitive sequence such as transposons (Ma et al., 2001, Evsikov et al., 2004). Many 
transcripts identified in oocytes are cis-encoded RNAs that are transcripts from the 
same gene but in the opposite orientation. For example, Suv39h1 mRNA is not detected 
in oocytes but Suv39h1 antisense appears in the oocyte; this antisense RNA may have a 
role in regulating mRNA (Evsikov et al., 2006).  
Another wave of gene expression in mouse preimplantation development is found 
between the 4 to 8 cell stages, named mid-preimplantation gene activation (MGA). This 
gene expression contributes to cell lineage specification and is particularly important for 
the formation of the inner cell mass and trophectoderm of the blastocyst (review by Bell 
et al., 2008).  
3.1.2 Protein synthesis in preimplantation embryos 
After fertilisation, oocyte proteins remain in the zygote but very few persist to the two-
cell stage (Howe and Solter, 1979, Levinson et al., 1978). Many new proteins appear in 
two-cell embryos and some of these are two-cell specific proteins which disappear at 
the four-cell stage (Howe and Solter, 1979, Levinson et al., 1978). Stage-specific 
proteins are also found in four to eight-cell stage and blastocyst embryos (Howe and 
Solter, 1979, Levinson et al., 1978). Protein synthesis significantly changes (mainly 
increases) in two-cell embryos, but is stable in four-cell embryos (Latham et al., 1991). 
3.1.3 Histone lysine methylation in preimplantation embryos 
Asymmetry of parental histone modifications has been found in zygote to two-cell stage 
embryos. Typically, paternal chromatin lacks many types of histone methylation while 
maternal chromatin is fully modified. Asymmetry of histone methylation disappears at 
the four-cell stage, suggesting that the parental genomes are homogenously mixed after 
this stage. (Santos et al., 2005, Arney et al., 2002, Lepikhov and Walter, 2004, Erhardt 
et al., 2003, Torres-Padilla et al., 2006, Sarmento et al., 2004, van der Heijden et al., 
2005). The asymmetry of parental epigenetic and chromatin modifications may play an 
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important role in cellular reprogramming and ZGA. For example, embryos 
reconstructed by nuclear transfer mainly fail at the two-cell stage and show aberrant 
expression of ZGA (Inoue et al., 2006, Suzuki et al., 2006, Sebastiano et al., 2005). The 
epigenetic asymmetry of parental genomes does not occur in cloned two cell embryos 
(Merico et al., 2007, Yoshida et al., 2007). The somatic patterns of chromocentres and 
histone methylation persist in cloned embryos (Martin et al., 2006a, Martin et al., 
2006b, Merico et al., 2007) and the resulting aberrant methylation pattern at the two-cell 
stage causes early development failure (Shi and Haaf, 2002) . 
Histone methylations are regulated by histone methyltransferases (HMTs) and 
demethylases. Eset, Ehmt1, Ehmt2, Suv3-9h1 and Suv39h2 are histone 
methyltransferases that catalyse H3K9 methylation in mammalian cells. Deletion of 
each gene causes developmental failure at a different stage (see Table 1.2 in Chapter 1). 
Histone methylations were widely believed to be irreversible (Bannister et al., 2002) 
until the first histone demethylase was recently discovered (Shi et al., 2004). Little is 
known about the function of histone demethylases in mouse development. H3K27 
demethylases Jmjd3 and UTX are involved in HOX gene regulation and development in 
C. elegans (Agger et al., 2007) and zebrafish (Lan et al., 2007). Jmjd3 is also involved 
in cell differentiation in mouse epidermal stem cells (Sen et al., 2008) and is required 
for neural commitment in mouse ES cells (Burgold et al., 2008). H3K9me1/2 
demethylase Jmjd1a has an important role in spermatogenesis and the disruption of this 
gene may cause male infertility (Okada et al., 2007). Jmjd1a and Jmjd2c also play 
important roles for maintaining pluripotency in mouse ES cells by prevention of 
methylation at promoter regions of pluripotency genes (Loh et al., 2007).  
3.1.4 Non-coding transcripts from repetitive element in preimplantation embryos  
Repeat sequences are usually epigenetically silenced in differentiated cells compared to 
early developmental cells or pluripotent cells. This is associated with DNA methylation 
and histone methylation marks such as H3K9me2, H3K9me3, H4K20me2 and 
H4K20me3 (Martens et al., 2005). Epigenetic reprogramming at repetitive sequences 
can occur at early development (Santos et al., 2002, Santos et al., 2005, Reik, 2007) and 
during germ cell formation (Hajkova et al., 2008, Surani et al., 2008, Reik, 2007) and it 
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may activate the transcription process at repeat sequences. After fertilisation, DNA 
methylation is significantly decreased, compared to parental germ cells and somatic 
cells, at least at early transposon (Etn) and centromeric satellites but not intracisternal-A 
particle (IAP) (Kim et al., 2004). A comprehensive analysis of transposable element 
expression in mouse unfertilised oocytes revealed that long terminal repeat (LTR) class 
III retrotransposons make a large contribution to the maternal mRNA pool (12 %), 
which persist in cleavage stage embryos, and expression of transposable elements (TES) 
is developmentally regulated (Peaston et al., 2004). Furthermore, TES can act as 
alternative promoters and first exons for a subset of host genes, regulating their 
expression in oocyte and cleavage embryos (Peaston et al., 2004). Other reports also 
show that many endogenous retrovirus (ERV) particles and non-LTR transposons are 
also highly expressed in mature oocytes (Puschendorf et al., 2006). 
Transcriptome analysis of two-cell embryos revealed that 8 % of transcripts are 
repetitive elements in which 80 % of them are retrotransposons including ERV 
(Evsikov et al., 2004). This is consistent with other meta-analyses showing that many 
transposons are highly expressed in two-cell embryos (Stanton and Green, 2001). 
Murine endogenous retrovirus (MuERV-L) is the one of the earliest transcribed genes in 
mouse zygotes and is highly expressed in two cell embryos and is suppressed in four-
cell embryos (Peaston et al., 2004, Kigami et al., 2003, Svoboda et al., 2004) while IAP 
expresses highly at eight-cell and blastocyst stages (Svoboda et al., 2004). Inhibiting the 
RNAi pathway by knocking down Dicer causes an increase in expression of these two 
repetitive elements (Svoboda et al., 2004). These ERVs were found to act as alternative 
promoter and first exon to diverse genes in two-cell embryos, synchronising their 
expression (Peaston et al., 2007). Inhibition ERVs activity using antisense RNA causes 
embryos to arrest at the four-cell stage (Kigami et al., 2003). 
3.15 Objectives. 
Currently there is a lack of reports profiling the level of histone methylation and their 
modifiers in mouse preimplantation embryos. The aim of this study was to investigate 
dynamic changes in global histone methylation and their modifiers during 
preimplantation development.  
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3.2 Materials and methods 
3.3 Experimental design 
Zygotes were collected from B6CBAF1 mice and cultured in KSOM medium. Embryos 
from all preimplantation stage were collected for immunofluorescence and RT-PCR. A 
total of approximately 30 embryos per stage for each antibody were collected to do 
immunofluorescence. Each time, ten embryos per stage were stained and observed 
under the fluorescence microscope. The experiment was repeated three times with 
different sample groups.. For QPCR, thirty embryos in total were collected to quantify 
gene expression by qPCR. Fifteen embryos per stage were pooled for RNA extraction 
and each pooled sample was performed in triplicate. The PCR was repeated twice with a 
different pooled sample. These details of the techniques used are described in Chapter 2 
Materials and Methods. 
3.4 Comparative and Relative gene expression Analysis 
In this experiment, comparative and relative quantification was used to study the trend 
of gene expression in preimplantation embryos (see Chapter 2, Materials and Methods). 
Relative gene expression requires the use of an endogenous control such as a 
housekeeping gene to monitor RNA integrity, concentration and PCR efficiency (Fleige 
et al., 2006, Pfaffl, 2006). Many previous reports show that gene expression of 
housekeeping genes in embryos is highly dynamic during preimplantation development, 
(Mamo et al., 2007, Goossens et al., 2005, Kuijk et al., 2007), and comparative 
expression (non-normalisation with house keeping gene) may be suitable and not bias 
the data (Pfaffl, 2006). My studies reveal that expression of the housekeeping gene 
Gapdh either per embryo or per individual cells is dynamic especially during oocyte to 
two-cell stage where mRNA degradation occurs (Figure 3.1), however; the overall 
result suggested that normalisation with a housekeeping gene could be used to compare 
only some stage of embryos (Figure 3.1). Alternatively, some studies suggest the use of 
an external control such as synthetic RNA to monitor sample RNA concentration 
(McGraw et al., 2007) but this cannot replace the use of an endogenous gene as it 
cannot measure RNA integrity which may cause changes to the relative concentration 
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(Fleige et al., 2006). Taking together, I have shown both gene expression ratios per 
embryo and also relative to house keeping gene (Gapdh) and believe this may be the 
best way to demonstrate the results without bias. Gapdh can be used as endogenous 
control for RNA concentration, RNA quality and PCR efficiency.  
 In the present studies the cell number of the embryos and the use ROX dye helped to 
adjust or ‘normalise’ the amount of input material and volume variation in each tube. 
Quantification of individual transcripts was performed using the comparative 
quantification analysis included in the Rotor-gene 600 series software (Corbett life 
science, UK). The feature "Comparative Quantification" was used to obtain threshold 
cycle (Ct) value and amplification efficiency, which were comparable to reaction 
efficiency. Gene expression was mathematically compared between calibrator and 
sample (Warton et al., 2004). The software calculates the Ct value using a take-off point 
defined as the cycle at which 20 % of the maximum level of fluorescence is reached in 
the reaction, and also indicates the end of the noise and the transition into the 
exponential phase (Figure 3.2). The reaction efficiency (sample amplification) was 
calculated at exponential phase, by detection of the average increase in raw data four 
cycles following the take-off (Figure 3.3). A 100 % efficient reaction would result in an 
amplification value of 2 for every sample, which means that a doubling of amplicons 
takes place in every cycle. The mean efficiency of a group was used to calculate a fold 
change according to the formula 1 for comparative quantification. For relative 
quantification the gene of interest (GOI) was normalised with a reference gene (REF) as 
shown in formula 2. This is one of the best models for relative gene expression due to 
the fact it can minimise the interference of variation from PCR efficiency, manual error, 
and RNA stability (Pfaffl, 2004, Pfaffl et al., 2002, Pfaffl, 2001, Fleige et al., 2006, 
Pfaffl, 2006). 
                                          R = E(GOI)Ct1-Ct2                  (1) 
                                          R = E(GOI)Ct1-Ct2                  (2) 
                                                 E(REF)Ct1-Ct2          
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R = gene expression ratio, E = amplication efficiency, Ct1= take off value of calibrator 




Figure 3.1 Comparative expression of reference gene Gapdh in oocytes and 
preimplantation embryos. (A) Expression of Gapdh per cell. (B) Expression of Gapdh per 
embryo. The value shown is gene expression ratio (GV embryo was used as a calibrator). Error 
bar represented standard deviation. 
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Figure 3.2 Model for calculation of Ct value. Ct value was calculated using take-off point and 
reaction efficiency (sample amplification). This image was modified from Rotor Gene software 
manual. 
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3.5 Statistics 
Statistical software SPSS14 was used to analyse statistical changes in fluorescence 
intensity. Data was evaluated for normal distribution. Total nuclear fluorescence 
intensity is shown in mean ± standard error. Statistic difference was analysed using 
ANOVA and Student’s t test. For comparison between embryos and ES cells, the REST 
software was used, this software use the Pair Wise Fixed Allocation Randomisation 
Test to calculate statistical differences (Pfaffl et al., 2002, Horgan and Rouault, 2000). 
 
3.3 Results 
3.3.1 Asymmetry of histone lysine methylation in zygotes 
My immunofluorescence results showed that H3K9me2, H3K9me3, H3K27me3, 
H3K4me3 and H4K20me3 were strongly detected after fertilisation in female 
chromatin, whereas the signal from paternal chromatin was very weak or undetectable 
(Figures 3.4, 3.5, 3.8, and 3.10). Unlike other histone methylations, H4K20me1 and 
H3K9me1 were clearly found in both male and female chromatin (Figure 3.3 and 3.6), 
but were preferentially enriched in male rather than female chromatin based on 
quantification of fluorescence intensity (Figure 3.11 and 3.12). This may suggest that 
these markers have an important role in the heterochromatin of the paternal genome. 
Only H4K20me2 was not detected in either parental chromatin (Figure 3.7 and 3.12). 
This asymmetry of histone methylation between parental genomes found in the present 
study was mostly similar to previous reports (van der Heijden et al., 2005, Santos et al., 
2005) with the exception of H3K27me3, reported to be present in male and female 
pronuclei (Puschendorf et al., 2008) and H3K9me reported to be detectable only in 
female chromatin (van der Heijden et al., 2005). These differences between previous 
and the present studies may reflect the specificity and sensitivity of each antibody to the 
antigen epitope. Moreover, some diversity of pattern of histone methylations may also 
occur between mouse strains (See Table 1) (Peaston and Whitelaw, 2006).  
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Table 3.1 Mouse strains that are commonly used to study embryo epigenetics during 
development  
Mouse strain References 
B6CBAF1  
(C57BL/6 x CBA) 
Wongtawan T, (van der Heijden et al., 2005, Martin et al., 2006b, 
Kim et al., 2004) 
C57BL6 (Puschendorf et al., 2008, Houlard et al., 2006, Lewis et al., 2006) 
B6D2F1 
(C57BL/6 x DBA/2) 
(Chung et al., 2003, Kageyama et al., 2007a, Moreira et al., 2003) 
CF1 (Puschendorf et al., 2006) 
CD1 (ICR) (Puschendorf et al., 2006, Godmann et al., 2007, Kigami et al., 
2003) 
B6CDF1 (SLC) (Kim et al., 2003) 
 
3.3.2 Similar dynamic patterns of H3K9me2 and H3K9me3 but not H3K9me1 
Many studies show that methylations of H3K9 are strongly associated with gene 
repression (Lachner et al., 2003, Mikkelsen et al., 2007, Huebert et al., 2006). The 
quantification in the present study showed that highly dynamic changes in methylation 
of H3K9 were found in H3K9me2 and H3K9me3 but not H3K9me1 which was more 
stable. The patterns of H3K9me2 and H3K9me3 are very similar: in two-cell embryos. 
H3K9me3, H3K9me2 fluorescence signal was dramatically reduced (approximately 
seven times reduction), but then the signal became stronger in four-cell embryos 
(Figures 3.4, 3.5 and 3.11). This result suggests that active demethylation of H3K9me2, 
H3K9me3 occurs in two-cell embryos while de novo methylation occurs in four-cell 
embryos. Moreover, quantitative analysis showed that at eight-cell embryo stage, the 
total intensity of H3K9me2, H3K9me3 was highest (Figure 3.11). Interestingly, at the 
morula stage, H3K9me2 and H3K9me3 seem to have undergone a passive 
demethylation (two times reduction) and maintenance demethylation is instated in the 
blastocyst. The demethylation and remethylation of H3K9me2 at two to four cell stage 
has been observed in a previous study (Liu et al., 2004), showing that it occurs in both 
male (androgenetic embryo) and female (parthenogenetic embryo) chromatin.  
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3.3.3 Distinct pattern of H4K20me1, H4K20me2 and H4K20me3  
H4K20me1 was the only type of H4K20 methylation found in all preimplantation 
stages. The highest signal was observed in the paternal pronucleus of the zygote. The 
signal was stable from zygote (maternal pronuclei) to eight-cell stage, and then the 
signal decreased at morula and blastocyst (Figure 3.12). H4K20me2 was not found at 
zygote and two-cell, but it became visible but very weak in four-cell embryos and 
increased at eight-cell embryos to blastocysts (Figure 3.2 and 3.7). There was no 
difference between TE and ICM for H4K20me1 and H4K20me2 (Figure 3.6, 3.7, 3.12). 
H4K20me3 was found in female chromatin and was specifically localised at 
perinucleolar ring (Figure 3.8) where pericentric heterochromatin is located (Probst et 
al., 2007). In my studies, H4K20me3 was completely undetectable from two-cell 
embryos until blastocysts. Demethylation of H4K20me3 was also noted in previous 
study with a hardly detectable level of H4K20me3 (Kourmouli et al., 2004).  
3.3.4 H3K4me3 and H3K27me3 
Generally, H3K4me3 marks transcriptionally active promoters and permissive 
chromatin whereas H3K27me3 is related to gene repression in euchromatin (Lopez-
Bigas et al., 2008, Schubeler et al., 2004, Mikkelsen et al., 2007). A bivalent 
modification was reported in ES cells, in which H3K4me3 and H3K27me3 bind to the 
same promoter of many developmental genes (Bernstein et al., 2006, Azuara et al., 
2006). The bivalent modification is believed to play an important role in maintaining 
pluripotency and prepares the cell for differentiation (Bernstein et al., 2006, Azuara et 
al., 2006). In the present study, the global level of H3K4me3 was highest in zygotic 
female chromatin (Figure 3.09, 3.13) and then demethylation occurred at two- and four-
cell embryos. Fluorescence intensity was low and steady until early blastocyst, 
thereafter remethylation occurred in late blastocyst, but only in ICM, not TE.  
The level of H3K27me3 was highly detected in male pronuclei; the signal was steady 
from two-cell to eight-cell stage (Figure 3.13). Thereafter the fluorescence signal 
decreased (around two times) in morula and then remethylation occurred only in ICM of 
blastocysts (Figure 3.13). It seems likely that remethylation of both H3K4me3 and 
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H3K27me3 concurrently occur at ICM and may be related to the bivalent modification 
of pluripotent ICM. 
3.3.5 Most histone demethylases but not methyltransferases were detected 
throughout preimplantation development 
In order to investigate the mechanism of dynamic histone methylations in 
preimplantation embryos, quantitative gene expression analysis of HMTs and 
demethylases was used. Relative gene expression was normalised to either reference 
gene Gapdh or embryo number.  
The present studies showed that most histone demethylases (Figure 3.16 and 3.17) but 
not methyltransferase were detected throughout preimplantation (Figure 3.14 and 3.15). 
Suv3-9h1 and Suv3-9h2 work together to catalyse H3K9me3 at constitutive 
heterochromatin in somatic cells (Peters et al., 2001). Suv3-9h1 and 2 however, behave 
differently; Suv39h2 was predominantly found in unfertilised oocytes and early 
preimplantation stages whereas Suv3-9h1 was clearly detected in late preimplantation 
embryos (Figure 3.15 and 3.16). Eset is responsible for H3K9me3 in euchromatin, it 
was found throughout preimplantation development but the expression was dynamic. 
Ehmt2 preferably catalyses for both H3K9me2 and H3K9me3 (Wang et al., 2003), and 
was detected only in the blastocyst stage (Figure 15). The expression pattern of Ehmt2, 
Suv3-9h1 and Suv3-9h2, but not Eset, were similar to a previous report (Kageyama et 
al., 2007b). 
Histone demethylase Jmjd2c was found in all stages but at a low level in oocytes 
compared to preimplantation embryos. Jmjd2c mRNA is synthesised in unfertilised 
oocytes and decreases rapidly after fertilisation. The expression increased slightly at the 
two-cell stage and then increased after four-cell stage. Jmjd1a was lowly expressed in 
immature oocytes and was undetectable in mature oocytes and zygotes. The expression 
of Jmjd1a was detected again after the two-cell stage but there was a substantial 
reduction at the blastocyst. Jmjd2a was found mostly in all stages except in four-cell 
stage.  
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3.3.6 Histone demethylation of H3K9 at the two-cell stage  
In my immunofluorescence experiments, the active demethylation of H3K9me3 and 
H3K9me2 occurred at two-cell embryos and remethylation happened in the four-cell 
embryos (Figure 3.4 and 3.5), so I questioned whether demethylase enzymes were 
responsible for this event. Comparative gene expression RT-PCR analysis from 
unfertilised oocytes, zygote, two-cell and four-cell embryos showed that methylases 
Eset and Suv39h2 were highly expressed in unfertilised oocytes and then substantially 
decreased after fertilisation, whereas Suv39h1 and Ehmt2 were not detected in these 
stages (Figure 3.14, and 3.15). Demethylases Jmjd2c and Jmjd2a but not Jmjd1a were 
found in unfertilised metaphase II oocytes (Figure 3.16 and 3.17). However, only 
Jmjd2a and Jmjd1a transcripts increased postfertilisation specifically at zygote and two-
cell stages.  
It seems that most histone methyltransferase transcripts were not detected or very low 
between zygote to two-cell stage where most demethylase transcripts were present. 
These results could also suggest that the presence and relative increase of histone 
demethylases in zygotes and two-cell stage embryos and lack of some H3K9 histone 
methylases may create an unbalanced status of epigenetic modifiers and lead to histone 
demethylation of H3K9me2 and H3K9me3 at the two-cell stage.  
3.3.7 Suv4-20h detection in the late preimplantation embryos 
Suv4-20h1 and Suv4-20h2 are responsible for H4K20me2 and H4K20me3 (Schotta et 
al., 2008), neither of these gene transcripts were found in oocytes and early 
preimplantation embryos (Zygote to Morula). Transcripts of both genes were clearly 
detectable in the blastocyst, which may be related to the presence of H4K20me2 at the 
blastocyst stage and of H4K20me3 in the postimplantation embryos (Figure 4.3, 
Chapter 4). These observations are comparable to a previous report that revealed neither 
Suv4-20h is found in mature oocytes and early preimplantation embryos (Kageyama et 
al., 2007b). 
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3.3.8 Differential expression of histone modifiers in blastocysts and ES cells 
This experiment extends the previous studies and compares preimplantation blastocysts, 
postimplantation blastocysts and ES cells. There were statistical differences in the 
expression of demethylases (Figure 3.21) but not histone methyltransferases (Figure 
3.20).The results show that most histone methyltransferases (Eset, Suv39h1, Suv39h2) 
tend to increase their expression level towards postimplantation whereas demethylases 
Jmjd2c, Jmjd2a decrease their expression. One exception was the expression of Jmjd1a 
which tended to increase in expression during postimplantation. 
In comparison to ES cells, expression of Eset, Jmjd2c, Jmjd2a and Suv39h1 in 
preimplantation blastocysts was higher whereas expression Jmjd1a and Suv39h2 was 
lower.  
3.3.9 The expression profile of major satellite and minor satellite DNA sequences 
The expression profiles of satellite sequences are shown in Figure 3.18 and 3.19. Major 
satellite DNA is located at pericentric heterochromatin while minor satellite DNA is 
found at centromeric heterochromatin (Schotta et al., 2008). Notably, the majority of 
both satellites were observed at unfertilised mature oocytes (MII), eight-cell and two-
cell stage embryos. Moreover, two-cell embryos had a higher transcript level than 
zygote and four-cell embryos correlating with the histone demethylation at the two-cell 
embryos. It could be suggested that increased expression of repeat sequences at the two-
cell stage might result from demethylation of the repressive histone mark (H3K9me2, 
H3K9me3 and H4K20me3). 
 
3.4 Discussion 
In the present study I found that demethylation of H3K9me2, H3K9me3 and 
H4K20me3 occurs in the two-cell embryo. Repressive histone methylation peaked at 
the eight-cell stage. An imbalance of H3K9 modifiers was found in preimplantation 
embryos and may responsible for histone demethylation at the two-cell stage. 
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Demethylase Jmjd2a was specifically expressed at blastocyst while Jmjd1a was specific 
in ES cells. Demethylation at the two-cell stage may cause up regulation of satellite 
transcripts from pericentric and centromeric heterochromatin. Satellite transcripts were 
also highly expressed in mature oocytes.  
3.4.1 Reprogramming of histone lysine methylation 
In somatic cells, H3K9me3, H3K27me1, H4K20me3 are involved in formation of 
pericentric heterochromatin. This process is sequential: the first step requires the 
activities for H3K27me1 and H3K9me1, then Suv3-9h1 and Suv3-9h2 enzymes 
catalyze H3K9me3. Thereafter stabilized binding of HP1α and HP1β to H3K9me3 in 
nucleosomes occurs, followed by recruitment of the Suv4-20 enzyme to catalyse 
H4K20me3 (Schotta et al., 2004).  
In the present study heterochromatin marker H3K9me3 (Figure 3.4), H3K9me2 (Figure 
3.5) and H4K20me3 (Figure 3.8) were demethylated at the two-cell stage, then 
remethylation occurred in four-cell embryos, except for H4K20me3 where 
remethylation was not observed until postimplantation (see Chapter 4). Notably, 
demethylation of heterochromatin at the two-cell stage occurs at the same time as 
zygotic gene activation starts (Kanka, 2003). The majority of transcription during ZGA 
is from repetitive elements; especially LTR retrotransposons, which are abundant in 
two-cell embryos (Evsikov et al., 2004). These active repetitive sequences such as 
retrotransposons might have a possible role in introducing genomic variation, creating 
alternative promoters or a first exon to synchronise their expression, and trigger zygotic 
gene expression in the early embryos (Evsikov et al., 2004, Peaston et al., 2007, Peaston 
et al., 2004). Moreover, the present studies showed that satellite transcripts from 
centromeric and pericentric heterochromatin were up regulated at the two-cell stage. 
Taking the data together, the advantage of erasing heterochromatin markers in 
preimplantation embryos may lie in the reactivation of repetitive sequences which are 
commonly silenced in somatic differentiated cells (Martens et al., 2005, Peaston et al., 
2007).  
H4K20me3 removal was shown in this study, which is consistent with previously 
published reports (Kourmouli et al., 2004, van der Heijden et al., 2005), however the 
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mechanism is still unknown. In Chapter 4 I propose that the possible mechanism of 
H4K20me3 demethylation could be associated with the lack of HP1α in the 
preimplantation embryo (see Chapter 4). However, absence of H4K20me3 in this work 
may result from several other reasons such as a lack of prerequisite HMTs specific for 
H4K20me3 and HP1α or the presence of unknown demethylases in two-cell embryos. 
Histone modifications in somatic cells are removed by the activity of recently identified 
histone demethylases. The enzyme named Jmjd1a is responsible for demethylation of 
H3K9me2, while Jmjd2 is specific for both H3K9me2 and H3K9me3 (Klose and 
Zhang, 2007). However, the demethylation enzymes for H4K20me3 have not been 
discovered yet.  
3.4.2 Repressive histone lysine methylations peak at the eight cell embryo stage 
Quantitative analysis showed that the total intensities of repressive heterochromatin 
markers H3K9me1, H3K9me2, H3K9me3, H4K20me1, H4K20me2 and H3K27me3 
were highest at the eight-cell embryo stage (Figure 3.11-3.13). The function of this 
temporary enrichment in these histone markers in eight-cell embryos is still unclear. 
However, it could be explained by previous reports in nuclear transfer in which 
blastomeres from eight-cell stage embryos are less effective as donor cells in achieving 
development compared with two- and four-cell blastomeres (Egli et al., 2007, Hiiragi 
and Solter, 2005, Wilmut et al., 2002). Taking together, this may suggest that the lower 
developmental success rate of nuclear transfer may be associated with enrichment of 
epigenetic heterochromatin markers.  
3.4.3 Function of satellite transcripts in oocytes 
In this study, an abundance of minor and major satellite transcripts were found in 
mature oocytes. An earlier study in ES cells showed that most satellite transcripts are 
double stranded RNA (dsRNA) (Martens et al., 2005) that can be a precursor of small 
RNA used in RNAi pathway (Watanabe et al., 2008). The presence of many small 
RNAs in mouse oocytes and the fact that they are mainly derived from repeat sequences 
suggests that they may act as master controllers of mobile elements and regulated 
protein encoding genes. This data is consistent with other published reports (Tam et al., 
2008, Watanabe et al., 2008). Disruption of Dicer and Argonaute 2 which are essential 
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for the RNAi pathway, results in lethality early in development (Bernstein et al., 2003, 
Lykke-Andersen et al., 2008). This could suggest that satellite transcripts may act as 
small RNA precursors that can be used to silence maternal genes before fertilisation and 
degrade maternal RNA after fertilisation. 
 




Figure 3.3 H3K9me1 in preimplantation embryos. Embryos were immunostained with anti-
H3K9me1 and FITC conjugated secondary antibody (green), and DNA dye DAPI 
(pseudocolour red). In the merged panels, the yellow colour designates colocalisation between 
the two markers. The scale bar represents 20 µm. Thirty embryos per stage were immunostained 
and all embryos showed a similar pattern of staining. In zygotes, the female pronucleus (F) is 
smaller and closer to the polar body than the male pronucleus (M). 




Figure 3.4 H3K9me2 in preimplantation embryos. Embryos were immunostained with anti-
H3K9me2 and FITC conjugated secondary antibody (green), and DNA dye DAPI 
(pseudocoloured red). In the merged panels, the yellow colour designates colocalisation 
between the two markers. In zygotes, female chromatin was strongly detected for H3K9me2 
while male chromatin was very weak or undetectable. Demethylation occurred at the two-cell 
stage and de novo methylation at the four-cell stage. Scale bar represents 20 µm. Thirty embryos 
per stage were immunostained and all embryos showed a similar pattern of staining. In zygotes, 
the female pronucleus (F) is smaller and closer to the polar body than the male pronucleus (M). 
 




Figure 3.5 H3K9me3 in preimplantation embryos. Embryos were immunostained with anti-
H3K9me3 and FITC conjugated secondary antibody (green), and DNA dye DAPI 
(pseudocoloured red). In the merged panels, the yellow colour designates colocalisation 
between the two markers. In zygotes, female chromatin was strongly detected for H3K9me3 
while male chromatin was very weak or undetectable. Demethylation occurred at the two-cell 
stage and de novo methylation at the four-cell stage. Scale bar represents 20 µm. Thirty embryos 
per stage were immunostained and all embryos showed a similar pattern of staining. In zygotes, 
the female pronucleus (F) is smaller and closer to the polar body than the male pronucleus (M). 




Figure 3.6 H4K20me1 in preimplantation embryos. Embryos were immunostained with anti-
H4K20me1 and FITC conjugated secondary antibody (green), and DNA dye DAPI 
(pseudocolour red). In the merged panels, the yellow colour designates colocalisation between 
the two markers. Scale bar is 20 µm. Thirty embryos per stage were immunostained and all 
embryos showed a similar pattern of staining. In zygotes, the female pronucleus (F) is smaller 
and closer to the polar body than the male pronucleus (M). 




Figure 3.7 H4K20me2 in preimplantation embryos. Embryos were immunostained with anti-
H4K20me2 and FITC conjugated secondary antibody (green), and DNA dye DAPI 
(pseudocolour red). In the merged panels, the yellow colour designates colocalisation between 
the two markers. H4K20me2 was not found in early preimplantation embryos but was detected 
from eight-cell stage. Scale bar is 20 µm. Thirty embryos per stage were immunostained and all 
embryos showed a similar pattern of staining. In zygotes, the female pronucleus (F) is smaller 
and closer to the polar body than the male pronucleus (M). 




Figure 3.8 H4K20me3 in preimplantation embryos. Embryos were immunostained with anti-
H4K20me3 and TRITC conjugated secondary antibody (red), and DNA dye DAPI (blue). In the 
merged panels, the pink colour designates co-localisation between the two markers. H4K20me3 
was found only in female chromatin of zygotes and specifically stained pericentric 
heterochromatin and co-localised with dense DAPI staining. Demethylation occurred at the two-
cell stage. The scale bar represents 20 µm. Thirty embryos per stage were immunostained and 
all embryos showed a similar pattern of staining. In zygotes, the female pronucleus (F) is 
smaller and closer to the polar body than the male pronucleus (M). 




Figure 3.9 H3K4me3 in preimplantation embryos. Embryos were immunostained with anti-
H3K4me3 and FITC conjugated secondary antibody (green), and DNA dye DAPI 
(pseudocoloured red). In the merged panels, the yellow colour designates co-localisation 
between the two markers. The scale bar represents 20 µm. Thirty embryos per stage were 
immunostained and all embryos showed a similar pattern of staining. In zygotes, the female 
pronucleus (F) is smaller and closer to the polar body than the male pronucleus (M). 
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Figure 3.10 H3K27me3 in preimplantation embryos. Embryos were immunostained with 
anti-H3K27me3 and FITC conjugated secondary antibody (green), and DNA dye DAPI 
(pseudocoloured red). In the merged panels, the yellow colour designates co-localisation 
between the two markers. The scale bar represents 20 µm. Thirsty embryos per stage were 
immunostained and all embryos showed similar pattern of staining except male and female 
blastocyst. A white arrow points a green speckle represent Barr body or X inactive chromosome 
in female blastocyst and these spots are not found in male blastocyst (data not shown). In 
zygotes, the female pronucleus (F) is smaller and closer to the polar body than the male 
pronucleus (M). 




Figure 3.11 Semi-quantification of total nuclear fluorescence intensity of H3K9me1, 
H3K9me2 and H3K9me3 in preimplantation embryos. Thirty embryos per stage were used 
for analysis. Total nuclear fluorescence intensity is shown relative to the embryo stage 
indicated. Statistical differences (P<0.05) are shown as a-g. Y axis is total nuclear intensity and 
x axis is embryonic stage. Total nuclear fluorescence intensity is shown in mean ± standard 
error. Statistic difference was analysed using ANOVA and Student’s t test .Bar represent 
standard error of mean (SEM) 




Figure 3.12 Semi-quantification of total nuclear fluorescence intensity of H4K20me1 and 
H4K20me2 in preimplantation embryos. Thirty embryos per stage were used for analysis. 
Total nuclear fluorescence intensity is shown relative to the embryo stage indicated. Statistical 
differences (P<0.05) are shown as a-g. Y axis is total nuclear intensity and x axis is embryonic 
stage. Total nuclear fluorescence intensity is shown in mean ± standard error. Statistic 
difference was analysed using ANOVA and Student’s t test. Bar represent standard error of 
mean (SEM) 




Figure 3.13 Semi-quantification of total nuclear fluorescence intensity of H3K4me3 and 
H3K27me3 in preimplantation embryos.  Thirty embryos per stage were used for analysis. 
Total nuclear fluorescence intensity is shown relative to the embryo stage indicated. Statistical 
differences (P<0.05) are shown as a-g. Y axis is total nuclear intensity and x axis is embryonic 
stage. Total nuclear fluorescence intensity is shown in mean ± standard error. Statistic 
difference was analysed using ANOVA and Student’s t test. Bar represent standard error of 
mean (SEM) 
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Figure 3.14 Comparative and relative gene expression of Suv39h1 and Suv39h2 in 
preimplantation embryos. RT-QPCR of histone methyltransferase mRNA expression in the 
embryo stages indicated gene expression. The value is gene expression ratio either per embryo 
(non-normalisation with reference gene) or relative to Gapdh (normalised with Gapdh). Error 
Bar represents standard deviation. Y axis is gene expression ratio and x axis is embryonic stage.  
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Figure 3.15 Comparative and relative gene expression of Eset in preimplantation embryo. 
RT-QPCR of histone methyltransferase mRNA expression in the embryo stages indicated gene 
expression. The value is gene expression ratio either per embryo (non-normalised) or relative to 
Gapdh (normalised with Gapdh). Error Bar represents standard deviation. Y axis is gene 
expression ratio and x axis is embryonic stage. 
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Figure 3.16 Comparative and relative gene expression of Jmjd2a and Jmjd2c in 
preimplantation embryo. RT-QPCR of histone methyltansferase mRNA expression in the 
embryo stages indicated gene expression. The value is gene expression ratio either per embryo 
(non-normalisation with reference gene) or relative to Gapdh (normalised with Gapdh). Error 
Bar represents standard deviation. Y axis is gene expression ratio and x axis is embryonic stage. 
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Figure 3.17 Comparative and relative gene expression of Jmjd1a in preimplantation 
embryo.  RT-QPCR of histone methyltansferase mRNA expression in the embryo stages 
indicated gene expression. The value is gene expression ratio either per embryo (non-
normalisation with reference gene) or relative to Gapdh (normalised with Gapdh). Error Bar 
represents standard deviation. Y axis is gene expression ratio and x axis is embryonic stage. 
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Figure 3.18 Comparative and relative gene expression of major satellite in 
preimplantation embryo. RT-QPCR of histone methyltansferase mRNA expression in the 
embryo stages indicated gene expression. The value is gene expression ratio either per embryo 
(non-normalisation with reference gene) or relative to Gapdh (normalised with Gapdh). Error 
Bar represents standard deviation. Y axis is gene expression ratio and x axis is embryonic stage. 
RT negative samples were used to exclude DNA contamination for analysis of satellite 
transcripts. 
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Figure 3.19 Comparative and relative gene expression of minor satellite in 
preimplantation embryo. RT-QPCR of histone methyltansferase mRNA expression in the 
embryo stages indicated gene expression. The value is gene expression ratio either per embryo 
(non-normalisation with reference gene) or relative to Gapdh (normalised with Gapdh). Error 
Bar represents standard deviation. Y axis is gene expression ratio and x axis is embryonic stage. 
RT negative samples were used to exclude DNA contamination for analysis of satellite 
transcripts. 
. 
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Figure 3.20 Relative gene expression of Eset, Suv39h1 and Suv39h2 compared between 
blastocysts and ES cells. The value is a gene expression ratio relative to Gapdh (per Gapdh). 
Pre-BL=preimplantation blastocyst, Post-BL= in vitro implantation blstocyst, ES=ES cell. Y 
axis is gene expression ratio and x axis is embryonic stage. Pair Wise Fixed Allocation 
Randomisation Test was used to calculate statistical differences. Bar represent standard error of 
mean (SEM) 
Dynamics of histone lysine methylation  Chapter 3 
 112
 
Figure 3.21 Relative gene expression of Jmjd1a, Jmjd2a and Jmjd2c compared between 
blastocyst and ES cell. The value is gene expression ratio relative to Gapdh (per Gapdh). Pre-
BL=preimplantation blastocyst, Post-BL= in vitro implantation blstocyst, ES=ES cell. a-c 
represent statistical difference (P<0.05) between samples. Y axis is gene expression ratio and x 
axis is embryonic stage. Pair Wise Fixed Allocation Randomisation Test was used to calculate 
statistical differences. Bar represent standard error of mean (SEM). 
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Chapter 4  
Heterochromatin maturation in mouse development 
and ES cells. 
 
4.1 Introduction 
Heterochromatin describes the highly condensed and transcriptionally silent chromatin 
of the genome. Rich in repetitive sequences and low in gene density, it has a 
characteristic chromatin signature. One important key feature of heterochromatin is its 
ability to extend its domain and self propagate through cell division. When 
heterochromatin spreads across domains, gene repression may directly result either from 
the association of heterochromatin markers such as histone methylation, 
heterochromatin protein 1 (HP1) and DNA methylation with gene promoters or from 
the relocation of active genes to the vicinity of heterochromatin (Grewal and Jia, 2007, 
Elgin and Reuter, 2006) (see Figure 4.1A and 4.1B).  
4.1.1 Epigenetic regulation heterochromatin formation 
The formation of heterochromatin is likely to be regulated by epigenetic processes such 
as DNA and histone methylation. Domains of constitutive heterochromatin possess an 
abundance of DNA methylation (Bird, 2002), histone methylation marks such as 
H3K9me3 (Peters et al., 2003) and H4K20me3 (Kourmouli et al., 2004) as well as HP1 
(Kourmouli et al., 2005). Studies on mouse pericentric heterochromatin show that the 
formation of heterochromatin requires sequential histone modifications and HP1 
proteins (Kourmouli et al., 2004, Schotta et al., 2004, Kourmouli et al., 2005). First, 
repetitive sequence which already contains H3K27me1 and H3K9me1 recruits the 
methyltransferase suv3-9h to complete trimethylation of H3K9; next HP1α and HP1β 
bind to H3K9me3-containing nucleosomes to stabilise chromatin; and finally, suv4-20h 
enzymes are recruited that modify histone H4 to form H4K20me3.  
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In contrast to constitutive heterochromatin, trimethylation of histone 3 lysine 27 
(H3K27me3) is considered to be a feature of facultative heterochromatin. It is 
associated with transcriptional silencing by polycomb group (PcG) proteins especially in 
X chromosome inactivation (Okamoto and Heard, 2006). Moreover, this facultative 
heterochromatin also contains DNA methylation, dimethylation of histone 3 lysine 9 
(H3K9me2) (Peters et al., 2003), monomethylation of histone 4 lysine 20 (H4K20me1) 
(Sims et al., 2006) and HP1(Chadwick and Willard, 2004). 
4.1.2 Function of heterochromatin markers H4K20me3 and HP1α  
H4K20me3 is not only found at pericentric heterochromatin, but is also observed at 
telomere and subtelomere regions (Blasco, 2007a). Telomeres become shorter in aged 
cells, and this is a well-known marker for senescence (Blasco, 2007b). The abrogation 
of Suv4-20h enzymes results in decreasing H4K20me3 at telomeres and subtelomeres, 
concomitantly with an increase in telomere length and sister chromatid recombination 
(Benetti et al., 2007). These results suggest that H4K20me3 or Suv4-20h enzyme may 
control telomere length and DNA recombination. Recently, H4K20me3 together with 
H3K9me3 and HP1 were found to control imprinted genes by localising on the silenced 
imprinted gene promoter and a non-expressed pseudogene (Pannetier et al., 2008, 
Delaval et al., 2007, Regha et al., 2007). Suv4-20h knock-out mice show abnormality in 
placental and foetal growth (Schotta et al., 2008), these growth abnormalities may result 
from aberrant expression of imprinted genes such as Igf2 which are controlled by 
H4K20me3 (Schotta et al., 2008). Moreover, H4K20me3 is also reported to be related 
to the progression of many cancers in animals and human (Fraga et al., 2005, Pogribny 
et al., 2006). 
At centromeric and telomeric heterochromatin, HP1 is  required for the proper 
maintenance of chromosomal and genome integrity (Fanti and Pimpinelli, 2008). 
Moreover, HP1 at pericentric and centromeric heterochromatin plays an important role 
in recruiting the cohesin complex and kinetochore proteins that are crucial for 
chromosome segregation at mitosis and prevention of aneuploidy (Zhang et al., 2007, 
Nonaka et al., 2002). HP1 also associates with cancer in human; HP1α, but not HP1β or 
HP1γ, is down-regulated in highly invasive or metastatic breast cancer cells compared 
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to poorly invasive or non-metastatic cancer cells (Kirschmann et al., 2000, Norwood et 
al., 2006) and this also correlates to dimerisation of HP1α (Norwood et al., 2006). 
Furthermore over expression of HP1α in highly invasive/metastatic cells that have low 
levels of HP1α leads to a less invasive phenotype (Kirschmann et al., 2000). Taken 
together these lines of evidence may imply that the HP1α could modulate molecular 
properties of carcinoma cells needed for invasion or metastasis. One hypothesis is that 
HP1α normally silences genes required for metastasis, making HP1α a candidate 
metastasis suppressor. Depending on whether HP1α is down-regulated during tumour 
progression, HP1α could be used as a predictive marker for metastatic breast cancer.  
4.1.3 Hypothesis 
Recent reports suggest that the epigenetic profile and heterochromatin organisation in 
embryos is unique and different from somatic cells (Martin et al., 2006b, Probst et al., 
2007, Martin et al., 2006a). The hypothesis of the present study was that 
heterochromatin is immature in the early embryo and matures concomitantly with 
development. I have tested this hypothesis by recording the dynamics of various 
epigenetic markers in the developing embryo.  
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4.2 Materials and Methods 
4.2.1 Samples  
Embryos and mouse embryonic fibroblast (MEF) cells were collected from B6CBAF1 
mice. ES cells were obtained either from recent isolation in the lab (termed the ‘noo1’ 
line) or from the Institute of Stem Cell Research, MRC Centre for Regenerative 
Medicine, University of Edinburgh (E14tga-line). For each antibody, approximately 30 
embryos per stage were used for immunofluorescence. The techniques of embryo 
collection, in vitro implantation, ES cell isolation, cell culture, immunofluorescence, 
western blotting, RNA isolation, cDNA synthesis and PCR are described in Chapter 2 
(Materials and Methods). 
4.2.2 Experimental design 
The experimental design is summarised in Figure 4.2. Embryo and adult tissue were 
collected and analysed by immunofluorescence of whole embryo and sections, and 
western blotting of embryo extracts. Heterochromatin was detected by immunostaining 
with various markers: H4K20me3, H3K9me3, HP1α, 5MeC for constitutive 
heterochromatin, and H3K9me2, H4K20me1, H3K27me3 for facultative 
heterochromatin, and HP1β for both types of heterochromatin. Chi-squared analysis was 
used to calculate statistical differences between the numbers of fluorescent positive cells 
in E14.5 embryos compared to E17.5 embryos, and the difference between ES cell 
differentiation and in vitro implantation. Statistical analysis was performed using the 
online statistic software VassarStats (Lowly, 2009) 
(http://faculty.vassar.edu/lowry/odds2x2.html). 
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4.3 Results 
4.3.1 Epigenetic signature of mouse somatic heterochromatin 
Mouse somatic cells such as fibroblasts stained for DAPI showed a characteristic 
pattern of 10-20 bright dots in the nucleus indicating areas of higher DNA density 
(Figure 4.3). These regions of higher chromatin density correspond mainly to 
pericentromeric heterochromatin, which in the acrocentric chromosomes of the mouse is 
organised into chromocentres that join several chromosomes (Martens et al., 2005). 
These dots also stain brightly for DNA methylation, H3K9me3, H4K20me3 and HP1α 
(Figure 4.3) (Peters et al., 2002, Schotta et al., 2004, Kourmouli et al., 2004, Kourmouli 
et al., 2005), consistent with the classic epigenetic profile of constitutive 
heterochromatin (Martens et al., 2005). Uniquely in the mouse, the pericentromeric 
chromatin organisation allows a direct microscopic observation of the most abundant 
constitutive heterochromatin compartment in the nucleus. I have taken advantage of this 
aspect to follow the formation of heterochromatin through development in terms of the 
appearance of chromocentres and the epigenetic markers, as detected with antibodies. I 
chose antibodies that have been demonstrated in the literature (Martens et al., 2005, 
Schotta et al., 2004, Peters et al., 2002) as well as in our hands (Figure 4.3) to stain 
these epigenetic epitopes in somatic chromatin. 
4.3.2 Immature chromatin in preimplantation embryo 
In our studies, all heterochromatin epigenetic markers (DNA methylation, H3K9me3, 
H4K20me3, HP1α, HP1β, H4K20me1, H3K9me2 and H3K27me3) were found in most 
but not all developmental stages of preimplantation mouse development (Figure 4.4). 
H3K9me2, H3K9me3 and H4K20me3 were concurrently reduced in two-cell embryos, 
with the exception of H4K20me3 which was completely erased after the two-cell stage 
(Figure 4.4). The substantial reduction of H4K20me3 was also observed in another 
report (Kourmouli et al., 2004), and seems to be correlated with the presence of the 
corresponding methylases Suv4-20h for which the mRNA level was undetectable in 
early preimplantation embryos, but was later found in periimplantation blastocyts 
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(Figure 4.4). The Suv4-20h level may bear on another substrate, H4K20me2 which was 
clearly observed in late preimplantation embryos (see Chapter 3, Figure 3.7). 
Surprisingly, HP1α which is commonly found in constitutive heterochromatin of 
somatic cells (Schotta et al., 2004, Dialynas et al., 2007), was undetectable in all 
developmental stages before implantation. This observation was supported by van der 
Heijden et al (2005) and Beaujean, N. (personal communication), but inconsistent with 
Houlard et al (2006). Unlike previous reports for somatic cells (Wu et al., 2006, 
Schmiedeberg et al., 2004, Gilbert et al., 2003, Ayoub et al., 2008), in which HP1β is 
predominantly found in heterochromatin, the distribution of HP1β in our 
preimplantation embryos was throughout the whole nucleus (Figure 4.4) and was 
comparable to previous reports (Martin et al., 2006b, Martin et al., 2006a). The lack of 
H4K20me3, HP1α and Suv4-20h suggested that heterochromatin in the preimplantation 
embryo was more immature than in somatic cells. 
4.3.3 Heterochromatin matures post implantation 
The next question was when the mature heterochromatin was established. In vivo and in 
vitro implantation embryos at different stages of development were immunostained and 
observed. As it is difficult to control the exact postimplantation time of in vivo 
implantation embryos from pregnant mice, in vitro implantation was initially used as an 
alternative model for the study of very early implantation.  
Intriguingly, after in vitro implantation, H4K20me3 and HP1α - which previously were 
not found in the preimplantation blastocyst - were both detected. At approximately 24 to 
48 hours, H4K20me3 was firstly detected, but only in mural trophectoderm (mTE) not 
in polar trophectoderm (pTE) or inner cell mass (ICM) cells. The ICM cells were 
defined as cells that were positive for Oct4 (Figure 4.6). HP1α however, was hardly 
detectable at this stage. After four days of culture, both H4K20me3 and HP1α were 
strongly detected both in giant trophoblast and ICM-derived cell colonies (Figure 4.7B). 
TE cells showed a speckle pattern of H4K20me3 and HP1α specific for heterochromatin 
but not the ICM colony which seemed to have an equal distribution in both euchromatin 
and heterochromatin (Figure 4.7B). After initial implantation into the petri dish, further 
in vitro growth results in loss of the normal embryo organisation and differentiating 
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cells become difficult to identify. Positional developmental signals might also be lost to 
the cells, resulting in abnormal epigenetic patterns as well as disorganised tissues. For 
this reason, it was necessary to follow in utero embryo development. Similarly, in vivo 
implantation results showed that H4K20me3 was not found in E3.5 (preimplantation) 
but was early detected early in E4.5 (postimplantation), when it was only found in 
mural TE, not in polar TE and ICM cells (Figure 4.8).  
Next, I investigated when the establishment of H4K20me3 and HP1α occurred in 
postimplantation embryos. Embryos at different stages of development E5.5, E6.5 or 
E7.5 (early implantation) were stained with the H4K20me3 antibody using a whole 
mount method. However, H4K20me3 was not detected in interphase nuclei (Figure 
4.9A). To confirm that our whole mount immunofluorescence for postimplantation 
embryo is suitable for postimplantation embryo, the embryos were stained with anti-
H3K9me3 antibody, and the results showed that H3K9me3 was detected both in 
epiblast (derived from ICM) and extraembryonic ectoderm (derived from pTE). This 
demonstrated that our protocol allows antibody penetration through the embryo in both 
epiblast and extraembryonic ectoderm (Figure 4.9B).  
For embryos retrieved later during gestation, antibody staining was performed on thin 
sections. Postimplantation embryos E8.5, E14.5 or E17.5 were fixed and embedded in 
paraffin or frozen for cryosection. In paraffin sections, H4K20me3 was undetectable in 
most embryonic cells but it was visible in decidual cells of the placenta derived from the 
maternal uterus (Figure 4.10A). The control antibody H3K9me3 was detectable in both 
placental and embryonic tissue (Figure 4.10B). However, one common problem of 
using paraffin sections is that some antigens may lose antibody sensitivity after 
processing. Although antigen retrieval steps (see Chapter 2 Material and Methods) were 
performed, the recovery efficiency may not be complete and success will vary with 
individual antibodies or antigens. For this reason cryosections were also performed to 
confirm the results.  
Although cryosections preserve antigen accessibility, they can result in poor tissue 
morphology. To aid accurate identification of embryonic tissue, alternate sections of 
embryos were taken through a haematoxylin and eosin (H&E) staining protocol for both 
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paraffin section and cyosection. Cryosections from E8.5 embryos showed that 
heterochromatin markers H4K20me3 and HP1α were not detected while H3K9me3 was 
clearly positive (Figure 11). Later stages of embryo E14.5 and E17.5 were 
cryosectioned to investigate the signal of H4K20me3 and HP1α. Notably, H4K20me3 
became strongly detectable in E14.5 embryos (Figure 4.12, left) and this stage 
simultaneously showed the appearance of HP1α (Figure 4.13, left). The number of 
positive cells for H4K20me3 and HP1α (defined as having a high positive signal and 
more than 3 dots/cell) were counted and the cell counts from E14.5 embryos were 
compared with those from E17.5 embryos (Figure 4.12 and 4.13, left and right 
respectively). The results showed that H4K20me3 was found in 50.0% of cells 
(250/500) in E14.5 embryos, which increased to 80.0% (400/500) (statistical 
significance, P<0.001) in E 17.5 cells (Figure 4.13). A similar pattern was found for 
HP1α for which the number of positive cells of E17.5 was significantly higher 
(P<0.001) than in E14.5, with 75.8% (379/500) and 45.6% (228/500) positive cells, 
respectively. 
The overall amount of H4K20me3 was confirmed using western blotting.  
Unexpectedly, anti-histone H4 antibody (control antibody) from different commercial 
sources (Abcam, Santa Cruz and Upstate), but not anti-H4K20me3 antibody, could not 
bind the histone H4 in whole embryo and placenta tissue. However both anti-H4 and 
anti-H4K20me3 antibody could bind their epitopes in mouse embryonic fibroblasts 
(MEFs) that were derived from the same stage of embryo tissue (E14.5). Surprisingly, 
H4K20me3 in embryo and placenta tissues (E14.5 and E17.5) was shown to have a 
higher apparent molecular weight (14 KDa) compared with MEF derived from E14.5 
(10 KDa apparent MW) (Figure 4.14). Taken together, it is probable that MEFs which 
had been isolated from embryos lost some histone modifications during in vitro culture, 
and that this modification might have sterically prevented the antibody from binding to 
the histone H4 epitope. The results may suggest that increases in molecular weight of 
H4K20me3 protein may have been the result of other modifications occurring at the 
same nucleosomes where H4K20me3 appears in vivo but that these might be lost after 
in vitro culture. However; the large difference in molecular weight of proteins detected 
in extracts from in vivo and in vitro cells may also reflect the fact that anti-H4K20me3 
antibodies may be not specific enough to be analysed by western blot using  in vivo 
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embryos, as it might be possible could bind unknown non-specific proteins in 
developing embryos.  
Based on the absence/presence of H4K20me3 and HP1α in preimplantation and 
postimplantation embryos, I suggest that heterochromatin is immature in 
preimplantation embryos and only becomes mature post implantation. This immature 
heterochromatin could plausibly cause chromatin to be globally more open which might 
allow embryonic-specific transcription complexes access to chromatin, thus reactivating 
zygotic genes. Pericentric chromatin is poor in protein encoding genes, however, many 
of the early transcribed embryonic genes are repetitive sequences such as Murine 
Endogenous Retrovirus (MuERV-L), intracisternal A particle (IAP) and other mobile 
elements, which are commonly inactivated by heterochromatin in adult cells (Svoboda 
et al., 2004, Evsikov et al., 2004, Peaston et al., 2004, Ma et al., 2001, Puschendorf et 
al., 2006). In addition, mature heterochromatin may function as a gene silencing 
compartment to ectopic genes that are moved to within its proximity (Grewal and Jia, 
2007, Grewal and Elgin, 2007) 
4.3.4 Dynamics of H4K20me3 and HP1α in ES cells 
There is considerable evidence that epigenetics plays an important role in the regulation 
of gene expression patterns in ES cells. For example, the promoter regions of active 
pluripotency genes such as Oct4 and Nanog, are marked by acetylation of H3 and H4 
during active gene transcription, whereas after differentiation these genes are marked 
with repressive DNA and histone methylation (Gan et al., 2007, Azuara et al., 2006).  
One important piece of evidence is the finding that H3K27me3 may repress cell lineage 
specific genes in ES cells by forming a bivalent chromatin structure, where this 
repressive mark coexists with activating marks H3K9ac or H3K4me3 (Azuara et al., 
2006, Bernstein et al., 2006). The bivalent modification patterns disappear after the 
differentiation of ES cells (Azuara et al., 2006, Bernstein et al., 2006). This suggests 
that the presence of the epigenetic facultative marker H3K27me3 might be functionally 
important for maintaining pluripotency by preventing the expression of lineage-control 
genes in ES cells.  
Interestingly, I found that ES cells displayed two types of distributions for H4K20me3 
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as well as HP1α: either diffuse or in foci. The correlation between these HP1α and 
H4K20me3 patterns from immunofluorescence experiments was shown in Figure 4.14. 
Cells can be classified into 3 types; Types I (Figure 4.15, left panel) had diffuse HP1α 
and very weak signal of H4K20me3; in Type II (Figure 4.15, middle panel) HP1α was 
punctate but H4K20me3 was diffuse, and in Type III (Figure 4.15, right panel) both 
HP1α and H4K20me3 were punctate. Allocation of each cell type was done after 
manually counting 1,000 cells from randomly captured fluorescence images. The 
percentage of each cell type population was 10%, 54%, 36%, for Type I, II and III 
respectively. Importantly I did not observe cells in which H4K20me3 was punctate and 
HP1α was diffuse (i.e. the inverse of type II). These results may suggest that HP1α 
binds to heterochromatin before H4K20me3 and may be involved in recruiting 
H4K20me3 in ES cells. This is consistent with previous proporsal in Drosophila and 
mammals that the HP1α is required to recruit Suv4-20h to catalyse H4K20me3 (Schotta 
et al., 2004, Kourmouli et al., 2005). However, after ES cell differentiation by 
withdrawal of LIF for 7 days, only type III cells were found. Our results support the 
suggestion that although ES cell have all heterochromatin markers, the heterochromatin 
is still highly dynamic. Furthermore, if I assume that the diffuse staining corresponds to 
a less localised epigenetic marker, then this type of heterochromatin was only found in 
ES cells but not differentiated cells and it may make ES cell chromatin as more 
accessible for the transcription machinery more than in differentiated cell.  
4.3.5 H4K20me3 is more associated with cell differentiation in vitro implantation 
than in ES cell differentiation 
In the present study, H4K20me3 was not detected until postimplantation and the 
hypothesis that this mark may be associated with cell differentiation was tested. The ES 
cell differentiation (ESD) and in vitro implantation (IVP) methodologies were used as 
models for studying cell differentiation. I analysed the correlation between H4K20me3 
and differentiation by observing the signal of H4K20me3 at pericentric heterochromatin 
relative to the expression of Oct4 in nuclei. The specific hypothesis was that 
H4K20me3 may increase in signal after cells lose Oct4 during differentiation. The 
results showed that after differentiation, cells could be divided into four categories: (A) 
strong Oct4 but weak H4K20me3, (B) strong Oct4 and H4K20me3, (C) weak Oct4 but 
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strong H4K20me3 and (D) both Oct4 and H4K20me3 weak. The results are shown in 
Figure 4.16 for IVP and Figure 4.17 for ESD. In cells with low Oct4, H4K20me3 was 
increased in only 26% (60/230) in ESD cells but 64% (135/210) in IVP cells. It seems 
likely that a low level of Oct4 at IVP was correlated (P<0.0001) with H4K20me3, rather 
than in ESD. Moreover, 54% (95/175) of ESD cells and 45% (90/200) of IVP cells 
increased the levels of H4K20me3 while the Oct4 level was still clearly detectable, 
suggesting that during the differentiation H4K20me3 increased before the significant 
reduction of Oct4. 
4.3.6 Global heterochromatin shows plasticity in early differentiation 
Western blotting was used to analyse global chromatin modification changes during ES 
cell differentiation to embryoid bodies. After induction to embryoid bodies (day 7), the 
facultative heterochromatin markers H3K9me2, H4K20me1, H3K27me3 were 
significantly decreased. Constitutive heterochromatin H3K9me3 increased but HP1β 
decreased and H4K20me3 and HP1α were not significant changed (Figure 4.18).  
However, using flow cytometry, which can measure the fluorescence intensity in each 
cell within populations of more than 10,000 cells (Figure 4.19), I showed that 
H4K20me3 and HP1α seem preferentially enriched in cells that have a lower signal of 
Oct4.  
These results revealed that during the early events of ES cell differentiation, global level 
of constitutive heterochromatin markers were slightly increased or stable while 
facultative heterochromatin markers were dramatically decreased. It is possible to 
speculate that maintaining the level of constitutive heterochromatin marker such as 
H4K20me3 may help ES cell to protect centromeric function and chromosome stability 
(Schotta et al., 2008) while the decreased facultative heterochromatin may facilitate 
activation of  lineage genes that are normally repressed by H3K27me3 and H3K9me2 
(Bernstein et al., 2006). 
4.3.7 In vitro culture induce maturation of constitutive heterochromatin 
These results and those published by several other reports (Dialynas et al., 2007, 
Kourmouli et al., 2005, Benetti et al., 2007, Martens et al., 2005) have revealed the 
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presence of H4K20me3 and HP1α in ES cell lines. By contrast, H4K20me3 and HP1α 
were not found in ICM or epiblast. It is possible that H4K20me3 and HP1α may be 
established in ES cells in culture after many passages. To test this, new ES-like cells 
(named noo01) were isolated from blastocysts, and epigenetic and chromatin 
modifications were observed in the early passages of ES cells and compared to ICM and 
epiblast. These ES-like cells exhibited similar morphology to ES cells (Figure 4.20A) in 
that they were positive for Oct4 and Nanog protein (Figure 4.21D and E) and were able 
to form embryoid bodies (Figure 4.20B) and beating cardiomyocytes after 
differentiation. Remarkably by the early passage (passage 1-3) these ES-like cells had 
already established H4K20me3 and HP1α (Figure 4.21) at levels that were comparable 
to established ES cells (E14tg2a) (Figure 4.21D and E). H4K20me3 and HP1α were not 
observed in ICM cells (Figure 4.6A) or epiblast (Figure 4.8A).  
To study in more detail when cells from the ICM establish H4K20me3 after culture, 
blastocysts were placed into ES cell medium and observed from 24 hour to 96 hours. 
The results showed that trophectoderm differentiated to trophoblast and attached to the 
plate at approximately 24-48 hours. At this time H4K20me3 was visible in the 
trophoblast, but not in the ICM, and was specific to heterochromatin (Figure 4.6B). 
After 4 days culture, the ICM colonies outgrew and giant trophectoderm developed 
(Figure 4.7B). ICM-derived cells established H4K20me3 and HP1α but in diffuse form 
rather than punctuate form (Figure4.7B). Conversely, giant trophectoderm cells had 
HP1α and H4K20me3 in a punctuate form (Figure 4.7B). 
One possible explanation for this is that factors in the culture medium such as LIF or 
factors present in serum may induce H4K20me3 in ES cells and embryos. To test this 
hypothesis, ES cells were cultured in medium supplemented with serum (FBS) or with 
serum replacement (Knock-out serum replacement, KOSR, Invitrogen). No difference 
was found in either the pattern or amount of H4K20me3 in ES cells cultured with serum 
or in KOSR, as measured by immunofluorescence or western blot (Figure 4.22). In 
contrast there was a significant change in other modifications and heterochromatin 
proteins such as H3K9me2, H3K9me3, H4K20me1 and HP1β (Figure 4.22). Secondly, 
in vitro implantation embryos cultured with or without LIF were compared. 
Implantation embryos established H4K20me3 by 24 to 48 hours when supplemented 
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with or without LIF. Again, no difference in the pattern of H4K20me3 in vitro 
implantation embryo with or without LIF was detected by immunofluorescence. 
Thirdly, I used Trophectodermal Stem (TS) cell medium (commonly used for isolating 
TS cells from blastocysts) instead of ES cell medium for in vitro implantation.  
Culturing embryos for 4 days in TS cell medium resulted in a smaller colonies than 
those grown in ES cell medium. It was expected that thee cells were TS-like cells 
derived from the polar trophectoderm. Almost all of the cells in TS cell medium 
established H4K20me3 and HP1α (Figure 4.7A).  
Collectively, the data suggest that culturing embryos either in ES cell medium or TS 
cell medium can induce H4K20me3 and HP1α establishment. Although serum and LIF 
are not factors required for induction of H4K20me3 and HP1α, it could be another 
component in medium, for example a difference in nutrients between embryo and ES 
cell medium. Another possibility is loss of signals from other cells in vivo which may 
lead ES cells to established heterochromatin marker in vitro. 
 
4.4 Discussion 
These analyses of the changes in cell nuclear chromatin organisation in mouse embryos 
have revealed dynamic changes in heterochromatin patterns during preimplantation and 
post implantation development that continue even into late developmental stages. In 
addition, epigenetic differences between ES cells and the ICM cells have been 
identified.. These results call into question how epigenetic mechanisms help govern the 
fate of cells both in normal development and during tissue culture. Greater 
understanding is needed of how epigenetic modifications on histones and DNA can 
maintain and propagate heritable cell type characteristics. In turn this may provide cell 
nuclear differentiation markers to assess the epigenetic profile of cells in development 
and disease as well as the effects of tissue culture and in vitro assisted reproduction.  
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4.4.1 The difference between ICM and ES cells 
Mouse ES cells are isolated from the ICM of blastocysts, hence both cell types contain 
pluripotent transcription factors such as Oct4, Nanog and Sox2. However, some studies 
suggest that ES cells exhibit some properties that are not normally shown by embryos. 
For example, no pluripotent cell type in the embryo is capable of long-term self-renewal 
in vivo. In terms of genetic markers, ES cells express some specific markers such as Kit, 
DAZL and Ddx4 which have very low or no transcription in the ICM (Horie et al., 
1991, Zwaka and Thomson, 2005, Clark et al., 2004, Toyooka et al., 2003). In terms of 
chromatin composition, the results presented here clearly show that the ICM differs 
from ES cells with respect to the lack of H4K20me3 and HP1α to form mature 
heterochromatin. Moreover, previous studies showed that the chromatin marker H2A.Z 
is also not detected in the ICM but becomes positive after in vitro implantation 
(Rangasamy et al., 2003) and is also found in ES cells (Creyghton et al., 2008). 
Recently transcription profiles of the human ICM and ES cells has revealed these two 
cell types are significantly different (Reijo Pera et al., 2009) as well as the profile of 
H3K4me3/H4K27me3 on gene promoter also reveal the difference between mouse ICM 
and ES cells (Dahl et al.).  
4.4.2 Mechanism of heterochromatin maturation 
It has been shown in previous studies that H4K20me3 marks somatic heterochromatin, 
dependent on HP1 and Suv4-20h enzymes (Schotta et al., 2004, Kourmouli et al., 2005).  
The supporting evidence from the present study shows that first, H4K20me3, HP1α and 
Suv4-20h were absent from preimplantation embryos, but eventually become highly 
detectable postimplantation embryo; second, ES cells show a diffuse or punctuate 
staining pattern, possibly more dynamic of HP1α and H4K20me3 localisation, in which 
the pattern of H4K20me3 seems to depend on HP1α. Taken together, it is possible to 
speculate that loss of H4K20me3 in preimplantation embryo may result from a lack of 
HP1α and Suv4-20h enzymes. After implantation or establishment of ES cells, Suv4-
20h and HP1α were highly detectable, suggesting that Suv4-20h and HP1α may be very 
important for establishment of mature heterochromatin by recruiting H4K20me3 in 
development. Although active histone demethylation might be another potential 
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mechanism, there is no published report describing a H4K20me3-demethylase. It was 
thought that the demethylase Jmjd2a was a potential candidate for a H4K20me3 
demethylase as it has a domain specific for H4K20me3, but there is no functional proof 
that the activity can remove H4K20me3 (Lee et al., 2008).   
4.4.3 Chromatin and cell differentiation. 
The present experiments confirm and extend earlier observations suggesting an 
association between the appearance of H4K20me3 and the initiation of differentiation of 
the pluripotent cells. H4K20me3 was not seen in Oct4-positive cells, however, soon 
after implantation, it became clearly visible. A previous study (Biron et al., 2004) 
suggested that H4K20me3 may be associated with cellular differentiation of neural and 
muscle cells in postimplantation mouse embryos. Similar results have been observed in 
other species (Karachentsev et al., 2007), for instance in Drosophila in which the 
antibody against H4K20me3 failed to detect the epitope at any stage of early 
development until mid-gastrulation. An interpretation that might be considered is that 
H4K20me3 is associated with early differentiation of the epiblast, which in mice occurs 
soon after implantation embryos. In contrast to the postimplantation embryo, 
H4K20me3 was found in ES cells, and did not undergo a significant change after early 
differentiation. This suggests that the epigenetic state of chromatin which regulates 
early differentiation in postimplantation embryos may be different from that in ES cells. 
It is believed that at specific stages in development there may be biologically important 
differences in the openness of chromatin, for example that chromatin in preimplantation 
embryos is more open than in ES cells and differentiated cells (Table 4.1). A number of 
different studies have suggested that chromatin might be less compact and more 
transcription-permissive than that of in differentiated cells (Kobayakawa et al., 2007, 
Meshorer et al., 2006, Efroni et al., 2008, Martens et al., 2005). The differences in the 
presence and pattern of H4K20me3, HP1α and HP1β described in this study may 
account for these differences in chromatin structure.  
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4.4.4 Heterochromatin, tissue maturation and aging 
The present study indicated that a proportion of the H4K20me3 increases in late 
development and might be related to an ageing mechanism. A similar result from a 
previous report using mass spectrometry showed that liver and kidney cells from 
senescent animals acquired more H4K20me3 than young animals (Sarg et al., 2002). 
Moreover, two studies in human cell lines in which H4K20me3 is very low or 
undetectable show that H4K20me3 is visible or increases either in late passage cells or 
non-growing cells (Sarg et al., 2002, Shumaker et al., 2006). Furthermore, previous 
studies on global and specific gene expression levels in human neural development 
show that H4K20me3 is up-regulated in adult mature cerebellum compared to immature 
cerebrum from foetuses and infants, and is not related to gene transcription (Stadler et 
al., 2005). For all these reasons, it might be suggested that H4K20me3 is linked to tissue 
maturation or ageing. 
My work leads to a conclusion that constitutive heterochromatin undergoes very slow 
changes in composition from embryo to late foetal development. These changes may 
correlate to different stages of cell lineage specification. In particular, the appearance of 
H4K20me3 seems associated with terminal differentiation and tissue maturation in 
development or the continued maintenance of cells in the ES/epiblast lineage. Although 
its effect on heterochromatin structure and function is as yet unknown, other work 
suggests that H4K20me3 containing heterochromatin is essential for maintenance of 
perinatal, non-cancerous cell states and can confer heterochromatin maintenance 
capability (Schotta et al., 2008, Benetti et al., 2007, Pogribny et al., 2007). I propose 
that constitutive heterochromatin, while contributing to maintaining cell type, also 
retains the ability to adapt to sequential cell fate changes during cell lineage 
specification. As these changes come to an end, a necessary gradual stabilisation 
follows by increasing the maintenance capabilities of heterochromatin, which relies on 
the essential acquirement of H4K20me3 and HP1α. 
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Table 4.1 The presence and pattern of heterochromatin markers in mouse embryo 
development and in ES cells. 











Speckled Speckled Speckled Closed 
Undifferentiated 
ES cells 
Speckled/Diffuse Speckled/Diffuse Speckled Open 
Differentiated ES 
cells 
Speckled Speckled Speckled Closed 
 
 




Figure 4.1 Model for heterochromatin spreading and gene relocation affecting 
gene expression during development and differentiation. (A) Heterochromatin 
propagates to neighbouring gene causing gene silencing. (B) Active gene moving in the 
vicinity of heterochromatin can result in silencing of the gene. 




Figure 4.2 Experimental designs of the study. Embryos and ES cells were collected 
based on developmental stage and differentiation status, respectively. 
Immunocytochemistry was observed with fluorescence microscopy, flow cytometry and 
western blotting. 
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Figure 4.3 Heterochromatin markers in somatic cells. Mouse embryonic fibroblast 
cells were stained with heterochromatin markers H3K9me3, H4K20me3 HP1α and 
DNA methylation (green), DNA was counterstained with DAPI (blue). 
Heterochromatin maturation in mouse development and ES cells Chapter 4 
 134
 
Figure 4.4 Immunofluorescence microscopy images of heterochromatin markers in 
preimplantation embryo nuclei. Primary antibodies were against H3K9me3, 
H4K20me3, 5-methyl cytosine, HP1α, HP1β, H3K9me2, H3K27me3 and H4K20me1. 
Positive signal was visualised using secondary fluorescent antibodies (FITC =green, 
TRITC = red). Immunofluorescence was observed using confocal microscope. Most 
positive antibodies were shown in green colour except H4K20me3 which is shown in 
red. Embryos were counterstained with DAPI (blue). All antibodies showed positive 
staining, except for H4K20me3 which was detected only in zygote (female chromatin) 
and HP1α which were undetectable in preimplantation embryo nuclei. The scale bar 
(red) represents 20 µm. 30 embryos per stage for each antibody were used.  
 






Figure 4.5 The mRNA level of Suv4-20h1 and Suv4-20h2. mRNA level of Suv4-
20h1 and Suv4-20h2 enzymes which are H4K20me3 methyltransferases, detected by 
RT-PCR and separated by gel electrophoresis Both Suv4-20h1 (655 bp and Suv4-20h2 
(800 bp) were not found in oocyte or early implantation embryos, but were detected in 
blastocyst. Lane1 = immature oocyte, 2 = mature oocyte, 3 = zygote, 4 = two-cell 
embryo, 5 = four-cell embryo, 6 = eight-cell embryo, 7 = morula, 8 = preimplantation 
blastocyst, 9 = in vitro early postimplantation blastocyst (24 hours). Gapdh mRNA (458 








Figure 4.6 Immunofluorescence confocal microscopy images of in vitro 
implantation embryos. (A) H4K20me3 (red) was undetectable before implantation. 
(B) H4K20me3 was found at 48 hours post in vitro implantation in trophectoderm only 
(inside the oval). ICM was stained with anti-Oct4 antibody (green) and DNA was 
counterstained with DAPI (blue). The scale bar (red) represents 20 µm. 
 




Figure 4.7 Effect of culturing in vitro implantation embryos for 4 days. Embryos 
were immunostained for HP1α (green), H4K20me3 (red) and DNA was counter stained 
with DAPI (blue). (A) Embryos cultured with TS cell medium, shown inside the oval is 
preTS cell colony, and outside is trophoblast. (B) Embryos cultured in ES cell medium. 
Inside the oval is a preES cell colony, outside is trophoblast. The scale bar (red and 
yellow) represents 20 µm. 




Figure 4.8 Immunofluorescence confocal microscopy images of in vivo 
preimplantation (A) and postimplantation embryos (B). Embryos were 
immunostained for H4K20me3 (red), Oct4 (green) and DNA was counterstained with 
DAPI (blue). H4K20me3 was found in postimplantation embryos (E4.5) but not 
preimplantation embryos (E3.5). Only mural trophectoderm (TE) was positive for 
H4K0me3 but not ICM and polar TE. The scale bar (white) represents 20 µm. 
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Figure 4.9 H3K9me3, not H4K20me3 and HP1α, was found in early 
postimplantation embryos. Immunofluorescence and phase contrast images of in vivo 
postimplantation embryos (E6.5). (A) Embryo was double stained with anti-Oct4 
(green) and H4K20me3 (red) antibodies. Epiblast cells were positive for Oct4 but 
negative for H4K20me3. (B) Embryos were stained with anti-Oct4 (green) and anti-
H3K9me3 (red), the whole embryo was positive H3K9me3 while epiblast positive for 
Oct4. Exe=extraembryonic ectoderm. (C) Embryo was stained for HP1α and 
counterstained with DAPI (blue); embryos were negative for HP1α .The scale bar 
(white) represents 20 µm. 
 
 




Figure 4.10 Immunofluorescence images of postimplantation embryo (E8.5) from 
paraffin section. (A) H4K20me3 was detected only in maternal decidual cells and not 
in embryonic cells. (B) H3K9me3 (control antibody) was found both in maternal 
decidual cells and in embryonic cells. Green = antibodies (H4K20me3 or H3K9me3), 
Red = DAPI. The yellow arrow points to one of the heterochromatin foci positive for 
H4K20me3 which also colocalises with DAPI. The scale bar (white) represents 20 µm. 
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Figure 4.11 Heterochromatin marker H4K20me3 and HP1α was not detected in 
E8.5 embryos. E8.5 embryos were cryosectioned and stained with heterochromatin 
markers (green) H4K20me3 (A), H3K9me3 (B) and HP1α (C). Only H3K9me3 was 
detected. DNA was counterstained with DAPI (pseudo-coloured red). The scale bar 
(white) represents 20 µm. 




Figure 4.12 Immunofluorescence microscopy images of postimplantation embryos 
(cryosection of foetal liver tissue). E14.5 and E17.5 embryos are shown in left and 
right panels respectively. Green = H4K20me3, Red = DAPI. H4K20me3 positive cells 
increased from E14.5 to E17.5. The scale bar (white) represents 20 µm. 




Figure 4.13 Immunofluorescence images of postimplantation embryos (cryosection 
of foetal liver tissue). E14.5 and E17.5 embryos are shown in left and right panels 
respectively. Green fluorescent signal represents HP1α and red represents DAPI-DNA 
counterstaining. HP1α positive cells increased from E14.5 to E17.5. The scale bar 
(white) represents 20 µm. 
 




Figure 4.14 Western blots of postimplantation embryo extract SDS-PAGE. Protein 
was detected using antibodies against H4K20me3 and H4 (loading control) Lane 
number 1 = MEF first passage (P1); 2 = MEF eighth passage (P8); 3 = embryo E14.5; 4 
= placenta E14.5; 5 = embryo E17.5; 6 = placenta E17.5; 7 = MEF first passage (P1). 
 




Figure 4.15 Dynamics of H4K20me3 and HP1α in ES cells. ES cell line (E14tg2a) 
was immunostained using anti- H4K20me3 (red) and anti-HP1α (green) in ES cells. 
These images show the correlation between H4K20me3 and HP1α in ES cells. (A) 
Heterogeneous patterns of HP1α and H4K20me3 in ES cells. (B) Cells were classified 
into three types: Type I (left panel) diffuse HP1, weak or absent H4K20me3; Type II 
(middle panel) punctate HP1α but diffuse H4K20me3, and Type III (right panel) both 
HP1α and H4K20me3 were diffuse. Blue = DAPI, green = HP1α, Red = H4K20me3. 
The scale bar (red) represents 20 µm. 




Figure 4.16 Correlation between H4K20me3 and Oct4 of in vitro postimplantation 
embryo (14 days postimplantation). (A) Cells were immunostained using anti-Oct4 
antibody (green) and anti-H4K20me3 antibody (red). (B) Cells were counted based on 
the presence of fluorescence markers, green = Oct4; red = H4K20me3; yellow = Oct4 
and H4K20me3; and black = negative for Oct4 and H4K20me3. The scale bar (white) 
represents 20 µm.  
 




Figure 4.17 Correlation between H4K20me3 and Oct4of in vitro ES cell 
differentiation (14 day post-differentiation). (A) Cells were immunostained using anti-
Oct4 Oct4 (green) and anti-H4K20me3 (red). (B) Cells were counted based on the 
presence of fluorescence markers, green=Oct4, red=H4K20me3, yellow=Oct4 and 
H4K20me3, and black=negative for Oct4 and H4K20me3. The scale bar (white) 
represents 20 µm. 
 
 




Figure 4.18 Proteomic profile of epigenetic marker during ES cell differentiation 
(Day 7 post-differentiation). Western blot analysis was performed to detect changes in 
heterochromatin markers HP1α, HP1β, H3K9me3, H4K20me3, H4K20me1, H3K9me2, 
H3K27me3 in ES cells and embryoid bodies. Anti-H3, anti-H4 and anti-β-actin 
antibodies were used as loading controls. Pluripotent markers Oct4 and Nanog were 
used to analyse ES cell and embryoid bodies. After early differentiation, H3K9me3 
increases but H4K20me3 and HP1α are stable. H4K20me1, H3K27me3, and H3K9me3 
significantly decrease. Oct4 and Nanog dramatically decrease, confirming loss of 
pluripotency in differentiated cells. Loading control H3, H4 and β-actin are stable 
confirming equal loading of protein between lanes. 
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Figure 4.19 Heterogeneous populations of ES cells. Flow cytometry revealed ES cell 
heterogeneity after immunostaining with Oct4, HP1α and H4K20me3 antibodies. (A) 
ES cells were separated into two populations “a” (red) and “b” (green) by granularity 
(x-axis) and size population (y-axis). Images B-D, x-axis = fluorescent intensity, y-
axis=cell number. Two population (a=green and b=red) of ES cells was observed after 
staining with Oct4 (B), H4K20me3 (C) and HP1α (D). Population “a” (red) tended to 
have a higher signal of Oct4 (B) but lower signal of H4K20me3 (C) and HP1α (D) 
compare to population “b” (green). 
 




Figure 4.20 ES-like cells (noo01).Image of new ES-like cells (noo01) and their 
embryoid bodies. (A) The morphology of new ES-like cells were isolated from ICM of 
blastocyst and cultured with MEF-feeder cell. (B) ES-like cells were able to 
differentiate into embryoid bodies. Black arrows represent ES cell-like colonies and 
blue arrow shows a feeder cell (inactivated mouse embryonic fibroblast). The scale bar 
(black) represents 20 µm. 
 
 




Figure 4.21 Immunofluorescence microscopy images of ES cells. Established ES 
cells (E14tg2a) are shown in images A to C and ES-like cells (noo-01) are shown in 
images D to E. All cells were DNA counterstained with DAPI (blue), and pluripotency 
was confirmed using Oct4 and Nanog antibodies. (A) Cells were positive for 
H4K20me3 (red) and HP1α (green). (B-C) Pluripotency of E14tg2a cell line was 
confirmed using markers Oct4 (green) and Nanog (red). (D) noo-01 cells were 
positively stained for HP1α (green) and Nanog (red). (E) ES-like cells were positive for 
both Oct4 (green) and H4K20me3 (red). Both ES cells and ES-like cells show similar 








Figure 4.22 Western blot of ES cell cultured in medium contained serum compare 
with serum free medium. Expression of H4K20me3 and HP1α were not different in 
cells cultured in medium containing serum and serum replacement. ESK=ES cell 
cultured with medium contained Knockout serum replacement (serum free). ESQ=ES 
cell cultured medium contained with ES cell-Qualified foetal bovine serum. H3K9me1.  
 
 




Figure 4.23 Model for immature heterochromatin in early development. At the 
two-cell stage the only chromatin modifications present in embryos are DNA 
methylation, H4K20me1, H3K27me3, and HP1β, which may cause the onset of zygotic 
gene activation. In four-cell embryos, chromatin is further modified with H3K9me3 and 
H3K9me2. Heterochromatin matures postimplantation by enrichment of H4K20me3 
and HP1α. 
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Chapter 5 
Role of histone demethylases in mouse preimplantation 
development as epigenetic reprogramming modulators. 
 
5.1 Introduction 
Reprogramming of the parental epigenetic marks and chromatin organisation to an 
embryonic chromatin state is a critical event during preimplantation development (Reik, 
2007). At fertilisation in mammals, an asymmetry of parental epigenetic marks is set up; 
in which the paternal chromatin contains only few histone methylations while the 
maternal chromatin is packaged with histones that are fully modified (van der Heijden 
et al., 2005, van der Heijden et al., 2006, Santos et al., 2002, Santos et al., 2005, Adenot 
et al., 1997, Kim et al., 2003). Subsequently, active DNA demethylation is believed to 
occur only in the male chromatin of the zygote (Santos et al., 2002, Mayer et al., 2000, 
Yamazaki et al., 2007) and histone demethylation (H3K9 and H4K20) has been 
detected later at the two-cell stage (Kourmouli et al., 2004, Liu et al., 2004). The 
mechanisms of DNA and histone demethylation in the embryo still remain unknown. 
Epigenetic asymmetry and demethylation are believed to help reset adult chromatin to 
the embryonic state, which may lead to activation of zygotic gene expression (Minami 
et al., 2007). These ZGA genes are mainly repeat sequence related genes that are 
normally silenced by H3K9me3, H4K20me3 and DNA methylation (Martens et al., 
2005). 
Incomplete epigenetic reprogramming may cause developmental arrest as shown by 
many studies using nuclear transfer (Mann et al., 2003, Kang et al., 2001, Young et al., 
2001). Embryos reconstructed by nuclear transfer mainly fail at the two-cell stage (in 
mouse) and show abnormalities in the onset of zygotic gene activation (ZGA) (Inoue et 
al., 2006, Suzuki et al., 2006, Sebastiano et al., 2005). Epigenetic asymmetry of parental 
genomes is never occurs in cloned embryos (Merico et al., 2007, Yoshida et al., 2007) 
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which coincides with aberrant DNA methylation patterns (Shi and Haaf, 2002) and the 
remnants of the somatic form of chromocentre and histone methylation (Martin et al., 
2006a, Martin et al., 2006b, Merico et al., 2007). Moreover, incomplete epigenetic 
reprogramming may be related to developmental failure and abnormal development in 
embryos derived from assisted reproductive biotechnology such as in vitro embryo 
production and intracytoplasmic sperm injection (ICSI) (De Rycke et al., 2002, 
Wrenzycki et al., 2005). 
5.1.1 Histone demethylases 
Histone demethylases have only relatively recently been discovered (Whetstine et al., 
2006). There are two classes of enzymes which have been reported with histone lysine 
demethylase activity. The first class of enzyme is an amine oxidase homologue and 
LSD1 and LSD2 are the only enzymes which belong to this class (Karytinos et al., 
2009). LSD1 and 2 contain a flavin adenine dinucleotide (FAD)-dependent amine 
oxidase domain (Forneris et al., 2008, Marmorstein and Trievel, 2009, Culhane and 
Cole, 2007). These enzymes can convert H3K4me2 to H3K4me1, and H3K4me1 to 
unmethylated H3K4. However, LSD1 is unable to demethylated H3K4me3 (Forneris et 
al., 2008, Marmorstein and Trievel, 2009, Culhane and Cole, 2007). 
The second class contains the proteins which have Jumonji (JmjC)-domains. JMJC-
mediated demethylation requires multiple co-factors to act co-ordinately to hydroxylate 
the methyl group and demethylate mono-, di- or tri-methylation of H3K9, H3K36 and 
H3K27 (Nottke et al., 2009, Marmorstein and Trievel, 2009, Shin and Janknecht, 
2007b). The nomenclature of the demethylase enzymes found in mammals is 
summarised in Table 5.1.  
5.1.2 Objectives of the study 
Currently the role of histone demethylases in mouse development is poorly understood, 
and only two demethylase genes, Lsd1 and Jmjd1a have been studied in gene deletion 
experiments in mice (Wang et al., 2007, Okada et al., 2007). Some of these enzymes 
such as the Jmjd2 protein family may be responsible for histone demethylation 
postfertilisation, but there is no current evidence to support this. Furthermore, the 
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research information available for the Jmjd2 family has been limited. Several studies 
show that Jmjd2 genes have been related to cancer development (Vinatzer et al., 2008, 
Italiano et al., 2006), but only one recent publication has described Jmjd2c in mouse 
preimplantation  development (Wang et al., 2009). The specific aim of the this current 
study was to investigate the function of histone demethylase enzymes Jmjd1a, Jmjd2a 
and Jmjd2c in mouse preimplantation embryos using siRNA-mediated knock-down 
methodology. I hypothesise that Jmjd1a, Jmjd2a and Jmjd2c are essential for normal 
preimplantation development. 
Table 5.1 Summary of histone lysine (K) demethylase (KDM) nomenclature and substrate 









KDM1 KDM1 LSD1, AOF2, 
BHC1110 
H3K4me1/2 (Shi et al., 2004) 
KDM2 KDM2A JHDM1A, 
FBXL11 
H3K36me1/2/ 
 KDM2B JHDM1B, 
FBXL10 
 
(Yamane et al., 
2006, He et al., 
2008) 
KDM3 KDM3A JHDM2A, 
JMJD1A, TSGA 
H3K9me1/2 
 KDM3B JHDM2B, 
JMJD1B  
 
(Chen et al., 2006) 




 KDM4B JMJD2B  
 KDM4C JMJD2C, GASC1  
 KDM4D JMJD2D  
(Klose et al., 2006, 
Cloos et al., 2006) 
KDM5 KDM5A RBP2, JARID1A, H3K4me2/3 
 KDM5B PLU-1, JARID1B  
 KDM5C SMCX, JARID1C,  
 KDM5D SMCY, LARID1D  
(Klose et al., 2007, 
Scibetta et al., 
2007, Kim et al., 
2008, Akimoto et 
al., 2008) 
KDM6 KDM6A UTX H3K27me2/3 
 KDM6B JMJ3  
(Agger et al., 
2007) 
Role of histone demethylases in mouse preimplantation development Chapter 5 
 158
5.2 Materials and Methods 
Methods describing embryo collection, immunofluorescence and siRNA-mediated 
knock-down are described in Chapter 2 Materials and Methods. siRNA injections were 
repeated at least three times using more than 20 embryos per one injection time. 
Commercially validated Oct4-siRNA (Ambion) was used as a positive control, this 
siRNA has also been confirmed by Professor Wilmut’s lab to reduce Oct4 expression in 
embryos. 
5.2.1 Relative gene expression 
Quantitative analysis of relative gene expression and statistical differences were 
calculated using REST 2008 software (see Equation 1) (Pfaffl et al., 2002). Ct value and 
reaction efficiency were obtained from Rotor-gene 6000 software using comparative 
analysis. The REST software uses the Pair Wise Fixed Allocation Randomisation Test 
to calculate statistical value (Pfaffl et al., 2002, Horgan and Rouault, 2000). For 
comparison between control and treatment embryos (gene knock-down), multiple 
reference genes were used for normalisation between samples. Normalisation of gene 
expression was calculated using the geometric mean of multiple reference genes,  (see 
Equation 2) (Vandesompele et al., 2002, Pfaffl et al., 2002).  
R = (Etarget)Ctcontrol-Ctsample                             (Equation 1) 
                  (Eref)Ctcontrol-Ctsample                                   
R = gene expression ratio, Etarget = real-time PCR efficiency of target gene transcript; 
Eref = real-time PCR efficiency of reference gene transcript and Ct = cycle number 
5.2.2 Isolation of inner cell mass (ICM) and trophectoderm (TE) 
Trophectoderm (TE) cells were mechanically dissected with a mini-surgery blade 
(Swann Morton) while ICM was isolated using immunosurgery. The immunosurgery 
technique was slightly modified from the original report (Solter and Knowles, 1975). 
The zona pellucida was removed by incubation of blastocysts into acid tyrodes (Sigma). 
Zona free blastocysts were then incubated with rabbit anti-mouse antibody (Sigma, 
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1:100) for 30 minutes in 37 ºC incubator and then transferred to a drop of guinea pig 
complement to remove TE for 30 minutes in 37 ºC incubator. 
 
5.3 Results 
5.3.1 Validation of siRNA 
siRNAs used in this experiment were predesigned commercially. , Before embryo 
microinjection experiments were carried out the specificity of siRNA was tested in ES 
cells by transfection. The target gene expression was measured after 24 hours culture. 
The results showed that Jmjd2a, Jmjd2c and Jmjd1a siRNAs were specific and caused a 
significant reduction in targeted gene expression (Figure 5.1). 
5.3.1 Jmjd2c regulates cell fate during the morula to blastocyst transition 
 Jmjd2c is one of the most interesting demethylases and has been shown to be involved 
in carcinogenesis (Vinatzer et al., 2008), in the regulation of androgen receptor-
dependent gene expression (Wissmann et al., 2007) and in maintenance of pluripotency 
in stem cells (Loh et al., 2007). In ES cells, Jmjd2c prevents ES cell differentiation by 
inhibiting histone methylation (H3K9me3) at the Nanog promoter (Loh et al., 2007). In 
the present studies (see Chapter 3) Jmjd2c was found in maternal oocytes and its 
expression rapidly decreases after fertilisation. Zygotic gene expression of Jmjd2c was 
clearly evident at the four-cell stage (Figure 3.16 Chapter 3). Jmjd2c was preferentially 
expressed in ICM rather than TE cells  (Table 5.3).  
The effect of depleting Jmjd2c after injection of Jmjd2c-siRNA is shown in Table 5.2. 
The results revealed that approximately 24 % (24/100) of embryos arrested at the zygote 
stage, whilst most embryos arrested at morula (65 %; 65/100). The transition from 
morula to blastocyst was only 51 % (35/68), which is significantly lower than for 
control embryos (95% in non-injected group and 98% in the injected negative control 
siRNA embryos). The arrested embryos underwent degeneration during the next 24 
hours (Figure 5.2B and C) and the remaining embryos which progressed to blastocyst 
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stage seemed to be morphologically normal. Unlike the ES cell study by Loh et al 
(2007) which reported a decrease in Nanog expression after interruption of Jmjd2c 
gene, my QPCR results show that expression of Sox2 is reduced in morula  while Oct4 
and Nanog did not significantly change. However, expression of Cdx2 (a marker for 
TE) decreased. 
5.3.2 Jmjd2a is essential for very early development  
Apart from its demethylase function, Jmjd2a is known to activate the androgen receptor 
in prostate cancer (Shin and Janknecht, 2007a). The role of Jmjd2a in development has 
never been described. My studies reveal that Jmjd2a has two waves of gene expression; 
first at zygote to two-cell stage and later at eight-cell to blastocyst (Figure 3.16 chapter 
3). At blastocyst stage the expression of Jmjd2a in ICM was highly significant  relative 
to the TE (see Table 5.3). 
After Jmjd2a-siRNA injection (Table 5.2), 79 % (79/100) of zygotes developed to two-
cell embryo but most of these (65 %; 37/57) failed to reach the four-cell embryos stage 
(Figure 5.2A). The transition rate from four-cell to eight-cell was 50 % (10/20) compare 
to 100 % in control embryos (non-injection and negative control siRNA injection). Both 
control and siRNA-injected eight-cell embryos reached the morula, but only 40 % 
(4/10) of remaining siRNA-injected embryos developed to blastocyst. Overall, the 
developmental rate from zygote to blastocyst was very low at only 6 % (4/72) in 
Jmjd2a-depleted embryos compared to the control embryos in which 85-90 % 
developed to blastocyst.  
5.3.3 Jmjd1a is essential for early development and specific for the trophectoderm 
Recent studies indicate that Jmjd1a has an important role in nuclear hormone receptor-
mediated gene activation (Urbanucci et al., 2008), male germ cell development (Okada 
et al., 2007) and regulating metabolic gene expression and obesity resistance (Tateishi 
et al., 2009). Moreover, Jmjd1a demethylates H3K9Me2 at the promoter regions of 
Tcl1, Tcfcp2l1, and Zfp57 and positively regulates the expression of these pluripotency-
associated genes (Loh et al., 2007) 
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My studies (Figure 3.17in Chapter 3) revealed that Jmjd1a was not found in mature 
oocytes but gene expression occurs after fertilisation. However the expression level was 
significantly decreased from morula to blastocyst. Furthermore, the expression of 
Jmjd1a was specific to the TE as it was not found in the ICM (see Table 5.3). After 
Jmjd1a-siRNA injection (Table 5.2, Figure 5.3A) most embryos (67 %; 49/73) arrested 
at the two-cell stage. Embryo development rate from two-cell to four-cell was 53 % 
(26/49), four-cell to eight-cell was 30 % (8/26), eight-cell to morula was 87 % (7/8) and 
morula to blastocyst was 14 % (1/7). Overall the developmental rate from zygote to 
blastocyst was only 1 % (1/73).  
5.3.4 Preliminary studies of histone methylation in Jmjd1a and Jmjd2a deficient 
embryos 
In the present study, asymmetry of H3K9me2 and H3K9me3 was found in normal 
zygotes and at the two-cell stage ( 5 embryos for each marker) (see Chapter 3) which is 
similar to previously published studies (Santos et al., 2005, van der Heijden et al., 
2005). I hypothesised that Jmjd1a (H3K9me2 demethylase) or Jmjd2a (H3K9me3 
demethylase) may be involved in this process. Jmjd1a depleted embryos were stained 
H3K9me2 and Jmjd2a depleted embryos were stained for H3K9me3 and compare to 
normal embryos. Surprisingly, this pronuclear asymmetry of parental chromatin 
disappeared in either Jmjd1a or Jmjd2a deficient zygotes or two-cell embryos (Figure 
5.3-5.6). Consistent with this observation, semi-quantitative measurement showed that 
the fluorescence intensity between in female and male PN of zygotes seemed to be 
equal in Jmd1a/Kdm3a as well as Jmjd2a embryos. The intensity ratio (female/male) for 
H3K9me3 in the control zygote was 3.80 and higher than in Jmjd2a deficient zygotes 
(ratio=0.98). Similarly, the fluorescence intensity ratio in control embryos (2.50) was 
more than two times higher than in Jmjd1a depleted embryos (1.09). 
5.3.5 Zygotic gene expression in Jmjd1a and Jmjd2a deficient embryos 
The majority of Jmjd2a and Jmjd1a deficient embryos failed to develop after the two-
cell stage and four-cell stage. I hypothesised that removal of the repressive histone mark 
by Jmjd2 and Jmjd1 may help to activate some ZGA genes that are repressed by H3K9 
methylation, and interruption of demethylase may cause down regulation of ZGA. In 
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this experiment, the expression of three ZGA genes (Zcan4d, Elf1a, MuERV) were 
measured using QPCR which was normalised relative to three reference genes (Gapdh, 
Actin, Rpl1a). Relative gene expression levels are shown in Table 5.7 (Jmjd1a deficient 
embryos) and Table 5.9 (Jmjd2a deficient embryos). The raw data expression values for 
each gene before normalisation are shown in Table 5.6 and 5.8. The results showed that 
both Jmjd2a and Jmjd1a expression were reduced after each siRNA injection; Jmjd1a 
expression was reduced by 50% and Jmjd2a was undetectable. Among the three ZGA 
genes in the present studies, mRNA level of MuERV was decreased more than Elf and 
Zcan4d (Table 5.7 and 5.9). Expression of MuERV was reduced 47% in Jmjd2a 
deficient embryos and 12% in Jmjd1a deficient embryo compared to control.  
MuERV is a transposon related gene (Evsikov et al., 2004) which is normally silenced 
by H3K9me3, H4K20me3 or DNA methylation in somatic cells (Martens et al., 2005), 
but which expresses in zygotes and two-cell embryos (Kigami et al., 2003). Histone 
demethylase may help activate gene expression by removing or preventing methylation 
at gene promoter, and interruption of histone demethylase may lead to reduction of 
ZGA gene expression and subsequently, failure in preimplantation development as 
found in the present study. 
 
5.4 Discussion 
One important step for creating new life is the reprogramming of the parental epigenetic 
signatures and chromatin organisation by the maternal oocyte during preimplantation 
development. This process includes an asymmetry of parental epigenetic marks at the 
zygote and two-cell stage, the active DNA demethylation in the zygote and histone 
demethylation (H3K9 and H4K20) at the two-cell stage by unknown mechanisms. In 
the present study I discovered that the mechanism responsible for histone methylation 
asymmetry in the zygote and histone demethylation at the two-cell stage may involve 
histone demethylases Jmjd2a and Jmjd1a. Moreover, cell fate decisions during 
blastocyst formation could be regulated by demethylases Jmjd2c, Jmjd2a and Jmjd1a. 
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These results provide new insights into this area of early developmental biology and 
might be useful in improving success rates in assisted reproductive technology.  
5.4.1 Jmjd2 might control epigenetic asymmetry of parental genome 
Previous reports (van der Heijden et al., 2005, Santos et al., 2005) and my data show 
that H3K9me3 is strongly detected after fertilisation in female chromatin, whereas the 
signal from paternal chromatin is very weak or undetectable. This asymmetry between 
parental genomes has been suggested to be important for inducing ZGA from the 
paternal chromatin (Minami et al., 2007). The mechanism of epigenetic asymmetry may 
be simply explained by the lack of male chromatin modifications due to removal of 
histone proteins during spermatogenesis, while in the female all histone methylation 
remains during oogenesis (van der Heijden et al., 2005, van der Heijden et al., 2006). In 
contrast, my preliminary data shows that interruption of histone demethylase Jmjd2a 
could induce histone methylation in paternal chromatin to be equivalent to female 
chromatin. The majority of Jmjd1a and Jmjd2a-deficient embryos arrested at the zygote 
and two cell stage (Table 5.2). I propose that Jmjd2a may specifically prevent histone 
methylation at male chromatin, but Jmjd2a is possibly prevented access to female 
chromatin due to this chromatin already being occupied by heterochromatin markers 
H3K9me3 and H4K20me3. 
5.4.2 Histone demethylases and zygotic gene activation 
It is well established that ZGA genes mainly begin to be expressed in the two-cell 
embryo (Minami et al., 2007, Schultz, 2002). These genes mostly contain repetitive 
sequences (Evsikov et al., 2004), and gene activity is repressed by histone and/or DNA 
methylation in somatic cells (Martens et al., 2005). Notably, for three genes in my 
study, ZGA genes expression occurred simultaneously with global nuclear histone 
demethylation (H3K9me3, H3K9me2 and H4K20me3). The co-incidence between 
histone demethylation and ZGA was supported by the finding that Jmjd2a and Jmjd1a 
knock-down suggested a possible involvement in ZGA, and one of ZGA genes MuERV 
was affected after depletion of Jmjd2a. Hence, additional studies need to be performed 
to investigate whether histone demethylases Jmjd2a and Jmjd1a can affect other ZGA 
gene expression.  
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5.4.3 Histone demethylase is important for blastocyst formation 
The knock-down embryo experiments in this study demonstrated that three 
demethylases Jmjd2c, Jmjd2a and Jmjd1a are critical for blastocyst formation. 
Depletion of these individual genes caused significant failure of blastocyst formation. 
Both Jmjd2c and Jmjd2a were highly expressed in ICM while Jmjd1a was found in TE. 
These results may suggest that depletion of Jmjd2c or Jmjd2a genes may allow the 
development of embryos that cannot form an ICM proper, whereas Jmjd1a may cause 
TE formation. Both the present study and another recent report (Wang et al., 2009) 
showed that Jmjd2c depleted embryos fail to form blastocysts. The present studies also 
suggested that Jmjd2c may regulate the pluripotency gene Sox2 but not Oct4 and 
Nanog; however, this observation was different from recent study (Wang et al., 2009) 
which believed that Jmjd2c may control Oct4, Nanog and Sox2. 
5.4.4 Redundancy or functional difference of Jmjd1 and Jmjd2 family 
All Jmjd2 and Jmjd1 proteins have the ability to remove H3K9me3 and H3K9me2, but 
their non-demethylase function is still poorly known. The present studies showed that a 
temporal expression of Jmjd1a, Jmjd2a and Jmjd2c was found during early 
preimplantation development (Figure 3.17 and 3.18 in Chapter 3), which were 
comparable to published microarray data (Hamatani et al., 2004, Zeng et al., 2004). 
Using published microarray data (http://www.ncbi.nlm.nih.gov/geo/) (Hamatani et al., 
2004, Zeng et al., 2004) and results from in silico expression analysis (Katoh and 
Katoh, 2007) of mouse preimplantation embryos together with the result of the present 
studies, I was able to draw a hypothesis of temporal expression of Jmjd2 and Jmjd1 
family genes (Table 5.11). The temporal expressions of Jmjd2 genes suggest there may 
be a redundancy of these genes. 
In conclusion, histone demethylases Jmjd2a, Jmjd2c and Jmjd1a siRNA knock-down 
experiments showed that they were essential for preimplantation development. 
Specifically, Jmjd2c was vital for lineage specific (ICM and TE) and was required to 
form a blastocyst proper. Jmjd1a and Jmjd2a were very important for the transition 
from oocyte to embryo especially at two-cell and four-cell embryos. The developmental 
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failure of demethylase-deficient embryos might result from the loss of asymmetry in 
parental chromatin of the zygote and aberrant onset of zygotic gene expression.  
 
 













Zygote 66 (100, 100) 67 (100, 100) 100 (100, 100) 72 (100,100) 73 (100, 100) 
2-cell 61 (92, 92) 60 (90, 90) 76 (76, 76) 57 (79,79) 49 (67, 67) 
4-cell 61 (92, 100) 60 (90, 100) 72 (72, 95) 20 (28,35) 26 (36, 53) 
8-cell 61 (92, 100) 60 (90, 100) 71 (71, 99) 10 (14, 50) 8 (11, 30) 
Morula 61 (92, 100) 60 (90, 100) 68 (68, 96) 10 (14,100) 7 (10, 87) 
Blastocyst 60 (91, 98) 57 (85, 95) 35 (35, 51) 4 (6, 40) 1 (1, 14) 
%A= number of embryo each stage/number of zygote, %B=number of embryo each stage/number of 
embryo in previous stage (ex, 4-cell/2-cell), N=number of embryo. Grey highlight shows the stage that 
represents the majority of embryos 
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Table 5.3 Relative gene expression of ICM compared to TE  





Jmjd2a TRG 0.76 16.82 11.90 - 23.78 
Jmjd2c TRG 0.81 25.67 20.18 - 34.76 
Jmjd1a TRG 0.8125 0.00* # 
 
Table 5.4 Non-relative gene expression (no normalisation with reference genes) of ICM 
compared to TE  





Jmjd2a TRG 0.76 1.15 1.05 - 1.25 
Jmjd2c TRG 0.81 1.75 1.34 - 2.29 
Jmjd1a TRG 0.8125 0.00* # 
Rpl13a REF 0.8 0.21 0.19 - 0.23 
Actin REF 0.78 0.02 0.01 - 0.03 
ICM=inner cell mass, TE=Trophectoder,, TRG=Target gene, REF=Reference gene, CI=Confidential 
interval, SE=standard error, RE=reaction efficiency, * Gene expression is undetectable in the treatment, # 
Value can not be calculated. Expression ratio>1 = expression of ICM is higher than TE. Expression 
ratio<1= expression of ICM is lower than TE. 
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Table 5.5 Relative gene expression of Jmjd2c depletion embryos compared to control 
embryos. 





Jmjd2c TRG 0.76 0.00* # 
Oct4 TRG 0.69 0.99 0.67 - 1.37 
Nanog TRG 0.77 1.54 1.15 - 2.07 
Sox2 TRG 0.64 <0.01 0.00 - 0.00 
Cdx2 TRG 0.62 0.546 0.38 - 0.79 
Table 5.6 Non-relative gene expression (no normalisation with reference genes) of 
Jmjd2c depletion embryos compared to normal embryos. 





Jmjd2c TRG 0.76 0.00* # 
Oct4 TRG 0.69 0.54 0.36 - 0.85 
Nanog TRG 0.77 0.84 0.66 - 1.13 
Sox2 TRG 0.64 <0.01 0.00 - 0.00 
Cdx2 TRG 0.62 0.29 0.22 - 0.38 
Hprt1 REF 0.68 1.51 1.08 - 1.84 
Gapdh REF 0.62 0.19 0.13 - 0.29 
TRG=Target, gene, REF=Reference gene, CI=Confidential interval, SE=standard error, RE=reaction 
efficiency. * Gene expression is undetectable in the treatment, # Value can not be calculated. Expression 
ratio >1= increase in gene expression in treatment compare to control.  Expression ratio <1= decrease in 
gene expression in treatment compare to control.  
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Table 5.7 Relative gene expression in Jmjd1a deficient two-cell embryos compared 
with control 





Jmjd1a TRG 0.89 0.52 0.18-1.36 
Elf1a TRG 0.89 0.89 0.56-4.83 
Zcan4d TRG 0.93 0.93 0.09-2.50 
MuERV TRG 0.89 0.88 0.39-1.04 
Table 5.8 Non-relative gene expression in Jmjd1a deficient two-cell embryos compared 
with control 





Jmjd1a TRG 0.89 0.48 0.30 - 0.96 
Elf1a TRG 0.88 1.18 0.54 - 2.39 
Zcan4d TRG 0.93 0.46 0.18 - 0.90 
MuERV TRG 0.88 0.63 0.28 - 1.50 
Gapdh REF 0.74 0.74 0.31 - 1.28 
Actin REF 0.75 0.89 0.32 - 1.94 
Rpl1a REF 0.82 0.74 0.60 - 2.77 
TRG=Target, gene, REF=Reference gene, CI=Confidential interval, SE=standard error, RE=reaction 
efficiency,* Gene expression is undetectable in the treatment, # Value can not be calculated. Expression 
ratio >1= increase in gene expression in treatment compare to control.  Expression ratio <1= decrease in 
gene expression in treatment compare to control.  
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Table 5.9 Relative gene expression in Jmjd2a deficent two-cell embryos compared with 
control 





Jmjd2a TRG 0.86 0.00* # 
Elf1a TRG 0.90 1.32 0.776 - 3.098 
Zcan4d TRG 0.91 0.78 0.263 - 1.416 
MuERV TRG 0.86 0.53 0.330 - 0.764 
Table 5.10 Non-relative gene expression in Jmjd2a deficent two-cell embryos compare 
with control 





Jmjd2a TRG 0.86 0.00* # 
Elf1a TRG 0.90 0.71 0.354 - 1.232 
Zcan4d TRG 0.91 0.42 0.214 - 0.954 
MuERV TRG 0.86 0.28 0.123 - 0.772 
Gapdh REF 0.76 0.43 0.215 - 0.805 
Actin REF 0.77 0.58 0.287 - 1.043 
Rpl1a REF 0.81 0.62 0.430 - 0.788 
TRG=Target, gene, REF=Reference gene, CI=Confidential interval, SE=standard error, RE=reaction 
efficiency,* Gene expression is undetectable in the treatment, # Value can not be calculated. Expression 
ratio >1= increase in gene expression in treatment compare to control.  Expression ratio <1= decrease in 
gene expression in treatment compare to control.  
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Table 5.11 Estimated gene expression profile in early implantation embryo from 
microarray data and qPCR of the present study. 
Gene Oocyte Zygote 2-cell 4-cell 8-cell 
Jmjd2a + +++ ++ - + 
Jmjd2b ++ ++ ++ - + 
Jmjd2c +++ + + +++ +++ 
Jmjd2d ++ - - - - 
      
Jmjd1a - - ++ ++ +++ 
Jmj1b + + + +++ +++ 
Jmjd1c + + ++ ++ +++ 
-=absent, +=low expression, ++=moderate expression, +++=High expression 
















Figure 5.1 Validation siRNA by transfection into ES cells. ES cells were transfected 
with siRNA to examine gene expression of target gene Jmjd1a (A), Jmjd2a (B) and 
Jmjd2c (C). Control is ES cells that were incubated in transfection reagent without 
siRNA. 50 ng of cDNA was used for PCR. PCR Cycle number for Gapdh and Jmjd2c 
PCR were 28, Jmjd1a was 30 and 35 for Jmjd2a. 
 
Role of histone demethylases in mouse preimplantation development Chapter 5 
 172
 
Figure 5.2 In vitro development of siRNA-injected embryos. Brightfield microscopy images 
showing (A) After 3 days culture, Jmjd2a (middle) or Jmjd1a (right) depleted embryos 
developed more slowly than control embryo (RNAi negative), with some embryos arrested at 
three cell stage (red arrow). (B) After 4 days culture, control embryos reached the blastocyst 
stage whereas Oct4-injected embryos (Right) used as a positive control did not develop to 
blastocyst, similar to Jmjd2c-depleted embryo. (C) After 4 days culture, control embryos 
reached the expanded blastocyst stage while Jmjd2c- or Jmjd2a-depleted embryos degenerated 
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Figure 5.3 Loss of H3K9me2 asymmetry in Jmjd1a-deficient zygotes. Fluorescence 
microscopy images of zygotes stained with H3K9me2 antibodies (detected with 
fluorescent secondary antibody, green) and DNA was counterstained with DAPI 
(pseudo-coloured red). Control zygotes (non-injected) showed H3K9me2 pronuclear 
asymmetry of parental chromatin, in which H3K9me2 was highly enriched in the 
female pronucleus. By contrast, Jmjd1a-siRNA injected embryos lost this asymmetry 
and male and female pronuclear chromatin appeared to be equally stained. Female 
pronucleus (F) is smaller and closer to polar body than male pronucleus (M). The scale bar 
(red) is 20 µm. 
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Figure 5.4 Loss of H3K9me3 asymmetry in jmj2a-deficient zygotes. Zygotes were 
immunostained for H3K9me3 (green) and DNA was counterstained with DAPI 
(pseudo-coloured red). Control zygotes (non-injected) showed H3K9me3 pronuclear 
asymmetry of parental chromatin, in which H3K9me3 was highly enriched in the 
female pronucleus. By contrast, Jmjd2a-siRNA injected zygotes lost this asymmetry 
and male and female pronuclear chromatins appear to be equally stained. Female 
pronucleus (F) is smaller and closer to polar body than male pronucleus (M). The scale bar 
(red) is 20 µm. 
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Figure 5.5 Loss of H3K9me2 asymmetry in jmjd1a-deficient two-cell embryos. 
Embryos were immunostained for H3K9me2 (green) and DNA was counterstained with 
DAPI (pseudo-coloured red). Control embryos (non-injected) showed H3K9me2 
asymmetry of parental chromatin, in which H3K9me2 appeared to stain half of the 
nuclei (white arrow). By contrast, Jmjd1a-siRNA injected embryos lost this asymmetry 
and the whole nucleus seemed to have a uniform distribution of H3K9me2. The scale 
bar (red) is 20 µm. 
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Figure 5.6 Loss of H3K9me3 asymmetry in jmjd2a-deficient two-cell embryos. 
Embryos were immunostained for H3K9me3 (green) and DNA was counterstained with 
DAPI (pseudo-coloured red). Control embryos (non-injected) showed H3K9me3 
asymmetry of parental chromatin, in which H3K9me3 appeared to stain half of the 
nuclei (white arrow). By contrast, Jmjd2a-siRNA injected embryos lost this asymmetry 
and the whole nucleus seemed to have a uniform distribution of H3K9me3. The scale 
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Chapter 6 
General Discussions  
6.1 Overview and discussions 
Epigenetic and chromatin modifications are primary modulators of chromatin structure 
and nuclear organisation, which can control gene activities in unicellular organisms 
such as yeast, as well as in the developmental programme of multicellular organisms. 
Although all cells in one organism have the same genome, each cell type has a different 
and unique epigenome, which may be unique at individual cell nuclei. Different 
signatures of epigenetic modifications can create diversity in different cell phenotypes 
and may also stimulate cell differentiation and development. Under normal 
circumstances the epigenome differentiates in an irreversible manner except during 
preimplantation and germ cell development. In these phases, epigenetic and chromatin 
modifications are extensively reprogrammed. The present study has focussed on 
reprogramming of epigenetic and chromatin modifications during preimplantation, as 
well as describing significant epigenetic changes in the postimplantation embryo. In this 
chapter, the five main discoveries of this thesis are discussed: (i) the dynamics of 
heterochromatin markers in preimplantation embryos; (ii) heterochromatin maturation 
in postimplantation development and in ES cells; (iii) the function of H4K20me3 in 
development; (iv) global epigenome differences between ES cells and inner cell mass, 
and (v) the importance of demethylases in preimplantation development.  
6.1.1 The dynamics of heterochromatin markers in preimplantation embryos  
The dynamics of heterochromatin markers and other histone methylations are described 
in Chapters 3, 4 and 5. The summary of quantification of histone methylation in the 
present study and previous publications is shown in Figure 1.9. The data showed that 
demethylation of heterochromatin markers H3K9me2, H3K9me3 and H4K20me3 
occurs at the two-cell embryo stage and then de novo methylation takes place at the 
four-cell stage. H4K20me3 however, was absent during most of mouse development. 
The mark disappears from the maternal genome before fertilisation and does not 
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reappear in most tissues until well after mid-gestation. Intriguingly, demethylation of 
heterochromatin and zygotic gene activation occurred concurrently at the two-cell stage. 
Therefore I propose that the advantage of histone demethylation at the two-cell stage 
might be to remove heterochromatin marks leading to the transcription machinery 
activating ZGA satellite transcripts. These are derived mainly from repetitive elements 
in the pericentric/centromeric area and retrotransposons that are commonly silenced in 
somatic differentiated cells by heterochromatin marks (Martens et al., 2005, Peaston et 
al., 2007). This model does not exclude the contribution of CpG demethylation in ZGA, 
as demonstrate in early Xenopus laevis embryos (Dunican et al., 2008, Stancheva and 
Meehan, 2000) 
According to my evidence the mechanism of heterochromatin clearance of H3K9me2 
and H3K9me3 marks was related to either an imbalance of epigenetic modifiers or the 
presence of histone demethylases. Histone methyltransferase transcripts of early 
preimplantation embryos tend to be maternally inherited in oocytes and their mRNAs 
are degraded rapidly postfertilisation, whereas demethylase transcripts tend to be newly 
expressed postfertilisation. Hence the new expression of demethylases and degradation 
of methyltransferases has the potential for causing an imbalance of epigenetic 
modifiers. Additionally, the appearance of demethylase Jmjd2a and Jmjd1a in the 
embryo might be responsible for the removal of H3K9me2 and H3K9me3. I found that 
depletion of theses gene products causes a failure of zygotic pronuclear histone 
asymmetry and very early embryo development. Many Jmjd2a- and Jmjd1a-deficient 
embryos arrested at zygote and the two-cell stage suggesting that these two enzymes 
were essential for early preimplantation development and might be involved in 
epigenetic reprogramming after fertilisation. Unlike H3K9, the mechanism of 
H4K20me3 depletion might be a consequence of the lack HP1α and Suv4-20h 
methyltransferase to maintain and catalyse H4K20me3. A model for heterochromatin 
marker depletion is shown in Figure 6.1. 
6.1.2 Heterochromatin maturation in postimplantation development and in ES 
cells 
Heterochromatin maturation in mouse development was described in Chapters 3, 4 and 
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5. Heterochromatin in the preimplantation embryo was immature due to a lack of 
several chromatin modifications such as H4K20me2, H4K20me3 and HP1α. The 
immature heterochromatin in the preimplantation embryo probably lead to chromatin 
adopting a globally more open organisation, allowing transcriptional machinery access 
to chromatin and to reactivating embryonic genes that are generally repressed before 
fertilisation (Svoboda et al., 2004, Evsikov et al., 2004, Peaston et al., 2004, Ma et al., 
2001, Puschendorf et al., 2006). 
Initially, heterochromatin acquired mature epigenetic marks during early implantation 
and was limited to the trophectoderm lineage (about day 4.5) whereas maturation of the 
embryonic lineage began at a much later stage. Surprisingly, I demonstrated that the 
process of creating ES cells from ICM could induce heterochromatin maturation in 
vitro. H4K20me3 and HP1α appeared during the early passage of ES cells. Although 
undifferentiated ES cells have all heterochromatin markers, our results and others  
(Kobayakawa et al., 2007, Meshorer et al., 2006, Efroni et al., 2008, Martens et al., 
2005) have revealed that ES cell-heterochromatin is still highly dynamic, which may 
make ES cell chromatin more accessible for transcriptional complexes than 
differentiated cells.  
6.1.3 The function of H4K20me3 in development 
Collective results from the present and previous studies show that H4K20me3 might 
serve many functions. It is involved in silencing repeat sequences by 
heterochromatinisation at pericentric heterochromatin (Kourmouli et al., 2004, Schotta 
et al., 2004, Kourmouli et al., 2005, Martens et al., 2005) and at telomere and 
subtelomere regions (Blasco, 2007, Martens et al., 2005). It is related to progressive 
cancer both human and animals (Fraga et al., 2005, Pogribny et al., 2006). H4K20me3  
can also modulate telomere length and sister chromatid recombination (Benetti et al., 
2007), as well as combining with H3K9me3 and HP1 to regulate imprinted genes 
(Pannetier et al., 2008, Delaval et al., 2007, Regha et al., 2007). The present study and 
data presented by Schotta et al (2008) showed that H4K20me3 is important for 
pre/perinatal development. A reduction in H4K20me3 might lead to foetal mortality. 
There is evidence that H4K20me3 may be related to an ageing mechanism, as tissues 
General discussions   Chapter 6 
 181
from old rats gain more H4K20me3 than those from young rats (Sarg et al., 2002). 
Others have revealed that some human cell lines increase the level of H4K20me3 in late 
passage or senescent cells (Sarg et al., 2002, Shumaker et al., 2006). I found that 
H4K20me3 has an additional role as it appeared to be associated with cellular 
differentiation in vivo development, consistent with other observations in mouse (Biron 
et al., 2004) and Drosophila (Karachentsev et al., 2007). I also found that the greater 
proportion of H4K20me3 was observed in late development rather than early embryo 
development suggesting a role for H4K20me3 in tissue maturation; similar results have 
also been reported in rat brain development (Stadler et al., 2005). 
6.1.4 Global epigenetic different between ES cell and inner cell mass  
The difference between chromatin modification of ES cells and the inner cell mass 
(ICM) of embryos is detailed in Chapters 3, 4 and 5 and summarised in Figure 6.2. 
Typically, ES cells are derived from the inner cell mass of the blastocyst and are 
commonly used as a model for developmental biology based on the assumption that ES 
cells are functionally equivalent to their cell origin, the ICM. However transcription 
profiles of either human or mouse cells reveal a substantial difference between ICM 
compare to ES cells (Reijo Pera et al., 2009, Zwaka and Thomson, 2005, Horie et al., 
1991, Clark et al., 2004, Toyooka et al., 2003). In terms of epigenetic and chromatin 
modifications, our results clearly show that the ICM differs from ES cells with regards 
to the lack of H4K20me3 and HP1α to form mature heterochromatin. Chromatin 
modifiers histone demethylases also exhibited a divergence. Jmjd1a was specific to ES 
cells whereas Jmjd2a was expressed only in ICM. Surprisingly, we found that the 
transcriptional pathway was also different between ES cells and ICM. For instance, the 
demethylase and transcription factor Jmjd2c typically regulates Sox2 and Cdx2 in ICM, 
but it switched to regulate Nanog after ICM in vitro transformation to ES cells. In 
contrast to in vivo development, in which H4K20me3 was strongly associated with cell 
differentiation, H4K20me3 in ES cells seems not to be involved in differentiation. We 
found that H4K20me3 was already established in early passage ES cells and did not 
undergo a significant alteration after differentiation. This evidence suggests that the 
epigenetic and chromatin modifications regulating early differentiation in vivo 
development might differ from in vitro differentiation in ES cells. Based on the 
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epigenetic divergence of between ICM and ES cells, I would recommend that 
researchers should ensure that the relevant gene expression/pathways are similar 
between ES cells and ICM prior to using ES cell as a model for developmental biology. 
6.1.5 The importance of demethylases in preimplantation development 
Although histone methylation and histone methyltransferases were discovered about 30 
years ago (Honda et al., 1975, Spivak and Peck, 1979), histone demethylases have only 
recently been discovered (Shi et al., 2004, Chen et al., 2006, Agger et al., 2007). Apart 
from their demethylation function, not much is known about histone demethylases. 
Approximately 248 publications in several species have been found in PUBMED with 
approximately 200 publications related to mouse and human studies. However only one 
publication described the function of histone demethylase in preimplantation embryos 
(Wang et al., 2009) and other two reports expression of histone demethylase using 
microarray analysis (Hamatani et al., 2004, Zeng et al., 2004). Our present study 
confirms previous studies (Hamatani et al., 2004, Zeng et al., 2004, Wang et al., 2009) 
showing that many histone demethylases are present in preimplantation embryos and 
unfertilised oocytes. This could be linked to the importance of these genes for 
epigenetic and chromatin reprogramming postfertilisation and during preimplantation 
development. One recent study (Wang et al., 2009) and my data show that Jmjd2c are 
important for blastocyst formation, however, the gene expression profile of Jmjd2c 
during preimplantation appears to be variable (Hamatani et al., 2004, Zeng et al., 2004, 
Wang et al., 2009). This could be due to different breeds of mice and different culture 
systems. In the present study we show that Jmjd2a and Jmjd1a are important for early 
preimplantation development between zygote and 2-cell embryo stages, and that most 
Jmjd2a or Jmjd1a deficient embryos arrest at the two-cell stage. The failure to develop 
may result from the interruption of histone demethylation, the absence of parental 
pronuclear epigenetic asymmetry and subsequent aberrant expression of ZGA-repeat 
elements such as MuERV transcripts, which are normally silenced by H3K9 
methylation.  
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6.2. Conclusions  
This thesis demonstrates that epigenetic and heterochromatin markers are dynamic 
during development. Heterochromatin is immature postfertilisation and becomes more 
mature throughout development. The dynamics of epigenetic and heterochromatin may 
be regulated by the balance of their modifiers. Moreover we discover a novel function 
of histone demethylases during preimplantation development as they may be vital for 
development and epigenetic reprogramming postfertilisation. These results have 
emphasised gaps in our understanding of the basic mechanisms that allow the initiation 
of development from the fertilised zygote but have also contributed new clues. The new 
knowledge generated from this project will be beneficial to other epigenetic and cell 
reprogramming studies relevant to reproductive biology, stem cells, developmental 
biology and regenerative medicine. 
 
6.3 Directions for future research 
In addressing the research questions in this work, several interesting research topics 
have been observed. These open up several avenues for future work to further evaluate 
and expand the findings of this thesis: 
6.3.1 Chromatin modifications in development embryos 
In this study the dynamics of global chromatin modification have been investigated 
using immunofluorescence and microscopy methods. In preimplantation embryos I did 
not find the signal of H4K20me3, similar to other groups (Kourmouli et al., 2004, van 
der Heijden et al., 2005 and Beaujean, personal communication), however; it does not 
mean that there is no H4K20me3 present. It could be simply that the 
immunofluorescence epitope detected by anti-H4K20me3 may be completely masked 
by protein bound to this histone modification. In order to prove that I would need to 
extract embryonic proteins and analyse with western blot. In Drosohilla (Karachentsev 
et al., 2007), H4K20me3 is also not detected in early development using 
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immunofluorescence, however, H4K20me3 was detected by western blot specifically in 
free histone not in chromatin.  
Furthermore, in order to investigate this change at gene specific level, chromatin 
immunoprecipitation (ChIP) a common technique could be used to study chromatin 
modifications and protein-DNA interactions at gene level in many cell types. However, 
standard ChIP assays require large cell numbers which limit the capacity of ChIP to 
analyse small/expensive cell samples such as preimplantation embryos. Although 
recently modified ChIP protocols have been designed that work on very small samples 
(Dahl and Collas, 2008, O'Neill et al., 2006), there has been no report to assure that 
these protocols will work efficiently in very early mouse preimplantation embryos 
especially zygote and two-cell stage when chromatin is extensively reprogrammed. 
Further investigations on chromatin modifications at single gene level of 
postfertilisation embryo will be required. ZGA genes will be the first target to be 
examined as they express first and seem most important for very early development. 
6.3.2 Heterochromatin and pluripotency 
Although report of ES-like cells and inner cell mass lacking heterochromatin enzymes 
Suv3-9h or Suv4-20h have appeared in the literature (Benetti et al., 2007, Peters et al., 
2001), these cells have not been tested for pluripotency capacity. My studies and 
previous studies (Peters et al., 2001, Schotta et al., 2008) suggest that these enzymes 
may not be essential for in vivo pluripotency of ICM and epiblast cells; however, it is 
speculated that these cells may exhibit differentiation abnormalities due to terminally 
differentiated cells being unable form proper mature heterochromatin. To test this 
hypothesis, cellular markers for pluripotency and differentiation, and differentiation 
functional tests such as in vitro ES cell differentiations and teratoma test would be 
required. 
6.3.3 Functions of Histone demethylases in developments 
In the present study some but not all histone demethylases have been investigated 
regarding their expression and functions. The results suggest that some demethylases 
are essential for preimplantation development and their gene expression is dynamic. 
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However the mRNA levels in preimplantation embryos are frequently not related to the 
protein level, and many proteins remain in the embryo although their mRNAs are 
degraded to contribute to zygotic gene activation and proper development (Minami et 
al., 2007, Schultz, 1993). Moreover the diversity of demethylases genes (Shin and 
Janknecht, 2007) also suggests that they could have a functional redundancy role during 
preimplantation development. Further studies will need to investigate the complete 
proteomic profile, non-demethylation function and redundancy of histone demethylases 
during early embryonic development.  
6.3.4 Function of histone demethylases in cell reprogramming 
Cell reprogramming methodologies such as somatic cell nuclear transfer (SCNT) and 
induced pluripotent stem cells (iPSC) have been shown to reprogram somatic histone 
methylation into a totipotency- or pluripotency-like state (Wang et al., 2007, Mikkelsen 
et al., 2008). Recently, histone demethylase Jmjd3 has been suggested to be involved in 
the early step of iPSC (Banito et al., 2009) and a dynamic change of histone 
demethylases has been observed using microarray technology (Mikkelsen et al., 2008). 
Future studies will need to investigate the importance and the function of histone 
demethylases during cell reprogramming, as it may help to support reprogramming and 
may improve efficiency of reprogramming technology. 




Figure 6.1 Model for removal of heterochromatin markers (H3K9me2, H3K9me3, 
and H4K20me3). H3K9me2 and H3K9me3 is removed by Jmjd2a and Jmjd1a together 
with lack of Suv39h and Ehmt2. H4K20me3 was depleted due to deficiency of HP1α 
and Suv4-20h. 
 




Chromatin modification ICM (BL) ES cell 
H4K20me3 (Methylation) Absent High 
HP1α  (Protein) Absent High 
Jmjd2a (mRNA) High Very low 
Jmjd1a (mRNA) Very low High 
 
Figure 6.2 Summary of the differences between inner cell mass (ICM) and ES cells. 
Inner cell mass (ICM) of blastocyst expresses Jmjd2a and Jmjd2c but not Jmjd1a, HP1α 
or H4K20me3. After in vitro culture ICM transforms into ES cells when the makers 
H4K20me3, HP1α and Jmjd1a start to be expressed while Jmjd2a decreases. The gene 
regulation pathway is also different, Jmjd2c (which activates Sox2 and Cdx2 in vivo), 
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Detail of Chemicals and Reagents 
 
Name Companies Cat. no. 
Primary Antibodies   
Mouse anti-HP1α monoclonal antibody 
(Immunocytocheimistry) 
Millipore (Chemicon), UK MAB3584 
Mouse anti-HP1α monoclonal antibody 
(Western blot) 
Millipore (Chemicon), UK MAB3446 
Rabbit anti-nanog mouse affinity purified 
polyclonal antibody 
Millipore (Upstate), UK AB5731 
Mouse anti-Oct-3/4(POU5F1) 
monoclonal antibody 
Santa Cruz Biotechnology, 
USA 
sc-5279 
Mouse monoclonal anti-beta actin Abcam, UK ab8226 
Rabbit anti-trimethyl-histone H3 lysine 9 
polyclonal antibody 
Millipore (Upstate), UK 07-442 
Rabbit anti-dimethyl-histone H3 lysine 9 
polyclonal antibody 
Millipore (Upstate), UK 07-212 
 
Rabbit anti-monomethyl-histone H3 
lysine 9 polyclonal antibody 
Millipore (Upstate), UK 07-450 
Rabbit anti-trimethyl-histone H4 lysine 
20 polyclonal antibody 
Millipore (Upstate), UK 07-463 
Rabbit anti-dimethyl-histone H4 lysine 20 
polyclonal antibody 
Millipore (Upstate), UK 07-367 
Rabbit anti-monomethyl-histone H4 
lysine 20 polyclonal antibody 
Millipore (Upstate), UK 07-440 
Rabbit anti-trimethyl-histone H3 lysine 
27 polyclonal antibody 
Millipore (Upstate), UK 07-449 
Rabbit anti-trimethyl-histone H3 lysine 4 
polyclonal antibody 
Millipore (Upstate), UK 07-473 
Secondary antibodies   
Donkey anti-rabbit IgG phycoerythin 
conjugate (PE) 
Santa Cruz Biotechnology, 
USA 
sc-3745 
Donkey anti-mouse FITC Jackson Lab 715095151 
Donkey anti-rabbit FITC Jackson Lab 711095152 
Donkey anti-rabbit TRITC Jackson Lab 711075152 
Donkey anti-mouse Alexa Fluor 488 Molecular probe, 
Invitrogen, UK 
A21202 
Donkey anti-rabbit Alexa Fluor 488 Molecular probe, 
Invitrogen, UK 
A21206 
Donkey anti-mouse Alexa Fluor 546 Molecular probe, 
Invitrogen, UK 
A10036 
Donkey anti-mouse HRP Santa Cruz Biotechnology, 
USA 
Sc2005 
Donkey anti-rabbit HRP Amersham, UK NA934V 
Serum & BSA   
Donkey serum Sigma, UK.  D9663 
Chicken serum 
 





Foetal Bovine Serum Gibco, Invitrogen, UK  
Foetal Bovine Serum ES cell qualify Gibco, Invitrogen, UK 10439-016 
Bovine Serum Albumin 
(immunodetection) 
Sigma, UK. A6003 
Bovine Serum Albumin (embryo culture) Sigma, UK. A331-10G 
DNA stain and mounting reagents Companies Cat. no. 
Hoechst33342 Sigma, UK. B2261 
Vectashield® mounting medium with 
DAPI 
Vector Lab H-1200 
 
Vectashield® mounting medium Vector Lab H-1000 
 





Western Blot   
4-12% gradient Bis-tris-Gel 12 lane Invitrogen, UK NP0322BOX 
4-12% gradient Bis-tris-Gel 15 lane Invitrogen, UK NP0323BOX 
4-12% gradient Bis-tris-Gel 17 lane Invitrogen, UK NP0329BOX 
NuPage® LDS sample buffer Invitrogen, UK NP0007 
NuPage® Reducing agent Invitrogen, UK NP0009 
Xcell Surelock™ Mini-Cell Invitrogen, UK EI0001 
NuPage® MES SDS running buffer Invitrogen, UK NP0002 
NuPage® antioxidant Invitrogen, UK NP0005 
Xcell II™ Blot module Invitrogen, UK EI9051 
PVDF membrane Amersham, UK RPN303F 
X-ray film Fuji Fisher Scitific, UK AUT-300-010M 
NuPage Transfer buffer Invitrogen, UK NP0006 
Dc Protien assay reagent A BioRad, UK 500-0113 
Dc Protien assay reagent S BioRad, UK 500-0115 
Dc Protien assay reagent B BioRad, UK 500-0114 
PCR   
RNA later, Ambion, UK Ambion, UK 7020 
RNeasy mini kit Qiagen, UK 74104 
QIA shredder Qiagen, UK 79254 
DNaseI Qiagen, UK 79254 
Pellet Paint®, Co-precipitation Novagen, UK. 70748-3 
Verso™ cDNA Kit ABgene,UK AB1453 
Cloned AMV first strand synthesis kit Invitrogen, UK 12328-032 
0.5 ml PCR tube  ABgene,UK AB0350 
0.2 ml QPCR tube Corbett life science, UK P/N3001-001 
ABsolute™ Blue QPCR low ROX Mix ABgene,UK AB4323/A 
Rotor-GeneTM 6000 Corbett life science, UK  
Hybaid system, Thermo Thermo Fisher, UK  
DNA ladder New England Biolab, UK N04675 
SYBR gold Molecular probe, 
Invitrogen, UK 
S11494 
Hormones, growth factors and 
enzymes 
Companies Cat. no. 
Pregnant mare serum gonadotrophin Intervet, UK  
Human chorionic ganadotrophin Intervet, UK  
Follicular stimulating factor Sigma, UK F8174 
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2.5% Trypsin (10x) Lonza, UK BE17-160E 
Epithelium growth factor Sigma, UK  
Hyaluronidase Sigma, UK H4272 
Leukemia inhibiting factor (ESGRO®) Chemicon, Millipore, ESG1106 
Trypsin tablet (antigen retrieval) Sigma, UK T7168-20TAB 
Fetuin Sigma, UK F6131 
Media   
KSOM culture medium Chemicon, Millipore MR-020P-5F 
M2 medium Sigma, UK M7167 
αMEM Invitrogen, UK M8042 
DMEM high gluocose with L-glutamine Gibco, Invitrogen, UK 41966-029 
Knockout™ DMEM Gibco, Invitrogen, UK 10829-018 
Opti MEM Gibco, Invitrogen, UK 31985 
MEM Non essential amino acids Gibco, Invitrogen, UK 11140 
L-glutamine Invitrogen, UK 25030-024 
Penicillin/streptomycin Sigma, UK P4333 
PBS (liqiud) Lonza, UK BE17-512F 
PBS tablet Gibco, Invitrogen, UK 18912-014 
2-mercaptoethanol Invitrogen, UK 31350010 
Ultrapure water for embryo culture Chemicon, Millipore TMS-006-B 
Cell culture water Lonza, UK BE17-724Q 
Chemicals   
Paraformaldehyde Sigma, UK P6148 
Tween 20 Fisher Scientific BP337-100 
Triton X 100 Sigma, UK X-100 
Acid tyrode Sigma, UK T1788 
HEPES (pH7.9) Sigma, UK H3375 
MgCl2 BDH Lab, UK 101494V 
KCl BDH Lab, UK 1019874L 
DDT 443853B  
PMSF Sigma, UK P7626 
Tris HCl pH8 Promega, UKH5125 H5125 
Tris base Fisher Scitific BPE152-1 
Boric acid Fisher Scitific BPE168-1 
EDTA Sigma, UK EDS-500G 
Proteinase cocktail inhibitor Roeach, UK 11836170001 
Agarose Fisher Scitific BPE1356-500 
Lipofectamine 2000 Invitrogen, UK 11668-019  
Mitomycin C Sigma, UK M4287-2MG 
Mitomycin C Calbiochem, UK 47589 
HCl BDH Lab, UK 101256J 
siRNA Companies Cat. no. 
Jmjd2c Invitrogen, UK 10620318 
ID124473A12 
ID124473B01 
Oct4 Ambion, UK AM16704 
ID151960 





Suv39h2 Invitrogen, UK 10620318 
ID119928E11 
ID119928E12 
Silencer® Negative Control #1 Ambion, UK AM4635 
StealthTM RNAi negative control duplex Invitrogen, UK 12935300 
Block-itTM alexa Fluor® Red Fluorescent 
Oligo 
Invitrogen, UK 14750-100 
Others   
Multiwell slide Menzel GmBH, VWR XER308B 
Chamber slide Nunc, VWR 7342050 
Cell culture dish 100x20mm  Corning, MVM store 430167 
Cell culture dish 60x15mm Falcon, MVM store 353004 
Cell culture dish 35x10mm Falcon, MVM store 353001 
4 well dish Nunc, VWR 176740 
50 ml centrifuge tube Corning, MVM store 430828 
15 ml centrifuge tube Corning, MVM store 430790 
1.5 ml centrifuge tube Greiner, MVM store 616201 
2 ml centrifuge tube Eppendorf, UK 120094 
1.8 ml cryotube Nunc, MVM store 65234 
1.5 ml amber tubes (light protect) Anachem. VWR 1220-07 







1. NIH Image J (free) http://rsbweb.nih.gov/ij/ 
2. WCIF Image J (free) http://www.uhnresearch.ca/facilities/wcif/imagej/ 
3. MacBiophotonics ImageJ (free) http://www.macbiophotonics.ca/imagej/ 
4. LSM browser (free version), Zeiss. 
http://www.zeiss.de/C12567BE0045ACF1/Contents-
Frame/CAA2EF638EC5F0D3C1256ADF0050E2F1 
5. Velocity (free version), Improvision, UK http://www.improvision.com/downloads/ 





Recipes of Buffer Media and Stock solutions 
 
Mitomycin C Stock solution 
Mitomycin C is a carcinogen. It may be fatal by inhalation, ingestion, or skin 
absorption. Do not breathe the dust. Wear appropriate gloves and safety goggles and use 
only in a chemical fume hood.  
Add 5 ml of sterile PBS to a 2-mg vial of mitomycin C.  
This stock solution should be stored at 4oC, wrapped in aluminum foil, for no more than 
2 weeks. It is diluted in MEF growth medium to a final concentration of 10 µg/ml to 
prepare MEF feeders. 
 
10x TBE (Tris-Boric-EDTA) stock 
Makes 1 litre 
• Tris  108g 
• Boric Acid 55g 
• EDTA  9.3g 
• dH2O  800ml 
 
• Stir to mix, check the pH it should be at 8.3, and adjust if necessary. 
• Make volume up to 1L with dH2O. 
• Autoclave. 
 
Gelatine for extracellular matrix 
• Prepare 0.1% gelatine in water for by mix 1 g of gelatine (Sigma cat#G1890) in 
1000 ml H2O cell culture (Lonza cat# BE17-724Q). 
• Put mixture into microwave until gelatine dissolve (Do not lid or close the 
bottle) 
 
Fibroblast cell medium 
• DMEM  89 ml 
• FFBS  10 ml 
• Pen/Strep 1 ml 









Mouse embryonic stem cell medium 
 
Volume  volume  Reagent company Cat# Storage
ºC 500 ml 100 ml 
Final 
conc 
1 L-glutamine Invitrogen 25030 -20  











4 1000 ul 200 ul 0.1mM 
3 MEM nonesseantial 
amino acid (NEAA) 
Invitrogen 11140-
035 
4 6 ml 1.2 ml 0.1mM 
4 Penicilluin/steptomycin Invitrogen 15140-
122 
-20 5 ml 1 ml  
5 Leukemia inhibiting 
factor (LIF) 
Chemicon ESG1106 4 500 ul 100 ul 1000 
IU/ml 
 OR LIF (in house) Dundee  4 or -20 50 ul 10 ul  





 OR FBS (ES qualified) Invitrogen 10439-
016 
-20 





















• 5 ml stock trypsin (10x) (Lonza) 
• 5 ml chicken serum 
• 100 ml EDTA Na salt (1.85 g/l) autoclaved 
• 390 ml PBS  
 
0.25% Trypsin 
• 10 ml trypsin 
• 5 ml chicken serum 
• 100 ml EDTA 
• 385 ml PBS 
 
• Solution was filtered with 0.2µm and then stored at -80 ºC 
• After thawing, trypsin can kept in fridge (4 ºC) for a month 
 
Phosphate Buffered Saline (PBS) 
• Add 1 PBS tablet (Invitrogen) per 400 ml distilled water and allow dissolving in 
a glass bottle.   




Histone extraction Buffer 
 
Components MW Stock 10 ml solution Note 
10mMHEPES, 
pH7.8 
11.915 100mM 1 mL  
1.5mM MgCl2 4.761 100mM 150 uL Add powder 
into water, 
do not add 
water onto 
powder 
10mM KCl  1mM 100 uL  
MQ water   8..75 mL  
     
1.5mM PMSF  100mM in 
ethanol, keep 
dark 








Lysis buffer   93.5 ul  
 
Paraformaldehyde (PFA) 20 % stock solution  
• Weigh 4 g PFA (Sigma) into glass bottle and add 16 ml PBS.  Add 2 drops of 
1M sodium hydroxide (NaOH) using P20 Gilson pipette.   
• Heat to 65°C until dissolved in a water bath and allow cooling. pH, should be 
7.0-7.4, add more 1M NaOH if necessary. 
• Filter into universal tube and cover with foil.  Store at 4°C for up to 1 month or 
store at -20°C in aliquots.   
• Dilute to working concentration of 4 % (1:5) with PBS  
 
Triton X-100 10 % stock solution 
• Weigh 1 g Triton X-100 (Sigma) into universal tube and add 9 ml PBS.  
• Place tube on a rotating platform to mix thoroughly (takes 1-2 hours) 
• Store 10 % stock at 4°C for 2 weeks 






Tween 20 (5 % stock solution) 
• Add 2.5 ml of Tween 20  to 47.5 ml PBS 
• Place tube on a rotating platform to mix thoroughly 
• Store 5 % stock at 4°C for up to 1 month 
• Dilute to working concentration of 0.05 % (1:100) with PBS 
 
Blocking Solutions  
• 2 % Bovine Serum Albumin (BSA) in PBS: Add 200 mg BSA (Sigma) to 10 
ml PBS.  Allow to dissolve and filter through 0.22 µm filter.  
• 5% donkey serum. Add 250 µl serum in 5 ml PBS and filter through 0.22 µm 
filter. 
 
Cryopreservation medium (2x) (10 ml) 
fibroblast cell 
• DMEM 6.9 ml 
• FCS  3 ml  
• DMSO 2 ml 
• Pen/Strep 100 µl 
 
ES cell 
• DMEM 3.4 ml 
• FCS  4.5 ml  
• DMSO 2 ml 
• Pen/Strep 100 µl 
 
RIPA buffer (Radioimmunoprecipitation assay) 
• 50mM Tris HCl pH 8 
• 150 mM NaCl 
• 1% NP-40 
• 0.5% Sodium deoxycholate 
• 0.1% SDS 
• 2 mM EDTA pH7.4 
 
